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Abstract
Since the discovery of the CFTR gene over a decade ago, Cystic Fibrosis (CF) has
been regarded as amenable to intervention by gene therapy. The ultimate aim of gene
therapy must be the correction, within cells capable of repopulating the tissue, of the
genetic defect in its chromosomal context. Towards that end, a mouse model
designed to evaluate the efficiency of gene correction was created, and a transgenic
approach was taken to the investigation of a putative progenitor cell population in the
adult murine respiratory tract.
Before gene correction systems can be considered as valid therapeutic agents, their
utility in the cells and tissues of living animals must be demonstrated. Thus, an in
vivo system permitting the simple quantification of correction frequency in a wide
range of tissues would be a valuable resource for the gene correction community.
The generation and analysis of a transgenic mouse carrying an inactivated, but
potentially correctable, reporter transgene is described.
The full potential of a gene correction strategy to provide a single-dose, permanent
solution to a genetically-diseased tissue will only be realised once the therapy is able
to target resident stem cells. For CF lung disease, this will require the prior
identification of stem cells in the respiratory epithelium. Previous work has indicated
that potential stem cells are spatially coincident with small groups of cells expressing
high levels of keratin 5 (K5) protein in the proximal murine trachea. In order to
investigate lineage arising from this putative stem cell niche, transgenic mice have
been generated which express an inducible form of Cre recombinase from the K5
promoter. Preliminary experiments demonstrate recombination of a conditional
reporter gene after induction of Cre activity in K5-expressing tissue. Comparison of
the inducible system with a constitutive K5 promoter-driven Cre line validated the
choice of the former, as the clarity of data obtained from the conventional system
was undermined as a result of K5 promoter activity causing reporter gene activation
prior to the onset of the experiment.
In the course of these studies it became evident that the conventional, constitutive
Cre line gave rise to segregating patterns of reporter gene activation. While some
mice displayed the expected K5-derived expression profile, other animals
demonstrated ubiquitous expression. Universal activation of the conditional reporter
was detected only in animals derived from females carrying the Cre transgene, and
was found to be the result of unanticipated production of Cre protein in the maternal
germline. This transgenic line is unusual and valuable in offering a choice of tissue-
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Throughout this thesis, transgenic mice are referred to after the name of the
transgene carried. For example, mice carrying the K5CE transgene are known as
K5CE mice. Individual transgenic lines are referred to by the transgene name
suffixed with a number, for example K5CE100 and K5CE200. This may be
abbreviated to K5CE100,200.
For clarity in experiments involving compound transgenic and mono-transgenic
mice, the suffixes "tg" and "wt" are used to signify transgene-positive and transgene-
negative, respectively. For example, a K5CE'S R26R'8 mouse carries both K5CE and
R26R transgenes, whereas a K5CEtg R26Rwt mouse harbours only the K5CE
transgene. Where appropriate, this nomenclature also signifies transgene





1.1 Why is it important to identify airway epithelial
stem cells?
Contrary to the situation in certain tissues, progenitor-progeny relationships and
patterns of cell lineage have not been definitively established within the mammalian
respiratory epithelium. Other than out of fundamental biological interest, there are
several clinical justifications for efforts aimed at elucidating airway epithelial
lineages and the identification of multipotent progenitor cells.
The airway epithelium is highly labile in its cellular composition and function, and
deviations from the steady-state likely contribute to the deterioration in lung function
of patients with chronic airway diseases such as asthma, bronchitis and cystic fibrosis
(CF). Alterations in the composition of the surface epithelium can reflect ongoing
cycles of injury and repair, or may result from atypical differentiation profiles
amongst epithelial cell types in response to aberrant cell signalling. An
understanding of epithelial cell lineage relationships is a prerequisite to potentially
intervening in disease processes. For example, it is possible that a "failure" of stem
cells may underlie the loss of epithelium in airway allografts characteristic of
bronchiolitis obliterans (Neuringer et al., 2002; Schoch et al., 2003), the single
greatest cause of morbidity and mortality following lung transplantation (Hertz et al.,
2002). Gaining an insight into this process might suggest approaches to improving
patient outcome. Also, adult stem cells have been implicated in carcinogenesis, with
malignant transformation often preceded by progressive phenotypic changes (Trosko,
2003). An appreciation of the location and characteristics of stem cells in the
respiratory epithelium would benefit efforts to understand the mechanisms involved,
to potentially therapeutic ends.
Of most relevance within the context of this thesis, stem cells of the respiratory
epithelium would be the ideal cellular targets of gene therapy for airway diseases
such as CF, which has been the longstanding interest of the research group in which
this work was undertaken. Complementation or correction of a genetic defect within
2
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airway progenitors should be transmitted to their differentiated progeny, potentially
allowing a permanent, single-dose gene therapy to be realised.
1.2 Stem cell theory
1.2.1 Adult tissue-specific stem cells
Although the concept of a stem cell has begun to evolve in recent years, the existence
of tissue-specific adult stem cells active in both homeostatic maintenance and injury-
induced regeneration of their host tissue, is well established (Blau et al., 2001).
While useful molecular markers have been identified for the resident stem cells in a
minority of tissues, such as keratin (K) 15 for human hair follicle stem cells (Lyle et
al., 1998), and stem cell enrichment is possible using the side population (SP)
protocol in several tissues (Goodell et al., 1997; Gussoni et al., 1999; Dunnwald et
al., 2001), no universal molecular identifier for stem cells has been discovered
(Ivanova et al., 2002; Ramalho-Santos et al., 2002; Fortunel et al., 2003). As such,
stem cells can only truly be defined by their future potential, that is, the number and
nature of their cellular progeny. Inherent in this concept is that the functional
capabilities of a cell must be tested before it can be considered a stem cell.
Analogous to the uncertainty principle in physics, the experimental manipulation
required to evaluate the function of a cell may alter its properties. Nevertheless,
criteria have been proposed which, to greater or lesser degrees, candidate stem cells
should fulfil. In addition to lacking markers of differentiation, they should be:
capable of proliferation; able to self-maintain; able to produce a large number of
differentiated, functional progeny; able to regenerate the tissue after injury, and able
to exercise a flexible control over these attributes (Potten and Loeffler, 1990). Cells
or populations of cells fulfilling all of these criteria at a given instance comprise the
"actual stem cells", while others harbouring such latent capabilities, for example the
non-dividing stem cells of quiescent tissues, are considered "potential stem cells"
(Potten and Loeffler, 1990).
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If proliferation and differentiation are considered independent characteristics, then
the cells of self-renewing tissues such as epithelia can be perceived as existing at
varying positions on an axis where proliferative capacity is inversely proportional to
the degree of differentiation (Potten and Loeffler, 1990) (Figure 1.1). At one extreme
lie the undifferentiated stem cells with an apparently infinite capacity for
proliferation and self-renewal, while at the opposite extent exist the functionally
mature end point cells, exhibiting little or no proliferative potential. The latter
population are known as terminally differentiated (TD) cells. Situated between the
stem and TD compartments are the transit amplifying (TA) cells, exhibiting
properties intermediate to those of the stem cells and TD cells: while TA cells are
developmentally committed and normally show the onset of differentiation marker
expression, they retain a significant but finite proliferative capability, and are likely
capable of limited self-renewal. Thus the key difference between stem cells and early
TA cells is the former's ability for unlimited self-renewal. The TA compartment can
therefore be considered to represent a spectrum of declining stem cell properties,
with early TA cells (or "progenitors") possibly representing potential stem cells
capable of re-occupying a vacant stem cell compartment (Loeffler and Potten, 1997).
However under normal circumstances, the TA cell population exists essentially to
amplify the number of output functional cells generated from a low number of input
stem cells, thereby permitting a smaller stem cell pool and a reduced target for
genetic and carcinogenic damage. Most of the proliferation occurring in a steady-
state tissue is performed by TA cells, while the stem cells cycle slowly. This affords
the stem cell population a measure of protection from the accumulation of genetic
errors which result from high levels of DNA replication and mitosis.
There are two general strategies by which a stem cell can both self-maintain, and
give rise to daughter cells committed to terminal differentiation. One mechanism is
invariant and results in the predetermined asymmetric production of one stem cell
and one destined-to-differentiate daughter cell (Figure 1.2a). There are numerous
examples of such lineages in unicellular organisms and invertebrates. In the
Drosophila peripheral nervous system, asymmetric divisions of the sensory organ









Figure 1.1 Stem (S), transit amplifying (TA), and terminally differentiated (TD) cells can be considered
to reside on independent axes of proliferation capacity and differentiation.
The dashed arrow represents finite self-renewal capability amongst TA cells.
stem ceil
niche cell
Figure 1.2 The generation of differentiated daughter cells from stem cells can occur by invariant or
regulative mechanisms (modified from Watt and Hogan, 2000).
(a) Invariant asymmetry. A stem cell (S) gives rise to another stem cell and a non-stem "progenitor" (P)
daughter which differentiates in response to extrinsic signals (thick green arrows). The stem cell state
is regulated by reciprocal interactions with niche cells (thick blue and red arrows). The concept of the
stem cell niche is discussed in section 1.2.2. (b) Regulative (populational) asymmetry. In response to
tissue demand, stem cells can undergo symmetric division, to produce only stem cells (top) or only
progenitor cells (middle), or asymmetric division (bottom). Daughter cells differentiate along different
pathways (1, 2 and 3) depending on the combination of extrinsic factors to which they are exposed. ECM
= extracellular matrix.
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asymmetric localisation of cell fate determinants and influence the orientation of
mitotic spindles such that, following cell division, the two daughter cells occupy
specific positions which likely dictate their exposure to different extracellular signals
(Jan and Jan, 1998). In strictly asymmetric stem cell lineages, no regulation of stem
cell number is possible (Morrison et al., 1997), yet there is ample evidence for
changes in the size of stem cell populations in mammals, for example the
amplification of foetal primordial germ cells during their migration into the genital
ridge (Tarn and Snow, 1981). This is consistent with the view that most mammalian
self-renewing tissues are produced through highly regulative mechanisms in which a
stem cell gives rise to daughter cells capable of becoming either stem cells or
committed progenitors (Watt and Hogan, 2000) (Figure 1.2b). In such systems,
steady-state stem cell divisions give rise to, on average, one stem cell and one
committed cell, with asymmetry achieved on a population level through symmetric
stem cell divisions. Populational asymmetry facilitates the response to variable
physiological needs, such as regeneration following injury, and can be mediated by
stochastic events, heterogeneity amongst the stem cell population, and environmental
regulation through intercellular and extracellular signalling (Hall and Watt, 1989).
1.2.2 The stem cell niche
The intrinsic cell-autonomous regulators of stem cell fate, including proteins
responsible for establishing asymmetric cell divisions, nuclear factors controlling
gene expression and chromosomal modifications, and timing mechanisms which
"count" cell divisions prior to differentiation, are modulated by external signals.
These extrinsic regulators of stem cell behaviour, including secreted factors, direct
cell-cell interactions, and adhesion to the extracellular matrix (Watt and Hogan,
2000), comprise a microenvironment which is often defined by a discrete physical
location within a tissue. Indeed, it has been speculated that since many of the
specialised functions required to ensure proper stem cell function are manifest in
neighbouring differentiated cells, stem cells themselves may be relatively
unspecialised, and may be characterised more by their localisation within physically
defined compartments rather than distinctive patterns of gene expression (Spradling
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et al., 2001). Units comprising a subset of tissue cells and extracellular substrates and
signals, which create a distinct microenvironment able to house and regulate stem
cells, are known as niches. While the location of the niche remains obscure in most
stem cells systems, it is believed to have been identified in several tissues including
the epidermis (hair follicle bulge) (Taylor et al., 2000), gut (crypt) (Booth and
Potten, 2000), and the blood (osteoblasts within the bone marrow) (Calvi et al.,
2003).
The mode of stem cell regulation, asymmetric or symmetric, within a given tissue
system can be considered to be a consequence of interactions between the stem cells
and extracellular niche components. In asymmetric stem cell systems, so-called
"lineage niches" specify precisely individual stem cell divisions and daughter cell
fates (Spradling et al., 2001). This might occur through contact of the stem cell with
the underlying stroma: by appropriately orientating its division plane, the stem cell
can ensure that only one daughter inherits adhesive contacts with the basement
membrane (Figure 1.3). While this daughter will be retained in the niche, the other
daughter is free to move away from the stem cell-maintaining stromal signals, and
will thus begin to differentiate. Precisely such a mechanism operates in the
Drosophila male germline stem cell niche (Yamashita et al., 2003). In stem cell
systems regulated on a population basis, local cues could stimulate differentiation, or
retention of stem cell characteristics in both daughters by influencing the orientation
of the division plane, or by other means. While some niches may only operate by a
single mechanism, others, such as the Drosophila female germline stem cells, are
able to switch between invariant and regulative mechanisms (Xie and Spradling,
2000).
One of the best characterised examples of the classic stem-TA-TD model of tissue
maintenance is the vertebrate small intestine, which is composed of outwardly
projecting ciliated villi surrounded by embedded crypts (Figure 1.4). Lineage tracing
experiments have identified that approximately 4-5 multipotent stem cells reside near
the bottom of each crypt (Bjerknes and Cheng, 1999), though no markers are known









Figure 1.3 Niches can mediate stem cell regulation through control of mitotic orientation (from Spradling
etal, 2001).
Niche cells (green) underlying the basement membrane signal to stem cells (red) to block differentiation
and regulate division. Invariant asymmetric division (lower mitotic cell) can result from the orientation
of mitosis permitting only one daughter cell to remain attached to the niche. The unattached daughter
(yellow) moves away from niche signals and differentiates. The attachment of both daughters (upper
mitotic cell) or neither daughter (not shown) causes symmetric division in systems which are regulated









Figure 1.4 The stem cell niche of the mammalian intestinal crypt (modified from Spradling etal, 2001).
Stem cells (red) are located in the basal region of the crypt, and give rise to transit amplifying (TA) cells
(yellow) which migrate up the walls of the crypt towards the villi. Secretory Paneth cells are also produced,
but remain in the basal compartment. Signals emanating from mesenchymal cells (green) under the
basement membrane are believed to regulate stem cell activity.
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of the crypt and differentiate into the absorptive brush-border enterocytes, mucous-
secreting goblet cells, or enteroendocrine cells of the villi. As the TD cells die they
are shed from the villi tips into the gut lumen. Thus the stem, TA and TD
compartments occupy distinct spatial domains. Paneth cells are also produced and
remain in the crypt where they secrete antimicrobial peptides, digestive enzymes, and
growth factors. Studies using an inducible lineage marking system have revealed a
homogenisation of marking amongst the crypt cells, suggesting a population mode of
stem cell regulation (an asymmetric mechanism would not be expected to affect the
number of marked stem cells) (Wong et al., 2000).
Intestinal crypts have also revealed the involvement of extracellular factors which
likely constitute elements of the niche microenvironment. Signals emanating from
the mesenchyme underlying the crypt cells are thought to maintain the activity of
crypt stem cells, and include the intestinal-specific Lef/Tcf family member Tcf4.
Tcf4 functions as part of the Wnt pathway, and mice null for Tcf4 lack intestinal
stem cells (Korinek et al., 1998). The product of Wnt signalling is the accumulation
of (3-catenin, which is thought to play a role in regulating the "release" of stem cell
daughters from the niche, and their subsequent proliferation and differentiation
(Fuchs and Segre, 2000). Further evidence for the role of Wnt pathway factors in
stem cell maintenance/commitment regulation is the finding that stabilised Tcf/Lef/p-
catenin complexes can induce de novo hair follicle production, which follows from
the observation that Tcf3 is expressed in the hair follicle bulge, known to represent
an epidermal stem cell niche (DasGupta and Fuchs, 1999).
1.2.3 The evolving concept of the stem cell
The importance of the niche in regulating stem cell characteristics has been
reinforced by recent studies indicating an unanticipated degree of plasticity of stem
cells when removed from their usual residence and transferred to foreign physiologic
microenvironments. While adult stem cells have traditionally been thought to be
restricted in their differentiative and regenerative potential to their tissues of origin,
numerous reports now document the "transdifferentiation" of bone marrow (BM)-
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derived cells (haematopoietic stem cells, HSCs) into a range of other somatic tissues,
including across embryonic germ layers. Such cells have now been shown to
contribute to both chemically-damaged and dystrophic skeletal muscle (Ferrari et al.,
1998; Gussoni et al., 1999), and can differentiate into cardiac myocytes, smooth
muscle cells and endothelial cells in animal models of myocardial infarction (Orlic et
al., 2001; Kocher et al., 2001). BM-derived cells were shown to reconstitute 30-50%
of hepatocytes in enzymatically-deficient liver, rescuing the otherwise lethal
phenotype (Lagasse et al., 2000), and form glomeruli and renal tubules in both
mouse and human kidneys (Poulsom et al., 2001). Differentiation of a single BM-
derived cell into mature epithelial cells of the liver, lung, gastrointestinal tract and
skin, as well as HSCs, has also been described (Krause et al., 2001). This plasticity is
apparently not confined to BM-derived cells: neural and skeletal muscle cells are
both able to repopulate the BM of irradiated mice (Bjornson et al., 1999; Jackson et
al., 1999), and dermal cells can differentiate into a range of other cell types (Toma et
al, 2001).
These studies, and many others, have prompted a re-evaluation of how stem cells are
conceptually envisioned, with Blau and colleagues proposing that a stem cell might
usefully be considered a biological activity, rather than a discrete entity, that under
the right circumstances can be induced in many distinct cell types (Blau et al., 2001).
They suggested a model whereby cells from diverse organs transit systemically
through the circulation, responding to "homing" signals from sites of local damage or
tissue demand (Figure 1.5). Once a stem cell has entered a foreign tissue,
microenvironmental elements within the local niche would induce the cell to
participate in the functions of that tissue.
Much of the interest in the phenomenon of adult pluripotent stem cells derives from
their potentially significant impact on cell-based therapies and regenerative
medicine. The ability to culture some of these BM-derived cells prior to
transplantation (Jiang et al., 2002) should in principle facilitate ex vivo gene therapy
protocols. Even without modification, enrichment of adult BM-derived pluripotent
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Figure 1.5 The "stem cell highway" (modified from Blau etal, 2001).
A model showing documented (solid arrows) and hypothesised (dashed arrows) transitions in stem cell
identity and differentiation. In addition to tissue-specific stem cells, some cells may transit systemically
through the circulation. If this is considered a "highway" for stem cells, then homing signals and growth
factors are depicted on "billboards" near "on-ramps", which stimulate stem cells to enter the tissue and
participate in its functions, respectively. The model suggests that stem cells can contribute to the existing
pool of stem cells, or directly generate differentiated cells.
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stem cells using cell surface markers allows autologous cell transplantation,
circumventing problems of immunogenicity.
However, despite the promise of the newly recognised plasticity of adult stem cells,
the field remains controversial (Wagers et al., 2002), and much work remains to
establish its physiological relevance. Reported frequencies of engraftment of donor
cells within recipient tissues are low, particularly in the absence of injury, and there
has been little evidence of functional integration (Lemischka, 2002). Alternative
explanations for such results include fusion of donor and recipient cells (Ying et al.,
2002; Weimann et al., 2003; Alvarez-Dolado et al., 2003), or phagocytosis of donor
cells by host macrophages, creating "cells" containing both donor- and tissue-
specific markers (Lemischka, 2002). To address these points and make a credible
case for the clinical potential of adult pluripotent stem cells, further studies should
aim to demonstrate the abilities of single cells to make robust, functional
contributions to the expected and unexpected tissues (Lemischka, 2002). From a
fundamental biological point of view, further investigation of the role of circulating
stem cells in steady-state tissue maintenance, and the relationship between these
pluripotent cells and tissue-resident stem cells populations, is required.
1.3 Epithelial stem cells
1.3.1 Identification of stem cells
It is thought that most, if not all, epithelial tissues contain stem cells responsible for
normal tissue renewal or for regeneration from damage (Slack, 2000). In the absence
of known molecular markers for the stem cells of most tissues, their predicted
characteristics have been exploited in attempts to define the locations of stem cell
populations. The long lifetime and slow-cycling phenotype of stem cells in steady-
state conditions render them amenable to identification through their prolonged
retention of a nucleotide analogue such as bromodeoxyuridine (BrdU) or tritiated
thymidine ([3H]TdR). The rationale behind this approach is that dividing cells will
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incorporate the nuclear label, which will become progressively diluted amongst the
DNA of daughter cells during subsequent proliferation. Thus, after a pulse of
sufficient duration to ensure uptake of the label by infrequently dividing stem cells,
and following a chase period of appropriate length such that the label becomes
detectably less abundant in highly proliferative TA cells, the remaining highly-
labelled cells (label-retaining cells, LRCs) should represent the slow-cycling, stem
cell compartment. This technique has been used extensively in the search for stem
cells, including the epidermis and oral mucosa (Bickenbach, 1981), cornea
(Cotsarelis et al., 1989), and hair follicle (Cotsarelis et al., 1990).
That hair follicle stem cells exist in the bulge region, rather than in the matrix which
represents the TA compartment, was revealed by seven days of repeated
subcutaneous injections of [3H]TdR into neonatal mice (Cotsarelis et al., 1990).
After a four-week chase period, LRCs were confined to the bulge region, now known
to represent a niche of stem cells feeding both the follicle and neighbouring
epidermis (Taylor et al., 2000). Attempts to identify LRCs in the relatively quiescent
corneal epithelium required prolonged [3H]TdR labelling combined with wounding
to stimulate stem cell recruitment and division (Cotsarelis et al., 1989). After a two-
week pulse and four-week chase period, 30% of cells in the corneal limbus were
classed at LRCs, while no LRCs were detected in the corneal epithelium. This
indicated that, following induced proliferation and consequent labelling, the stem
cells had reverted back to their slow-cycling state. Application of the tumour
promoter TPA revealed a significantly elevated proliferative capacity in limbal
epithelial cells compared to corneal epithelia, further supporting the notion that
corneal epithelial stem cells reside in the limbus.
Another experimental approach to identifying potential stem cells is based on the
notion that they should exhibit considerable proliferative potential, and that this
should be reflected by the extent of clonal expansion observed in vitro: stem cells
form large, self-renewing clones, whereas their TA daughters form abortive clones
due to their finite capacity for proliferation (Braun et al., 2003). Clonal analysis has
been used to confirm that, within the hair follicle, cells with a high proliferative
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capability (clonogenic cells) are confined to the bulge region, and are absent from the
matrix-containing hair bulb (Rochat et al., 1994), consistent with the LRC data of
Cotsarelis and colleagues (Cotsarelis et al., 1990). In the epidermis, the level of (3i-
integrin expression, and the rapidity of adhesion to extracellular matrix proteins, both
predicted characteristics of basal epidermal stem cells attached to the basal lamina,
were found to correlate with in vitro colony-forming efficiency (Jones and Watt,
1993). While the removal of cells from their native in vivo environments is likely to
alter their characteristics, and may therefore misrepresent their physiologic
behaviour, studies in which label-retaining and clonogenic cells have been directly
compared revealed that stem cells do share both of these properties (Morris and
Potten, 1994; Oshima et al., 2001).
1.3.2 Epithelial stem cells share common features
Following the identification of the LRC compartment within the corneal limbus,
Cotsarelis and co-workers noted that various epithelial tissues displayed similarities
with respect to the location and biological properties of their resident stem cell
populations (Cotsarelis et al., 1989). They are often located in physically protected
compartments separate from, but spatially proximal to, their differentiated progeny.
For example, the intestinal stem cells are confined to the crypt (Booth and Potten,
2000), removed from the contents of the gut lumen, and epidermal stem cells are
located at the bottom of deep rete ridges (Lavker and Sun, 1982; Lavker and Sun,
1983). Corneal limbal stem cells are confined to the edge of the cornea and, unlike
the remaining corneal epithelium, are protected from solar damage by heavy
pigmentation (Cotsarelis et al., 1989). Both the corneal limbus and the follicular
bulge region are more resistant to physical damage than neighbouring corneal
epithelium or follicular matrix (bulb), respectively (Cotsarelis et al., 1989; Cotsarelis
et al., 1990). Limbal stem cells are found to be associated with nourishing
vasculature, as are the stem cells of the palm and trunk epidermis (Lavker and Sun,
1982; Lavker and Sun, 1983), the tongue epithelium (Hume and Potten, 1976), and
the hair follicle (Cotsarelis et al., 1990). Given the dependency of epithelial tissues
on their stem cells for regeneration following damage, the observation that the stem
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cells are usually protected, either intrinsically (for example, pigmentation) or
extrinsically (physical sequestration), is intuitive, and this characteristic may provide
a useful anatomical clue as to where stem cells may reside.
The discrete spatial positioning of the stem cell compartment with respect to
differentiated cells, and the consequences of such an arrangement on histological
structure, has led to the concept of "structural-proliferative units" (SPUs), in which
one or a few stem cells feed a defined differentiated compartment (Potten, 1978).
The intestinal crypt-villus is a good example of such a unit, though many other
epithelia exhibit similar histological structures, for example the glands of the
stomach, the lobules of the liver, and the nephrons of the kidney (Slack, 2000).
Although little evidence supports the notion, studies of the clonal composition of
epithelia suggest that these structures may also represent units of cell renewal.
Although initially polyclonal, intestinal crypts become monoclonal over time
(Schmidt et al., 1988). While more than one stem cell is thought to operate in each
crypt (Bjerknes and Cheng, 1999), these could be genetically identical as a result of
symmetric stem cell division (Loeffler et al., 1993) which, along with crypt fission
(Cheng and Bjerknes, 1985), could also result in loss of genetic diversity within the
stem cells of a crypt. According to Slack, gastric glands and hair follicles likely
comprise SPUs, but their existence in other tissues is not yet clear as a result of slow
cell turnover prolonging the polyclonal phase (Slack, 2000).
1.4 Stem cells of the respiratory epithelium
Stem cell research into the respiratory system has progressed slowly for several
reasons, including the anatomical and functional complexities associated with
numerous distinct cell types, and differences in the composition and distribution of
cells between rodents and primates. Great plasticity in growth capacity amongst
resident airway cells in response to injury, often deemed necessary to stimulate stem
cell proliferation in this largely quiescent tissue, has reduced the clarity of
experimental data and often led to apparently contradictory interpretations. Also, the
relationship between stem cells involved in reparative proliferation and those active
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in the steady-state and during development, is not clear. The recent discovery of non-
tissue-specific, circulating stem cells has further complicated the field. However,
several studies in recent years have been informative with regard to lineage and
potential progenitors in the airways, and will form the main focus of this discussion.
As this thesis is primarily concerned with the prospect of stem cells in the conducting
airways, specifically the trachea, only a brief mention will be made of cell lineage in
the alveolar regions.
1.4.1 Development of the mammalian respiratory system
The mammalian respiratory system develops from E9.5 foregut in two parts, the
unbranched trachea and the remainder of the lung (bronchi plus respiratory tree). The
former is created by the division of the foregut into two tubes, the oesophagus and
the trachea, and is controlled by mesenchymal expression of Glil and Gli2,
transcription factors that act downstream of sonic hedgehog (Hogan, 1999). The lung
arises by branching morphogenesis of two primary buds that appear on the
ventrolateral wall of the foregut, and is thought to be stimulated by FgflO expression
in the distal mesenchyme around the budding endoderm tips (Hogan and Yingling,
1998). Numerous other morphogenetic signalling factors have been implicated in the
process, including Bmp4, Egf, Fox, and Gata-family members (Hogan, 1999; Perl et
al., 2002). While it has been speculated that the Gli gene family, and Nkx2.1, might
act as "master genes" to impart specificity on the system, deficiencies in these genes
have consequences beyond the respiratory system, and no factors specific to
morphogenesis of the lung have yet been identified (Warburton et al., 2000).
Using a doxycycline-dependent system to induce permanent lineage marking from
surfactant protein C (SP-C)-expressing cells, cell lineages lining bronchioles, acini
and alveoli were distinguished from conducting airway lineages lining the trachea
and bronchi early in development, prior to formation of the lung buds (Perl et al.,
2002). Interestingly, cell marking was never observed in neuroepithelial bodies
(NEBs) or tracheal glands, both putative stem cell niches (discussed in section
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1.4.5.3), indicating that the cells of these structures do not share a common lineage
with other airway cells.
Embryonic development of the lung has been divided into three major stages (Hogan
and Yingling, 1998): the pseudoglandular stage, during which most of the branching
morphogenesis occurs; the canalicular stage, when the columnar epithelium becomes
cuboidal or flattened; and the terminal sac stage, when septation results in the
formation of distal saccules. The differentiation of alveolar type I and type II
pneumocytes, and the formation of an efficient gas exchange interface, occurs
postnatally.
1.4.2 Anatomy of the mammalian respiratory system
The mammalian respiratory system is a complex structure that serves as the site for
gas exchange between the pulmonary capillaries and the external environment. At its
most basic structure, the respiratory system is composed of two distinct
compartments. The first is the conducting portion, comprising a series of bifurcating
tubes of ever-decreasing lumen, the function of which is to deliver the inspired air to
the alveolar spaces. The trachea is the most proximal, and therefore the largest (in
terms of the luminal capacity) of these tubes, connecting the lung to the nose and
mouth through the larynx. Distally the trachea splits at the carina into two bronchi,
serving the two lobes of the lung. While the trachea and bronchi are supported by
cartilage rings, the further distal bronchioles which branch off the bronchi are non-
cartilaginous. Ultimately, the bronchioles split to form the alveolar sacs within the
lung, the second compartment of the respiratory system, which presents a large
surface area to facilitate efficient gaseous exchange. The epithelial layer of
cartilaginous airways is pseudostratified, becoming a simple, monolayered
epithelium in the distal bronchioles and alveoli.
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1.4.3 Cellular composition and kinetics of the mammalian
respiratory system
1.4.3.1 Alveolar cells
The alveolar epithelium is simple, being composed primarily of two morphologically
distinct cell types, known as type I and type II pneumocytes. Type I cells are large
squamous cells with a protruding nucleus and complex cytoplasmic processes, and
cover 97% of the alveolar surface, despite representing only 33% of the total cells
(Weibel et al., 1976; Hogan and Yingling, 1998). They form a tight sheet of cells
covering the alveolar septum to form the pulmonary capillary, by fusing to the basal
lamina of vascular endothelial cells. In this way type I cells generate the gas
exchange barrier. Type II cells, constituting the remaining 67% of alveolar epithelial
cells (though covering only approximately 3% of the surface) are cuboidal and
contain abundant mitochondria, endoplasmic reticulum, and Golgi complexes,
consistent with their role as secretory cells. The surfactant proteins which reduce the
surface tension in alveolar sacs are produced by type II cells. Type I cells are
believed to be incapable of cell division, and type II cells are considered bipotential
progenitors able to give rise to both type I and type II cells (Magdaleno et al., 1998).
In the normal lung, nearly all type II cells are quiescent. Cell division can only occur
following cell growth and DNA synthesis, and results in the production of two
relatively undifferentiated daughter cells. These cells have the potential to rapidly
revert to the type II phenotype, or differentiate into type I cells. It is now thought that
either phenotype can transform to the other without cell division, though only type II
cells are thought able to re-enter the cell cycle (Uhal, 1997).
While the type II cell is generally considered to be the stem cell responsible for
alveolar repair, its sheer frequency renders this notion inconsistent with observations
from other tissues, in which the true stem cell pool is represented by a small
subpopulation of cells. Mason and colleagues speculated that type II cells may not be
functionally identical, and that a subset may act as stem cells, with a candidate
population being type II cells located at the junction of the terminal bronchiole and
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alveolar duct, which are known to proliferate after injury (Mason et al., 1997).
Interestingly, a pollutant-resistant population of airway epithelial cells which
contribute to the restoration of injured bronchiolar epithelium, have been identified at
this location, discussed in section 1.4.5.2 (Giangreco et al., 2002). However, the
existence or location of alveolar epithelial stem cells has not been demonstrated.
In contrast to the alveolar epithelium, the airway epithelium is complex, containing a
range of cell types which vary in abundance and distribution between species
(Plopper et al., 1983). The major cell types are the ciliated cells, basal cells and Clara
(secretory) cells. Other, less abundant cell types include mucous, serous and
neuroendocrine cells.
1.4.3.2 Ciliated cells
The most distinctive cell type, with approximately 38% abundance in murine
tracheobronchiolar epithelium (Pack et al., 1981) is the ciliated cell, which is
common in the larger airways but less frequent in bronchioles. As the name implies,
ciliated cells contain abundant cilia at the apical end of the cell, which project into
the airway lumen and act to clear mucous and inhaled particles. Consistent with their
functionally mature phenotype, ciliated cells are generally considered to be TD, and
have a very low proliferative capacity, as evidenced by their failure to incorporate a
[ HjTdR label (Donnelly et al., 1982). However, exemplifying the plasticity
demonstrated by airway cell types in response to injury, selective damage to Clara
cells in the mouse airway has been shown to induce squamation of neighbouring
ciliated cells, with subsequent proliferation and re-differentiation into Clara cells
(Van Winkle et al., 1995).
1.4.3.3 Basal cells
Comprising approximately 10% of murine tracheobronchial cells (Pack et al., 1981),
basal cells are small and contact the basement membrane, but do not have an
interface with the airway lumen. Significant evidence exists to support a role for the
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basal cell as a multipotent airway progenitor. Basal cells were shown to be the
progenitors of rat primary tracheal epithelial cell cultures (Ford and Terzaghi-Howe,
1992a), and were found to give rise, via an intermediate cell stage (discussed later in
this section), to non-dividing ciliated cells by assessing [3H]TdR incorporation in
steady-state rat tracheal epithelium (Donnelly et al, 1982). Steady-state analysis of
[3H]TdR incorporation and retention in hamster bronchial epithelium attributed
epithelial renewal activity to both basal and secretory cells, though only basal cells
were observed to show a decreasing labelling index, indicating they were the most
proliferative cells (Breuer et al., 1990). Although the notion of high proliferative rate
is not consistent with current views on the slow-cycling nature of stem cells, the
study generated kinetic data which was interpreted to suggest that basal cells were
both self-renewing and gave rise to other cell types.
It had been previously shown that purified suspensions of rabbit tracheal basal cells
could give rise to all tracheal cell types after inoculation into denuded tracheal
xenografts (Inayama et al., 1988). However, the fact that the basal cell suspensions
were only 83% to 94% pure meant the involvement of a contaminating cell in
epithelial reconstitution could not be excluded. Phenotypic markers of normal airway
epithelium were used to assess the cell types involved in regeneration of rat tracheal
epithelium following mechanical injury (Shimizu et al., 1994). Adjacent non-
wounded epithelium was found to flatten and migrate into the denuded region, where
cells became "poorly differentiated" and expressed basal cell-specific markers. These
cells gave rise to secretory and ciliated cells which initially continued to express
markers typical of basal cells, implying a role for basal cell-like intermediates in
regeneration. When high purity basal and secretory/ciliated cell fractions of rat
tracheal epithelial cells were inoculated into denuded tracheal grafts, both fractions
were able to reconstitute a complete mucociliary epithelium (Randell et al., 1991).
However, in a subsequent study aimed at identifying airway progenitors involved in
de novo submucosal gland (SMG) development (discussed in section 1.4.4),
Engelhardt and colleagues studied airway reconstitution by retrovirally-labelling
human bronchial cells before seeding them into denuded rat tracheal xenografts
(Engelhardt et al., 1995). Following examination of the cellular composition of
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labelled clonal clusters, the absence of clones comprising certain combinations of
cell types led the authors to conclude that two basal pluripotent progenitor cell types
must exist, one of which is an airway stem cell that gives rise to all other cell types
(Figure 1.6).
Examination of normal human airway with the anti-Ki-67 proliferation marker
revealed that in the upper airway, 51% of the proliferative compartment was
comprised of basal cells, despite only 31 % of cells reacting with basal cell-specific
anti-K5 and -K14 antibodies (Boers et al., 1998). In the lower airways where only
6% of cells were classified as basal, these comprised 30% of the proliferating
fraction. This study also revealed a significant proliferative contribution from
"parabasal" cells, which correspond to the nebulous "intermediate" (Breuer et al.,
1990; Engelhardt et al., 1995) or "poorly differentiated" (Randell, 1992) cells
described by others. The parabasal cell type forms a layer located just above the
basal cells, though like basal cells they do not contact the airway lumen. They lack
the morphological characteristics of other airway cell types, but are immunoreactive
with anti-K5 and -K14 antibodies, suggesting they may be a direct descendent of
basal cells. A consensus on the legitimacy of the parabasal cell as a genuine
epithelial compartment has yet to be reached, however Boers and colleagues
considered the parabasal cell to represent the TA cells, with the basal cells acting as
stem or progenitor cells (Boers et al., 1998).
Despite the many reports in support of basal cells as airway progenitors, there are
several lines of evidence to challenge this concept. In the rhesus monkey, intense
proliferation of secretory cells occurs prior to extensive mitotic activity in basal cells,
where pre-ciliated cells were observed to contain both secretory granules and basal
bodies, suggesting a secretory to ciliated cell pathway (Plopper et al., 1986). The
observation that ciliated and secretory cells appear before basal cells during
development (McDowell et al., 1985) has been used to counter suggestions that basal
cells are airway progenitors. This argument appears less convincing in the light of







Figure 1.6 Lineage model of airway epithelial differentiation based on human bronchial xenograft
experiments (modified from Engelhardt et al, 1995).
The model shows that two basal progenitors exist. Basal1 is a stem cell from which all other cell types
are derived, including the progenitor cell, basal2. Submucosal glands (SMGs) were found to originate
from more than one progenitor cell, and were always with complex clones of all four cell types, indicating
an association between SMGs and multipotent progenitors. The model hypothesises that basal2 cells
must be activated to divide into intermediate1 and intermediate2 cells to initiate the process of SMG
formation. The absence of surface epithelial clones containing (i) only intermediate, secretory, and ciliated
cells (ii) two cell clones containing secretory cells and (iii) three cell clones containing basal, secretory
and ciliated cells, can be explained by the model. While intermediate1 cells divide to self-renew and
produce ciliated cells, intermediate2 cells can only divide to produce two secretory cells. The curved
arrows indicate that only basal1, basal2, and intermediate1 cells have the capacity to divide in culture
and therefore integrate retroviral lineage markers.
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developing tissue, but appear later to maintain the tissue during adulthood (van der
Kooy and Weiss, 2000). The apparent morphological simplicity of basal cells has
contributed to the notion that they represent "primitive" progenitor cells. However,
electron microscopic analysis of basal cells from several species has revealed the
presence of a complex system of junctional adhesion structures including keratin
filaments, desmosomes, and hemidesmosomes (Evans et al., 1989; Evans et al.,
1990). This indicated that basal cells do exhibit differentiated properties, and have a
function in attaching columnar cells to the basal lamina.
1.4.3.4 Clara cells
Clara cells are columnar, non-ciliated, secretory cells, and the most common cell in
the mouse trachea, constituting approximately 50% of cells, but diminishing slightly
distally (Pack et al., 1981). In this sense, the mouse trachea resembles the human
bronchiole, in which approximately 35% of cells are Clara cells, though the human
bronchiole has few if any basal cells (Mercer et al., 1994). By contrast, Clara cells
comprise only approximately 3% of human bronchial cells. Clara cells produce
significant amounts of Clara cell secretory protein (CCSP, otherwise known as
CC10), which has several functions, including an anti-inflammatory role (Magdaleno
et al., 1998). Several studies have implicated Clara cells in airway regeneration after
injury. Keenan and co-workers observed that, following mild mechanical injury to
the hamster tracheal epithelium, Clara cells mount the main proliferative response
(Keenan et al., 1982). Oxidant-induced injury specifically to ciliated cells (using
NO2), followed by [3H]TdR labelling, revealed that the Clara cell was the primary
progenitor cell giving rise to labelled ciliated cells, and that basal cells did not play a
role in this process (Evans et al., 1986). When denuded tracheal grafts were
inoculated with highly purified basal or secretory rat tracheal epithelial cells, only the
secretory fraction was able to reconstitute a complete epithelium: the basal fraction




Examination of normal human airway with the anti-Ki-67 proliferation marker
revealed that Clara cells, which were found to be confined to the bronchioles, make a
substantial contribution to airway maintenance (Boers et al., 1999). While Clara cells
constituted 11% and 22% of cells in the terminal and respiratory bronchioles,
respectively, their corresponding contributions to the proliferative compartments of
these regions were 15% and 44%. Clara cells contain P450 enzymes capable of
catalysing the metabolic activation of carcinogens or toxicants (Magdaleno et al.,
1998). As discussed further in section 1.4.5.2, this property renders Clara cells
specifically susceptible to ablation using naphthalene, permitting the analysis of
progenitors cells active following depletion of the Clara cell compartment.
1.4.3.5 Pulmonary neuroendocrine cells
Pulmonary neuroendocrine cells (PNECs) are small, infrequent cells distributed
throughout the airway epithelium as solitary cells or in clusters called neuroepithelial
bodies (NEBs). These cells secrete a variety of neuropeptides that affect the growth
and differentiation of airway epithelial cells, and may have a role in foetal lung
development (Hoyt, Jr. et al., 1993). PNECs can be identified using antibodies to one
of the secreted neuropeptides, calcitonin gene-related peptide (CGRP) and, both
independently and within NEBs, have been shown to undergo hyperplasia and
hypertrophy in response to Clara cell ablation (Peake et al., 2000). Evidence to
suggest that PNECs may be a component of an airway stem cell niche is discussed in
section 1.4.5.
1.4.4 Submucosal glands
SMGs consist of a network of secretory tubules and associated ducts, which act in
the production and delivery of mucous and antimicrobial agents to the epithelium of
cartilaginous airways. In humans, they are found in the trachea, bronchi and proximal
bronchioles, lying most commonly between the epithelium and plates of supporting
cartilage (Tos, 1966). The structure and composition of the glands is illustrated in
Figure 1.7. The ciliated duct, which connects the airway luminal epithelium to the
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collecting duct, is lined with ciliated cells and small numbers (approximately 6%) of
another type of cell containing numerous large mitochondria and a well developed
Golgi apparatus (Meyrick et al., 1969; Meyrick and Reid, 1970). The collecting duct
is lined with tall non-ciliated columnar cells and ends abruptly where it meets the
secretory tubules, which are composed entirely of mucous and serous cells. The
secretory tubules end in spherical acini composed of one or both cell types (Meyrick
et al., 1969).
SMGs are considered to be involved in the development of CF lung disease, for
several reasons. They are the predominant region of cystic fibrosis transmembrane
conductance regulator (CFTR) expression in the human bronchus, with serous cells
and a subpopulation of "flask-like" cells in the ciliated ducts identified as the sites of
expression (Engelhardt et al., 1992). Histologic evidence of SMG luminal dilation is
apparent in CF patients before any other signs of lung disease (Oppenheimer and
Esterly, 1975), and hypertrophy and hyperplasia of SMGs is associated with disease
progression (Sturgess and Imrie, 1982). When chloride transport in SMGs is blocked
in vitro, mucous production is severely reduced, and mucous obstructions resembling
those observed in CF occur (Inglis et al., 1997).
Until recently, mice were considered to be "essentially void" of SMGs (Engelhardt et
al., 1992). Since then, the presence of SMGs in murine airways has been confirmed,
where they exist at the same density as in the human airway, though in mice they are
confined to the proximal trachea just below the larynx (Borthwick et al., 1999)
(Figure 1.8). Murine SMGs were observed to be similar in structure to human SMGs,
and were found to produce mucous in both mucous and serous cells, and lysozyme
and Cftr protein in serous cells. Interestingly, SMGs were noted to be more distally
distributed in two mouse models of CF compared to congenic wild-type animals
(Borthwick et al., 1999), possibly reflecting the SMG hyperplasia observed in CF
individuals (Oppenheimer and Esterly, 1975). Subsequently, significant variation in
SMG distribution has been observed between inbred strains of mice, with glands



























Figure 1.7 Structure and cellular composition of human submucosal glands (SMGs) (from Borthwick,
1999).
(a) Three dimensional representation of a human SMG based on the observations of Meyrick and









Figure 1.8 Location and appearance of murine submucosal glands (SMGs) (modified from Borthwick
etal, 1999).
(a) Longitudinal section through a mouse trachea showing SMGs situated between proximal cartilage
ring and the luminal surface, (b) Higher magnification of SMG region showing an SMG duct opening onto
the luminal surface.
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C57BL/6N animals. A genetic determinant on chromosome nine was found to be
significantly linked to this phenotype (Innes and Dorin, 2001).
In humans, SMG development initiates during the 15th week of gestation and
continues for approximately 10 weeks (Filali et al., 2002). However, de novo
production of SMGs is thought to be possible in adult airways, as suggested by
apparent gland hyperplasia in CF patients (Oppenheimer and Esterly, 1975). As
SMGs are thought to arise from buds derived from surface airway epithelium during
foetal development (Thurlbeck et al., 1961; Tos, 1968), it was thought that the
epithelium of adult airways might contain progenitors capable of forming SMGs.
Engelhardt and colleagues demonstrated SMG production by seeding retrovirally-
labelled human bronchial epithelial cells into denuded rat tracheas, which were
implanted subcutaneously into athymic mice (Engelhardt et al., 1995). In addition to
generating a fully differentiated surface airway epithelium, the isolated bronchial
airway cells were able to develop SMGs. Labelled glands were commonly spatially
associated with neighbouring labelled clonal clusters of airway surface epithelial
cells. While heterogeneity in the composition of labelled clones was observed
throughout the surface epithelium, clones associated with adjacent labelled SMGs
were consistently found to contain all four of the cell types examined for (basal,
secretory, intermediate, and ciliated). The same series of experiments, involving the
simultaneous use of two different cellular labels, revealed that glands were often
composed of differently-labelled cells, indicating the action of multiple progenitors
in gland development. Likewise, partially transgenic glands were observed in
experiments using a single cell label. The authors concluded that all glands formed
from expansion of complex four cell type surface epithelial clones, and described a
model involving a basal stem and progenitor cell to explain these observations,
which incorporated the apparent absence of certain clone compositions (Figure 1.6).
Subsequently, analysis of mice chimaeric for detectable transgenes suggested SMGs
were clonally derived (Borthwick et al., 1999), contrary to the report of Engelhardt
and colleagues (Engelhardt et al., 1995). Also, the polyductal glands described by
Engelhardt and colleagues (Engelhardt et al., 1995) did not appear to be present in
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mice (Borthwick et al., 1999). The conflicting results obtained in these investigations
could be the result of differences in the experimental system, for example mouse vs
human, developmental vs adult SMG production, and in vivo vs xenograft context.
The high mobility transcription factor Lefl has recently been shown to be expressed
specifically in a subset of surface airway epithelial cells which give rise to gland-
forming buds, in ferret airway xenografts (Duan et al., 1998). In situ hybridisation
revealed Lefl expression during the earliest stages of gland development, and within
the distal tips of the primordial tubules for up to five weeks. While SMG
development occurs postnatally in both the ferret (Leigh et al., 1986) and the mouse
(Borthwick, 1999), the ferret was used because it shows the greater similarity in
SMG distribution and airway epithelial cell composition to the human. The impaired
development of several organs including the kidney, teeth, and mammary glands in
the Lefl "knockout" mouse revealed the transcription factor is involved in inductive
epithelial-mesenchymal interactions (van Genderen et al., 1994), and can activate a
variety of genes including keratins (Zhou et al., 1995) and the cell adhesion molecule
E-cadherin (Huber et al., 1996). The absence of nasal and tracheal SMGs in Lefl-
deficient mice, and an 8-fold decrease in SMG morphogenesis following antisense
oligonucleotide inhibition ofLefl expression in ferret tracheal xenografts, revealed a
requirement for Lefl in the promotion of SMG development (Duan et al., 1999).
Also, expression of human LEF1 from the CCSP promoter was shown to rescue the
glandless phenotype of Lefl-deficient animals. Lefl is thus considered to define a
distinct subpopulation of surface epithelial cells with progenitorial capacity to form
SMGs. However, the obligatory involvement of additional, undefined factors in
SMG development was demonstrated by the inability of overexpressed LEF1 to
increase the extent of gland development in human bronchial xenografts, or when
ectopically expressed in transgenic mouse airways. Interestingly, Lef/Tcf/p-catenin
complexes have been identified as important extrinsic factors in controlling stem cell
maintenance and/or commitment to differentiation in other epithelial tissues such as
the epidermis and intestine (Korinek et al., 1998; DasGupta and Fuchs, 1999).
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1.4.5 Zonal organisation of airway epithelial stem cell systems
The recognised differences in structure and cellular composition between the various
segments of the conducting airways (trachea, bronchus, bronchioles), and between
the airways and the alveolar regions, have led to a general consensus that resident
stem cell populations are likely partitioned between these portions of the respiratory
system (Borthwick et al., 2001; Engelhardt, 2001). The concept of local reserves of
stem cells able to respond rapidly to injury is intuitive, and has been supported by
most work to date (Otto, 2002), though alternative notions exist, including the
concept of adult multipotent stem cells (discussed in section 1.4.6). Recent
experiments aimed at identifying putative stem cells in the proximal (trachea) and
distal (bronchiolar) airway have provided further evidence of separate progenitor
populations existing in discrete niches both between and within the proximal and
distal segments, while also revealing similarities in potential niche elements.
1.4.5.1 The proximal airway
As discussed previously, the slow-cycling nature of stem cells can be exploited in
their identification, since they will retain a pulsed nucleotide label longer than the
more proliferative TA cells. Borthwick and colleagues used this technique to identify
slow-cycling cells within the mouse trachea (Borthwick et al., 2001). Because of the
low rate of cell division and turnover of cells in the steady-state airway, the tracheal
epithelium was purposely injured to stimulate the proliferation of reparative stem
cells, as cell division is required for incorporation of a nuclear label. The two
methods used to damage the epithelium, inhalation of SO2 and instillation of the
detergent polidocanol, produced similar results, and were combined with repetitive
administration of BrdU. Following repair of the epithelial surface, and an appropriate
chase period, LRCs were found to be confined to the SMG ducts in the proximal
trachea, and arranged in systematically arrayed foci along the surface epithelium in
the glandless distal trachea. These foci of primarily basal cells appeared to be
localised at cartilage-intercartilage junctions, where gland rudiments were
occasionally found. The pattern of LRCs throughout the trachea was reminiscent of
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the expression of lacZ from a human K5 promoter-driven transgene, which led to the
discover}' of cells rich in basal- and non-basal-specific keratins within the gland
ducts. The prospect that differential expression of certain keratins within tissue sub-
compartments may distinguish stem cells from their more differentiated progeny is
discussed in chapter 2. Antibodies to CGRP revealed that PNECs appeared to be
systematically distributed with LRCs in the glandless lower trachea, but that these
phenotypes defined separate cell populations.
To further evaluate whether gland ducts may contain progenitors capable of
regenerating the surface airway epithelium, tracheas in which the surface epithelium
had been completely removed by protease digestion were implanted subcutaneously
into athymic mice (Borthwick et al., 2001). After 28 days, a surface epithelium
resembling that present in mouse bronchi was present, supporting the notion of a
stem or progenitor population within tracheal gland ducts.
1.4.5.2 The distal airway
Clara cells, the major TA population of the rodent conducting epithelium (Hong et
al., 2001), are susceptible to specific ablation using naphthalene. Using this
technique, it had previously been shown that the proliferative response to bronchiolar
Clara cell loss occurred in two subsets of cells within NEBs, and resulted in
regeneration of the epithelium with associated hyperplasia of NEBs (Reynolds et al.,
2000a). These [3H]TdR label-retaining candidate stem cell populations were found to
be either CCSP-positive or CGRP-positive, (a pollution-resistant subset of Clara
cells, or PNECs, respectively). In subsequent experiments employing a transgenic
mouse expressing herpes simplex virus thymidine kinase from the CCSP promoter in
all Clara cells, regeneration of the distal airway epithelium was monitored after the
elimination of all Clara cells through administration of ganciclovir (Reynolds et al.,
2000b; Hong et al., 2001). Despite the occurrence of PNEC proliferation and
hyperplasia, indicating that CCSP-positive cells within NEBs were not necessary for
NEB hypertrophy, no epithelial regeneration was observed suggesting that PNECs,
while self-renewing, were unable to differentiate into Clara cells. These results
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indicated the importance of a subpopulation of naphthalene-resistant CCSP-
expressing cells associated with the NEB microenvironment in regenerating the
bronchiolar epithelium after injury. The authors postulated that the NEB may
represent an airway stem cell niche, though could not exclude the possibility that
naphthalene-resistant CCSP-expressing cells represented an accessory cell essential
for the proliferation and differentiation of a CGRP-positive (PNEC) progenitor. The
same authors have since reported the existence of a putative, NEB-independent stem
cell niche of pollutant-resistant CCSP-expressing cells situated at bronchoalveolar
duct junction (BADJ), which serves to regenerate terminal bronchiolar epithelium
after naphthalene injury (Giangreco et al., 2002).
1.4.5.3 Airway stem cell niches?
The findings of Borthwick and colleagues (Borthwick et al., 2001) and Hong and co¬
workers (Hong et al., 2001) are summarised in Figure 1.9. These experiments, with
the others, indicate that, even within anatomical segments of the airway, different
lineage systems likely operate. In the trachea, putative stem cells appear localised to
gland ducts proximally, and in regularly distributed foci near cartilage-intercartilage
junctions more distally. Similarly, possible bronchiolar stem cells are generally
located within NEBs, but a population also exists at the BADJ for renewal of the
most distal terminal bronchioles. Although no hyperplasia of PNECs was detected by
Borthwick and colleagues (Borthwick et al., 2001), the association of PNECs, which
are known to secrete neuropeptides thought to influence growth and differentiation of
airway cells (Hoyt, Jr. et al., 1993), with putative stem cell populations in both the
proximal and distal airways, may be indicative of a role for PNECs in creating a stem
cell-maintaining microenvironment. Given the characteristics of epithelial stem cell
niches discussed in section 1.3.2, the SMG duct would seem a highly appropriate
compartment, providing direct access to the overlying surface epithelium while
remaining protected from inhaled toxins. By contrast, the bronchiolar stem cells
resident in the epithelial surface appear to employ an intrinsic defence against
environmental insult, as evidenced by their apparent lack of immunoreactivity with
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Figure 1.9 Schematic representation of stem cell niches in murine proximal and distal airways (after
Borthwick et at, 2001 and Hong et at, 2001) (from Engelhardt, 2001).
For simplicity, two "trophic units" have been classified as label-retaining cells (LRCs, red), representing
candidate slow-cycling stem cells, or highly proliferative transit amplifying (TA) cells (TAC, blue). Following
injury, LRCs were found in submucosal gland (SMG) ducts and the immediate surrounding surface airway
epithelium in the proximal glandular trachea. In the non-glandular distal trachea and distal bronchiolar
airways, ablation of TA cells revealed LRC niches were found associated with innervated neuroepithelial
bodies (NEBs) containing calcitonin gene-related peptide (CGRP)-expressing pulmonary neuroendocrine
cells (PNECs, not shown). In the distal trachea, LRCs were mainly confined to inter-cartilaginous junctions
associated with vascularised (BV) and innervated regions of the airway, while LRCs co-localised with
NEBs in the non-cartilaginous bronchioles. NEBs, or their constituent PNECs, may serve as stem cell
niches in the distal trachea and bronchioles.
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antibodies against the cytochrome P450 isoenzyme responsible for producing the
toxic metabolite ofnaphthalene (Giangreco et al., 2002).
1.4.5.4 A single multipotent stem cell for the entire respiratory tract?
Despite general acceptance of the concept of region-specific stem cell niches in the
respiratory epithelia, re-examination of earlier work employing incompletely pure
"basal" and "secretory" cell isolates, which often led to conflicting results, and which
was often hampered by a lack of consensus regarding the "intermediate" cell type,
has led Emura to speculate that there is in fact a single multipotent stem cell for the
entire respiratory system (Emura, 1997). Observations that a cloned epithelial cell
line derived from a female foetal Syrian hamster lung could assume functional
features of other respiratory cells types in response to manipulation of the in vitro
environment was cited as support for the existence of CCSP-expressing cells with
pre-Clara phenotypes as candidate stem cells for the whole airway (Emura, 2002).
Engelhardt also speculated that, because Clara cells are present throughout murine
airways, CCSP-expressing cells could represent a similar stem cell phenotype in both
the proximal and distal respiratory tract (Engelhardt, 2001). This could also be
relevant to the human airway: although morphologic counterparts to Clara cells are
confined to human bronchioles, CCSP-expressing cells are also found in the
bronchus (Engelhardt et al., 1994). However, in a study correlating proliferation
(using anti-Ki-67 antibody) with expression of CCSP in normal, hyperplastic and
metaplastic human bronchial samples, CCSP-expressing bronchial cells
demonstrated no proliferative activity and were thus considered to have no precursor
function (Barth et al., 2000).
1.4.6 How do current stem cell concepts apply to the airway
epithelium?
Several studies demonstrating plasticity of BM-derived stem cells have revealed that
the injured or irradiated lung is a site of frequent stem cell engraftment. In a study
revealing contribution of a single BM-derived cell to liver, lung, gastrointestinal tract
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and skin, Krause and colleagues labelled male BM-derived cells depleted of lineage
markers and transplanted them into lethally-irradiated female recipients (Krause et
al., 2001). After 48 hours, donor-derived BM cells were found to be enriched for the
HSC markers CD34 and SCA-1. Single cells were obtained by limiting dilution and
transplanted into female lethally-irradiated hosts, where engraftment was detected by
Y chromosome-specific fluorescence in situ hybridisation in the bronchi and
pneumocytes of the respiratory epithelium. Anti-keratin antibodies were used to
demonstrate that the engrafted cells were appropriately differentiated, and not
haematopoietic cells. High-level engraftment in the lung was thought to be a result of
its particular susceptibility to radiation damage. In a subsequent study, radiation
induced pneumonitis was shown to promote engraftment of unffactionated BM as
type II pneumocytes (Theise et al., 2002). In some cases entire alveoli were donor-
derived, suggesting that type I pneumocytes differentiated from type II pneumocytes.
The prospect for genetic modification of donor cells was demonstrated by Grove and
co-workers, who retrovirally transduced enhanced green fluorescent protein (eGFP)
into BM-derived cells prior to serial transplantation in irradiated recipients (Grove et
al., 2002). eGFP-expressing type I and type II pneumocytes were detected in
recipients up to 11 months later, comprising an average of 3% of all alveolar cells in
the lung tissue analysed.
Using bleomycin-induced oxidative injury, rather than irradiation, of the respiratory
epithelium, Kotton and colleagues observed donor-derived type I, but not type II,
pneumocytes (Kotton et al., 2001). Although donor-derived cells were found in
clusters, they did not express proliferation-specific antigens. A low level of
engraftment was observed in control treated mice, indicating that injury is not an
absolute prerequisite for contribution from BM-derived stem cells. Differences in the
overall frequency and distribution of engrafted cells between this study and that of
Krause and colleagues (Krause et al., 2001) likely resulted from several differences
in the experimental protocol, including mode of lung damage, presence or ablation of
host BM, and the nature of the transplanted cells: while Krause and co-workers used
uncultured BM-derived cells (Krause et al., 2001), Kotton and colleagues
transplanted a selectively expanded plastic-adherent population (Kotton et al., 2001).
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Despite the demonstrated ability of BM-derived, pluripotent stem cells to contribute
to the regeneration of the injured respiratory system, the involvement of endogenous
BM-derived stem cells in steady-state tissue maintenance, and whether such cells
enter the local niche and adopt a tissue-specific stem cell phenotype in advance of
contributing to the tissue, has yet to be clearly established. Regardless of stem cell
origin, defined compartments of stem, TA, and TD cells have been identified in
several epithelial tissues, and most cell turnover within a tissue is likely to result
from transit through these populations. Thus, investigation of cell lineage patterns in





1.5.1 Investigation of a putative stem cell niche in murine tracheal
submucosal gland ducts
It has previously been observed that LRCs within the SMG ducts of the proximal
trachea, possibly representing slow-cycling stem cells, were spatially coincident with
cells expressing high levels of keratin protein (Borthwick et dl., 2001). That the
pattern of keratin protein was reflected by the activity of a K5 promoter-driven
reporter transgene provided the opportunity to use the promoter to investigate lineage
arising from the SMG duct in response to injury. The aim of this project was to use a
transgenic approach to determine whether K5 expression could be used as a marker
to verify the presence of a stem cell niche within SMG ducts which was capable of
contributing to repair of the airway epithelium.
1.5.2 An \n vivo model for gene correction
The positive identification of stem cells in any tissue raises the prospect of being able
to specifically target them in gene therapy protocols. In principle, this should
facilitate a single-dose application, with propagation of treated cells throughout the
tissue as a result of normal tissue renewal or in response to induced injury. Gene
correction is a relatively new concept in gene therapy, and describes the permanent,
site-specific correction of chromosomal defects by a range of small oligonucleotide-
based reagents. Comparative evaluation of different gene correction strategies in vivo
is difficult using existing systems, such as mouse disease models. The aim of this
project was to generate a transgenic mouse designed to permit the simple and rapid
evaluation, development, and optimisation of in vivo gene correction protocols.
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tracheal lineage analysis
A transgenic mousefor inducible tracheal lineage analysis
2.1 Introduction
The observation that the human keratin (K) 5 promoter directed expression of a lacZ
reporter transgene to a subset of keratin-rich cells within murine submucosal gland
(SMG) ducts ultimately led to the discovery of slow-cycling label-retaining cells
(LRCs) at this location (Borthwick et al., 2001). In the YJb-lacZ mice, (3gal activity
was visible only in a circumferential band in the upper trachea, in addition to
infrequent small patches distributed along a descending posterior stripe. This pattern
was consistent with the location of the tracheal glands, and upper tracheal sections
revealed (3gal positive basal cells scattered in the surface epithelium, and more
frequently in small groups within SMG ducts. Further analysis using anti-keratin
antibodies indicated a correlation with high-level keratin protein production. Both
basal-specific K14 (the co-expressed binding partner of K5), and K18, which is
otherwise expressed in supra-basal, columnar surface cells in the trachea, were found
to be expressed in basal gland duct cells.
2.1.1 Keratins as stem cell markers
Keratins are the intermediate filament proteins of epithelial cells, and are subdivided
into two groups, type I and type II, on the basis of their amino acid composition,
either acid or neutral-basic, respectively (Moll et al., 1982). Type I keratins (K9-20)
are co-expressed in pairs with type II keratins (Kl-8), the proteins forming obligate
heterodimers which constitute cytoskeletal subunits. These keratin pairs are
differentially expressed in epithelial tissues at various stages of development and
differentiation, and their cell type specificity is such that they are frequently used as
markers for epithelial cell identification. For example, K8/K18 are expressed in
simple epithelia, K1/K10 are expressed in the supra-basal layers of the epidermis,
K4/K13 are expressed supra-basally throughout internal stratified epithelia, while
K6/K16 are found in the supra-basal cells of the hair follicle outer root sheath (Byrne
and Fuchs, 1993). Differentiating cells of the cornea express K3 (Schermer et al.,
1986), together with its binding partner K12, and K15 is expressed mainly in internal
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epithelia during neonatal development, where it dimerises with K5 (Lloyd et al.,
1995).
Earlier studies had indicated that the differential expression of a keratin within the
cells of an epithelial tissue might distinguish stem cells from their more
differentiated progeny. Schermer and colleagues used a monoclonal antibody to
show that the basal cells of the corneal limbal region were negative for a 64K keratin
protein (K3), while limbal supra-basal cells, and both the basal and supra-basal
epithelia of the central cornea, expressed the protein (Schermer et al., 1986). The
authors interpreted this to suggest that the basal cells of the central cornea were more
differentiated than their limbal counterparts, and likely represented the transit
amplifying (TA) population which gave rise to the supra-basal layer. Evidence that
limbal basal cells constitute the corneal stem cell compartment was provided by a
label-retaining assay, in which corneal stem cells were stimulated to proliferate in
response to induced corneal wounding in the presence of a labelled nucleotide
analogue. Significant numbers of LRCs, representing putative stem cells, were found
in the limbal region, while none were detected in corneal epithelium (Cotsarelis et
al., 1989). Clonal analysis in chimaeric adult corneas has demonstrated directly that
marked cells arise in the basal limbal epithelium and migrate centripetally towards
the centre of the cornea (Collinson et al., 2002).
More recently, LRCs were localised to the bulge region of human hair follicles, for
which K15 was found to be a specific marker. K19, which had previously been
purported to be a stem cell marker for murine bulge LRCs (Michel et al., 1996) was
also found to be expressed in the human bulge region, though K19 expression
extended downward within the basal cell layer towards the bulb. The authors
speculated that, while K15 defined the undifferentiated cells of the LRC-containing
bulge region, K15-negative/K19-positive cells might represent the early TA
population of the human hair follicle (Lyle et al., 1998). Interestingly, K15 is an
alternative binding partner for K5 (Lloyd et al., 1995), which normally pairs with
K14 in basal epithelia. K5 has also been found to be expressed within the stem cell-
containing basal limbal region of cornea (Byrne and Fuchs, 1993).
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2.1.2 Keratin 5 and the human K5 promoter
K5 is normally associated with K14, which together are the most broadly expressed
keratins, and are found in mitotically active basal cells in all stratified epithelia,
regardless of anatomical location (Nelson and Sun, 1983). In the epidermis, K5/K14
expression in basal cells switches to K1/K10 as cells become committed to terminal
differentiation and migrate supra-basally. Given the apparent insensitivity of K5/K14
expression to the varied environments in which basal keratinocytes are found, and
the fact that the marked restriction of K5/K14 expression to basal epithelial layers
appeared to be mediated at the transcriptional level (Lersch et al., 1989; Stellmach et
al., 1991), their respective promoters have been used as tools to study cell type-
specific regulation of gene expression (Leask et al., 1990; Byrne and Fuchs, 1993;
Byrne et al., 1994). While both human promoters have been shown to drive in vivo
expression of reporter genes in a manner faithful to their respective endogenous
counterparts (Vassar et al., 1989; Byrne and Fuchs, 1993), the K14 promoter, which
was characterised first (Marchuk et al., 1985), or bovine K5 promoter sequence
(Ramirez et al., 1994), have tended to be used when basal epithelial-specific
transgene expression has been required (Cheng et al., 1992; Brakebusch et al., 2000).
Also, one group has used a 14kb human K5 promoter (Tarutani et al., 1997). The
following discussion is concerned only with the 6kb human K5 promoter fragment
isolated and characterised by Fuchs and colleagues (Lersch et al., 1989; Byrne and
Fuchs, 1993).
The activity of the human K5 gene promoter has been analysed both in vitro and in
vivo. When 6kb of the human K5 promoter was used to drive expression of reporter
genes after transient transfection into a range of cell lines, activity was detected in a
human epidermal keratinocyte line, but not in hepatocytes or fibroblasts (Byrne and
Fuchs, 1993). This suggested that 6kb of upstream sequence was sufficient to confer
cell type-specific expression in vitro, and agreed with the results of previous
experiments in which considerably shorter sequences were shown to drive
keratinocyte-preferred expression (Jiang et al., 1991; Ohtsuki et al., 1992).
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In order to evaluate the specificity of the 6kb sequence in vivo, transgenic mice were
generated carrying the lacZ reporter under the transcriptional control of the K5
promoter, and the pattern of Pgal activity was compared with that of endogenous K5
protein, as detected using anti-K5 antiserum (Byrne and Fuchs, 1993). In two
similarly expressing transgenic lines, Pgal activity in most tissues was found in a
pattern indistinguishable from that of endogenous K5, including the basal layer of
tail skin epidermis (including the sebaceous and eccrine glands) and tongue, and the
corneal limbus. The profile of Pgal deviated from that of endogenous protein in the
oesophagus, forestomach, and thymus, in which only a small minority of basal cells
expressed the transgene. The existence of keratin-positive basal cells lacking the
corresponding mRNAs had previously been reported (Schweizer et al., 1988), and
the authors speculated that the shorter half-life of Pgal compared to the durable K5
filaments may explain some of these observed disparities. Unanticipated expression
in non-epithelial tissues was confined to a subset of neurons in the brain, where no
K5 protein was detected. Parallel experiments revealed that while a truncated 90bp
K5 promoter maintained keratinocyte-specific expression of Pgal, it was not
sufficient to restrict transgene expression to basal epithelial layers, implying the
presence within the remaining 5.9kb of elements controlling basal specificity and
suppressing supra-basal expression (Byrne and Fuchs, 1993). Subsequently, the
profile of K5 promoter-driven Pgal expression in developing epidermis was
characterised in detail (Byrne et al., 1994), and their observations are briefly
described in section 2.2.4.
Given the described precedents for the presence or absence of certain keratins to
define stem cell compartments in some epithelial tissues, it is conceivable that the
observed co-localisation of LRCs in the mouse tracheal glands to regions containing
cells expressing high levels of K5, might indicate that K5 could be a specific marker
for these putative stem cells.
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2.1.3 Lineage analysis
Putative tissue-specific stem cells have been identified in a range of tissues by their
retention of a pulsed label following an appropriate chase period (Bickenbach, 1981;
Cotsarelis et al., 1989; Cotsarelis et al., 1990), indicative of a slow-cycling
phenotype, which is regarded as a characteristic of epithelial stem cells. However, a
stem cell can only truly be defined on the basis of its cellular progeny. Since
candidate stem cells should ideally be analysed in their native context, to prevent
potentially artefactual observations arising from their manipulation in a foreign
environment, strong evidence to support a claim of stem-ness can be obtained by
monitoring cell lineage relationships either during development, or in steady-state or
regenerating adult tissue. This necessarily requires that the putative stem cell
population be specifically and detectably tagged with a marker which is transmitted
to its cellular descendants. Retrospective clonal analysis has been achieved in the
mouse myotome (Bonnerot and Nicolas, 1993) and brain (Mathis and Nicolas, 2000)
using an inactivated lacZ reporter carrying an internal sequence duplication
("/aacZ") (Sanes, 1994). Spontaneous intragenic recombination occurred
infrequently (10~6) (Bonnerot and Nicolas, 1993), reconstituting functional lacZ
sequence which was transmitted to cellular progeny. lacZ encodes the
histochemically-detectable P-galactosidase enzyme (Pgal), allowing cell lineages to
be unambiguously visualised.
One major limitation of approaches in which expression of the reporter is under the
direct control of a promoter active within the putative progenitor population, is that
the progeny of these cells may not maintain expression of the reporter as they
differentiate. In recent years, techniques have been developed which permit tissue-
specific activation of a ubiquitously expressed reporter. In this way, initiation of
lineage marking can be confined to a subset of cells expressing a common promoter,
but cell fate can be tracked outside this compartment, regardless of the final
phenotype or destination of the daughter cells. Such approaches require the use of
site-specific recombinases, such as the Cre recombinase, an integrase protein
encoded by the bacteriophage PI (Sauer and Henderson, 1988). Cre catalyses
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recombination between 34bp target sequences called loxP sites, which are composed
of a core 8bp sequence and two 13bp palindromic flanking sequences. When two
loxP sites are arranged in cis in the same orientation, as defined by the core
sequence, Cre-mediated recombination between them results in the precise excision
of intervening (flanked by loxP, "floxed") DNA (Tranche et al., 2002). Since the
first demonstrations that Cre could be used to effect site-specific modifications
within the mouse genome (Lakso et al., 1992; Orban et al., 1992), numerous
transgenic lines have been created, expressing Cre from a variety of promoters for a
range of purposes ((Lobe and Nagy, 1998; Nagy, 2000) for review). In many such
experiments, the Cre-expressing line is crossed with another transgenic line in which
the gene of interest has been modified through gene targeting to include a pair of
loxP sites such that, in the presence of Cre protein, part or all of the gene is deleted
from the genome. These conditional knockouts, in which gene inactivation is
restricted to tissues expressing the Cre transgene promoter, have several advantages
over conventional knockouts, including the ability to bypass embryonic lethal
phenotypes (Tarutani et al., 1997).
When a novel Cre-expressing line is generated, it is usual to validate its stage- and
tissue-specific recombination profile by crossing with a Cre reporter line in which
the pattern of Cre activity is represented by excision-dependent reporter gene
activation. Several such lines exist, though all are similar in design, and are
comprised of a reporter gene separated from a ubiquitous promoter by a floxed
cassette containing transcriptional and/or translational termination signals (Figure
2.1). Ubiquitous expression of the reporter gene is dependent on Cre activity. The
floxed cassette can include a selectable marker (Araki et al., 1995; Soriano, 1999;
Mao et al., 1999) or a second reporter gene (Lobe et al., 1999; Novak et al., 2000).
In examples of the latter, the Cre reporter line expresses (3gal prior to Cre-mediated
recombination, and human placental alkaline phosphatase (hPAP) (Lobe et al., 1999)
or enhanced green fluorescent protein (eGFP) (Novak et al., 2000) following
excision of the lacZ sequence, permitting discrimination between a lack of Cre
excision and the absence of reporter expression. Despite the apparent advantages of
the double reporter system, the most widely used Cre reporter remains the R26R
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mouse, in which a floxed neomycin phosphotransferase (NEO) cassette including a
triple polyadenylation sequence was positioned upstream of lacZ, and targeted to the
ubiquitously active ROSA26 locus (Soriano, 1999). The ROSA26 locus was identified
in a promoter trap experiment, where it was observed to drive ubiquitous and robust
expression of a retrovirally integrated lacZ-NEO fusion gene throughout
development (Friedrich and Soriano, 1991). Subsequent characterisation of the
chromosome 6 locus revealed that the provirus trapped, and thus eliminated
expression of, two non-coding transcripts, but did not affect the expression of a third,
highly conserved transcript arising from the complementary strand (Zambrowicz et
al., 1997). ROSA26 mice have been widely used when ubiquitous expression of Pgal
is required, for example in aggregation chimaeras (Borthwick et al., 1999) and cell
transplantation experiments (Jiang et al., 2002). In the R26R Cre reporter line, robust
expression of Pgal is activated in Cre-expressing cells, and is maintained in all
generations of daughter cells as a result of the permanence of the genetic alteration
and the ubiquity of expression. Thus, transgenic lines used for evaluating expression
in novel, tissue-specific Cre lines are ideal tools for monitoring lineages arising from
Cre-expressing populations. This approach has been used to fate map the mid-
hindbrain border (Zinyk et al., 1998), neural-crest derivatives (Chai et al., 2000;
Jiang et al., 2000; Epstein et al., 2000), pancreatic islet cells (Herrera, 2000) and
memory T cells (Jacob and Baltimore, 1999).
2.1.4 Temporally controlled activation of tissue-specific lineage
marking
Although the combination of tissue-specific Cre expression with ubiquitous but
excision-dependent reporter activity is sufficient for many lineage studies, the
activation of the reporter at the onset of expression from the Cre transgene promoter
could be problematic in certain circumstances. For example, analysis of cell lineage
patterns in adult tissues could be complicated or rendered futile if the Cre transgene
had been expressed, and thus the reporter activated, in cells of the same tissue earlier
in development. Consequently, the utility of this strategy for adult fate mapping has
been greatly enhanced by overlaying the tissue-specificity, conferred by the promoter
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of the Cre transgene, with temporal control. This has been achieved by fusing the
Cre open reading frame with the ligand-binding domain (LBD) of the human (Indra
et al., 1999) and mouse (Danielian et al., 1998) oestrogen receptors (ERs). The LBD
acts by preventing the Cre portion of the fusion protein from interacting with the
nuclear DNA through heat shock protein (HSP)-mediated cytoplasmic sequestration
(Scherrer et al., 1993). In the presence of exogenous inducer, a synthetic oestrogen
agonist, the interaction with HSPs is disrupted and the fusion protein translocates to
the nucleus where it is able to effect site-specific recombination (Figure 2.1).
The principle of conferring regulation on protein function through the use of nuclear
receptor fusions had previously been established (Picard, 1994) when the first fusion
of Cre with the human ER (CreER) was shown to mediate oestradiol- or 4-
hydroxytamoxifen (OHT, a synthetic oestrogen analogue)-induced recombination of
a floxed selectable marker in cultured cells (Metzger et al., 1995). The authors
recognised that the sensitivity of the system to endogenous oestrogens would
undermine its use in vivo, so the first inducible Cre mouse carried the CreER1 fusion,
containing a mutation predicted to abolish activation by oestradiol but retain binding
to synthetic ligands such as tamoxifen (TAM) and its metabolite OHT (Danielian et
al., 1993). The CreER7 transgene was shown to mediate OHT-induced
recombination of a floxed allele in vivo, with no uninduced activity detectable by
polymerase chain reaction (PCR) for the presence or absence of the floxed cassette
(Feil et al., 1996). In mice expressing a similar transgene (CreERTAM), in which Cre
was fused with the murine ER containing the equivalent mutation to that in CreER7,
and driven by the K14 promoter, administration of TAM to adult mouse skin
efficiently activated the R26R reporter in the basal epidermis, including stem cells
(Vasioukhin et al., 1999). When a comparable construct {CreER™) was expressed
from the Wntl promoter, in utero administration of TAM caused approximately 25%
activation of a (3gal reporter in the embryonic nervous system. However, these
experiments revealed that the high concentration of TAM required to activate
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Figure 2.1 Schematic showing ligand-induced recombinase-mediated activation of ubiquitous reporter
expression.
In the example shown, the cell carries two transgenes: a ligand (L)-inducible Cre recombinase transgene
0CreLBD) driven by a tissue-specific promoter (TSP), and a ubiquitous promoter (UP)-driven Cre-dependent
reporter gene, in which transcription of lacZ is prevented by the triple polyadenylation (polyA) sequence
at the 3' end of the upstream floxed NEO cassette, (a) Under normal circumstances, CreLBD protein is
produced in cells expressing the tissue-specific promoter, but is cytoplasmically sequestered by heat-
shock proteins (HSP). Transcription of the Cre-dependent reporter gene does not proceed into the lacZ
sequence, (b) In the presence of exogenous ligand, the interaction between CreLBD and the HSP is
disrupted, promoting nuclear translocation of the fusion protein, where the Cre recombinase causes
excision of the floxed NEO cassette. In the absence of the transcriptional termination sequence, pgal
protein is ubiquitously produced as a result of lacZ transcription from the ubiquitous promoter.
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It had previously been noted by Schwenk and colleagues that the mutation used to
preferentially lower the sensitivity of their CreEBD construct to endogenous ligands,
identical to the mutation used by Metzger and co-workers (CreER1) (Metzger el: al.,
1995), and equivalent to the murine LBD mutation used by Danielian and colleagues
(CreER™) (Danielian et al., 1998), also caused a 100-fold reduction in affinity to
synthetic agonists (Schwenk et al., 1998). To address this, the original human ER
mutation was replaced by three new mutations, and the resulting CreER72 exhibited
an approximately 4-fold increase in affinity to OHT compared with CreER7 (Feil et
al., 1997). In vivo, the difference in sensitivity to OHT between CreER7 and CreER72
when expressed from the bovine K5 promoter, both in terms of nuclear translocation
and recombinase activity, was shown to be approximately 10-fold (Indra et al.,
1999). This experiment was elegant in demonstrating induced recombination in
proliferative basal epidermal cells, detected after supra-basal differentiation into cells
of the granular epidermal layer which specifically expressed the Cre reporter
transgene. CreER7 and CreER72 have since been used to effect temporally-regulated
site-specific recombination in a range of tissues including skin (Brocard et al., 1997),
liver (Imai et al., 2001b), nervous system (Doerflinger et al., 2003), internal epithelia
(Wen et al., 2003), adipocytes (Imai et al., 2001a), and brain (Weber et al., 2001).
While most of these studies did not involve lineage analysis per se, many of them
were proof of principle experiments for novel promoter-driven Cre fusion constructs,
necessarily using Cre reporter lines to evaluate patterns of induced expression, and
thereby demonstrating the potential of the technique for the temporal activation of
lineage marking.
One example of the use of an inducible Cre transgene for fate mapping was
demonstrated by Kimmel and colleagues, who used in utero administration of TAM
at various stages of embryonic development to characterise the location and
dynamics of the multiple borders influencing apical ectodermal ridge formation
(Kimmel et al., 2000). Given the extended time period over which the promoter
driving CreER7 expression was active, this experiment would have been significantly
less informative had the authors not been able to control the time at which lineage
marking was initiated.
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In addition to the CreER fusions described, a mutated progesterone receptor (PR)
sensitive to the synthetic steroid RU 486, has been used to regulate Cre activity
(Kellendonk et al., 1996). The CrePRl fusion was shown to induce site-specific
recombination in mouse brain, albeit with a low level of uninduced recombinase
activity. In cell culture, it was shown to perform with a similar efficiency to ER-
regulated Cre constructs (Kellendonk et al., 1999). Inducible recombination has since
been demonstrated in the skin (Arin et al., 2001; Zhou et al., 2002) and heart
(Minamino et al., 2001), though the CrePRl fusion has not been as widely used as
the various CreER constructs.
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2.1.5 Aims
The observation that LRCs identified in murine SMG ducts after tracheal epithelial
regeneration were spatially coincident with keratin-rich cells expressing a K5
promoter-driven lacZ transgene (Borthwick et al., 2001), suggested that K5 may be a
marker for this putative stem cell population. If this were the case, then analysis of
lineage arising from this K5-expressing population in response to epithelial injury
would directly reveal whether a relationship existed between these putative stem
cells and the differentiated cells of the tracheal epithelium. To this end, transgenic
mice were created which carried the CreERn inducible Cre fusion gene (Feil et al.,
1997) under the control of the human K5 promoter. While mice expressing the
T7
CreER transgene from the bovine K5 (bK5) promoter exist (Indra et al., 1999), the
pattern of bK5 promoter-directed transgene expression in the trachea has not been
characterised. Since the aim was to recapitulate the human K5 promoter-driven
tracheal expression described by Borthwick and colleagues (Borthwick et al., 2001),
the CreER72 transgene was cloned downstream of the human K5 promoter (Byrne
andFuchs, 1993).
The transgenic mouse was generated with the intention that administration of
exogenous ligand would activate permanent lineage marking, by means of a
ubiquitous conditional reporter transgene, from K5 promoter-expressing cells. An
inducible Cre recombinase was used to prevent lineage marking occurring as a result
of possible developmental or steady-state tracheal expression from the K5 promoter,
which could potentially lead to uninterpretable patterns of marked cells. Mice
carrying a K5 promoter-directed lacZ reporter transgene were created in parallel to
verify appropriate expression from the subcloned K5 promoter.
This chapter describes (1) the construction of both transgenic lines, (2) the analysis
of Pgal expression directed by the K5 promoter, and (3) the identification of
inducible Cre lines potentially useful for marking the lineage of the K5 promoter-
expressing SMG duct cells. A pilot experiment employing one of the inducible Cre
lines is described in chapter 3.
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Results
The K5 promoter-driven lacZ (K5A1) and inducible Cre (.K5CE) constructs, and the
cloning strategies used to create them, are shown schematically in Figure 2.2.
Briefly, both constructs contain the human K5 promoter subcloned into a promoter-
less vector containing an internal ribosome entry site (IRES)-enhanced green
fluorescent protein (eGFP) sequence. The IRES-eGAP was included with the
intention that it would provide a simple means of detecting transgene expression. In
K5A1, lacZ was positioned 3' of the K5 promoter, with the IRES-eGFP component
further downstream. The intron which was positioned 3' of the K5 promoter in the
parental pK5LH14 plasmid was incorporated into the K5A1 construct between the
K5 promoter and lacZ. To make K5CE, a fragment containing the inducible Cre
fusion gene CreER12 and an upstream intron, was subcloned 3' of the K5 promoter in
the pK5-eGFP intermediate from K5A1 construction. The K5A1 mouse was used as a
simple means to confirm appropriate expression from the subcloned K5 promoter
prior to use of the K5CE mouse, designed for inducible lineage analysis in the adult
trachea.
The DNA manipulations involved in the generation of these constructs are described
in detail in appendix Al. The intermediates in vector construction are named in
Figure 2.2 to allow referencing.
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Figure 2.2 Cloning strategy to generate K5A1 and K5CE transgenic mice.
Construct elements are represented by the following: CMV promoter (black triangle); K5 promoter (blue
triangle); pCI intron (yellow rectangle); lacZ gene (blue rectangle); IRES-eGFP (white-green rectangles);
CreER72 fusion gene with 5' intron (tan-red-orange rectangle). Intermediates in vector construction are
named to allow reference in main text.
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2.2 The transgenic K5 promoter-driven lacZ control
line, K5A1
The DNA manipulations required to generate the K5A1 construct are described in
appendix A1.1-3.
2.2.1 Microinjection of constructs and identification of transgenic
founders
In the absence of available cell lines known to express K5 for in vitro validation of
the construct, such as the human squamous cell carcinoma line SCC-13 (Wu and
Rheinwald, 1981; Byrne and Fuchs, 1993), pK5Al was linearised using BspHI to cut
twice in the pIRES2-eGFP-derived backbone, and microinjected into F1 fertilised
oocytes as described in chapter 7 section 7.6. The microinjection sessions are
summarised in Table 2.1. Genomic DNA prepared from ear-clip biopsies was used as
template for genotyping. A transgene-specific PCR, using primers based on lacZ
sequence, was combined with a PCR which produced a smaller product from the
genomic myogenin (jnyoG) gene, the latter serving as a control to ensure the quality
of the DNA preparations for PCR (Figure 2.3a,b).
Additional PCRs were conducted on founders identified by the GcZ-specific reaction
in order to check the 5' and 3' integrity of the transgenes, and to ensure that genomic
DNA preparations were not contaminated with the plasmids from which the
transgenes were derived. As illustrated in Figure 2.3a, an upstream-oriented primer
("5'K5") within the K5 promoter at the 5' end of the construct could generate two
PCR products of different length depending on whether it was used in conjunction
with primers "5'pos" or "5'neg". 5'pos lay in flanking vector sequence upstream of
the K5 promoter, but within the construct as defined by the BspHI sites, while 5'neg
was situated in the backbone fragment removed prior to microinjection. An
equivalent situation existed at the 3' end of the construct, with a primer in eGFP
("3'eGFP") opposing primers "3'pos" and "3'neg". Generation of a product from
PCRs of founder DNA using primer pairs 5'K5 - 5'pos and 3'eGFP - 3'pos indicated
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Total 453 281 230 178 17 4
K5CE
? ? ? ? ? 10 4
15/10/01 200 121 76 69 7 1
01/11/01 323 209 137 90 15 (4 died) 4
05/11/01 322 166 142 104 16 7
12/11/01 269 168 147 131 17 5
15/11/01 121 70 67 62 4 (1 died) 3
19/11/01 149 95 83 72 6 5
Total >1384 >829 >652 >528 70 29
Table 2.1 Summary of microinjection sessions for K5A1 and K5CE constructs.
"?" indicates that no records were available for one of the K5CE microinjection sessions, which
produced four founders from 10 offspring.
57 34 0 -
52 46 0 -
121 98 17 4
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Figure 2.3 PCR analysis of integrated K5A1 transgenes.
(a) Schematic showing the position and orientation of PCR primers on the K5A1 construct, including the
sizes of the amplification products. K5 promoter, lacZ and eGFP represented by black, blue and green
bars, respectively. The BspHI sites used to linearise the construct for microinjection, are shown, (b)
Genomic DNA samples from two positive (1,2) and two negative (3,4) potential K5A1 founders used as
template in the lacZ genotyping reaction (lacZ-F - lacZ-R, centre) and 5' and 3' integrity-checking reactions
(left and right, respectively) are shown. The lacZ genotyping reaction also includes myoG PCR primers,
which amplify a 245bp product in all four samples, indicating all samples are of PCR quality, (c) PCR
involving primers lying outside the BspHI sites, showing that both founders 1 and 2 are genuinely positive,
and not contaminated with pK5A1. M = 1kb ladder. Map not to scale, fragment sizes in bps.
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that the 5' and 3' ends of the transgene, respectively, were intact, and had not
undergone degradation prior to integration (Figure 2.3a,b). All four K5A1 founders
were found to contain intact transgenes and failed to amplify a PCR product with the
5'neg and 3'neg primers (Figure 2.3a,c). These PCRs demonstrated that both of the
reporter construct termini were present in the transgenic mice, suggesting integrity of
the transgene, and that there was no plasmid contamination of the genomic samples.
2.2.2 Analysis of K5A1 expression
The K5A1 mice were generated to ensure the subcloned human K5 promoter would
express according to published reports (Byrne and Fuchs, 1993; Byrne et al., 1994;
Borthwick et al., 2001). It was recognised that a lacZ reporter mouse would be easier
to analyse for its expression pattern than the inducible Cre mouse. Although both
constructs were designed with an IRES-eGAP sequence, with the aim of being able
to directly observe transgene expression in each line, it was recognised that
expression of the cistron downstream of the IRES is often downregulated with
respect to the first cistron, potentially limiting the usefulness of the second gene
(Mizuguchi et al., 2000). Regardless of the activity of the IRES in constructs K5A1
and K5CE, Pgal activity in the former line would provide a suitable means to assess
K5 promoter activity. K5 promoter-mediated expression was assessed by eGFP
fluorescence and xgal (or bluogal, an alternative Pgal substrate), staining in both
embryos and adult tissues.
To generate embryos for analysis of transgene expression, male founders, or male
progeny produced from crosses between female founders and C57BL/6 males, were
set up in timed matings with CD1 females. Embryos were collected at stage E15.5, as
K5 promoter activity is known to be robust at this stage, while the skin is still
permeable to fixing and staining reagents (Byrne et al., 1994). At least three E15.5
litters from each line were examined, in addition to embryos at other stages.
Genotyping was performed on genomic DNA prepared from yolk sacs or from
amputated limb or tail tissue. Both methods allowed embryos to be identified with
respect to their genotype, to confirm that phenotypically-detected transgene
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expression was associated with inheritance of the transgene, and indicated
transmission of the K5A1 transgene by all founders.
2.2.3 Embryonic expression of eGFP
Although all four K5A1 founders transmitted the transgene, analysis of eGFP by
fluorescence microscopy suggested that only two of the four lines (K5A1100,200)
expressed the transgene (Figure 2.4k-m, Figure 2.5 respectively). The pattern of
fluorescence was similar in both lines, with the strongest signal evident in the
vibrissae follicles. The follicles of the sensory vibrissae, the pinna, and the area
around the mouth also exhibited greater fluorescence than the rest of the body. The
transgene appeared more active in line K5A1200, as evidenced by a general but
subtle increase in eGFP signal over the entire embryo surface. The relative
differences in eGFP intensity predicted the presence, but not the extent, of the
variation in Pgal activity subsequently detected by xgal staining of fixed embryos.
2.2.4 Embryonic expression of (3gal
The embryonic xgal staining patterns were compared with the pattern described by
Byrne and colleagues (Byrne et al., 1994). The authors used K5 mRNA in situ
hybridisation to show faithful expression of Pgal from the same human K5 promoter
as used in these studies, in three independent lines. They first detected expression in
dorsolateral ectoderm at E9.5. Prior to the differentiation of the epidermis, K5
expression at El2.5 was most notable in the maxillary region, and subsequently in
the whisker pads. By E13.5, the K5 promoter was active in most lateral areas, though
it appeared to lag dorsally and ventrally, while expression was highest in the
vibrissae (whisker) follicles. At this stage, the first pelage (coat) follicles became
apparent as foci of Pgal production in the upper dorsolateral region. The activity of
the K5 promoter increased markedly between E13.5 and E14.5, with intense Pgal
expression in pelage follicles and in the innermost layer of differentiating
interfollicular epidermis. However, the intensity of expression remained visibly
reduced over the spine region, and also ventrally. This dorsal stripe of decreased
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promoter activity appeared to close during development to El6.5, with staining
apparent in follicles and interfollicular epithelia over the entire embryo.
2.2.4.1 Transgenic line K5A1100
E15.5 expression in line K5A1100 was observed to be predominantly in pelage
follicles, except for the face, where strong staining was evident extending dorsally
from the vibrissae follicles to the developing ear, and in patches of interfollicular
epithelia distributed over the body (Figure 2.4a-d). While uniform expression in the
vibrissae follicles and face was observed in all embryos, the extent of interfollicular
expression varied between individual embryos in the same litter. While this
observation could be related to differences in the developmental stage of littermates,
it may be a function of epigenetic modulation of transgene expression (Palmiter and
Brinster, 1986). The generally low level of interfollicular expression, and relatively
wide region of reduced dorsal staining, resembled the pattern observed by Byrne and
colleagues at E14.5 (Byrne et al., 1994) (Figure 2.4i). At E16.5, staining appeared
intense and uniform in the head region, and while pgal activity was more widespread
than at El5.5, staining in the truck remained spotted, indicating the presence of
unstained interfollicular epidermis (Figure 2.4e,f). Staining was still observed to lag
ventrally, and dorsally (data not shown).
To determine the localisation of Pgal within the layers of the skin, stained El5.5
embryos were paraffin embedded and sectioned sagittally (Figure 2.6). As expected,
bluogal staining was found localised to the single layer of cells at the junction
between the inner epidermis and the dermis. Even in non-transgenic embryos, the
boundary between the epidermis and dermis was easily distinguished on the basis of
the nuclear counterstain, which revealed significantly lower cell density in the dermis
compared to the epidermis (see Figure 2.8a). While bluogal staining was detectable
in the skin on all regions of the embryo surface (Figure 2.6b), expression in the basal
layer was not continuous. Figure 2.6b,c shows a region of the forelimb in close
proximity to the ventral trunk. Pgal activity appeared uniform in the basal layer of the
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Figure 2.6 Expression of pgal in K5A1100 embryonic epidermis.
(a) Sagittal section through bluogal stained E15.5 embryo, pgal expression was visible as thin layer around edge of
embryo, though it was difficult to visualise in the upper dorsal region, consistent with reduced dorsal and ventral
expression evident in wholemount embryos (Figure 2.4). pgal production was most conspicuous in epidermis of snout
and vibrissae follicles, (b) Magnification of blue-boxed ventral region in (a) showing adjacent ventral trunk epidermis
and developing forelimb epidermis, exhibiting patchy and continuous pgal expression, respectively. Intense staining
foci descending into trunk dermis are pelage follicles (arrowheads, (b)). (c) Magnification of boxed region in (b) showing
bluogal staining confined to the basal layer of both ventral trunk and forelimb epidermis (compare with anti-K14
immunostained embryonic skin, Figure 2.8a). (d) Magnification of red-boxed snout region in (a) showing bluogal
staining throughout layers of epidermis and vibrissae follicles. However, closer examination revealed staining was
most intense in basal epidermal layer and outer layer of follicle. Anti-pgal immunofluorescence indicated pgal expression
was confined to basal epidermis in limb (i,i), and in the basal layer of snout epidermis which was continuous with the
outer vibrissae follicle layer (e,f). (e,i) DAPI fluorescence revealed cell nuclei. (f-h,j) Anti-pgal-specific fluorescence.
No specific immunofluorescence was detected in the absence of primary (anti-pgal) antibody (g) or on non-transgenic
skin (h). Wax sections (a-d)/(e-j) were 10/7pm, counterstained with haematoxylin and eosin (a-d). Scale bar = 1600pm
(a); 100pm (b,d); 50pm (e-j); 20pm (c).
A transgenic mouse for inducible tracheal lineage analysis
occasionally observed in foci which extended into the dermal layer. These structures
are likely to be developing pelage follicles, with the lack of intervening Pgal activity
reflecting the low level of interfollicular staining apparent on the ventral (and dorsal)
surface in wholemount (Figure 2.4a-c). The region of most conspicuous Pgal activity,
when the sectioned embryo was viewed in its entirety (Figure 2.6a), was the skin
lining the snout, and the associated vibrissae follicles. On initial examination,
bluogal staining is apparent throughout the epidermal and follicular layers (Figure
2.6d), rather than being confined to basal and outer layers, respectively (Byrne et al.,
1994). To address whether this observation was the result of localised misexpression
of Pgal, or an artefact of the bluogal staining method, an anti-Pgal antibody was used
on unstained K5A1100 embryo sections. The antibody proved to be less sensitive
than the staining protocol, revealing the presence of Pgal only in the regions
corresponding to the most intense bluogal staining, including the snout region.
However, the immunofluorescence technique indicated that high levels of Pgal
production were restricted to the basal layer of the epidermis and outer follicle layer
(Figure 2.6e,f). The antibody also detected patchy Pgal production in the basal layer
of limb epidermis (Figure 2.6i,j), despite continuous bluogal staining in this region
(Figure 2.6b,c). The broader band of bluogal staining in the snout may have been the
result of bluogal reaction product leaching into neighbouring cells, or persistence of
Pgal protein into non-basal progeny of K5-expressing cells, or ectopic expression of
Pgal in non-basal layers, at a level below the threshold of detection by the antibody.
Close re-examination of the bluogal staining follicular region reveals the darkest
staining is found in a pattern consistent with the anti-Pgal immunofluorescence.
Elevated staining in surrounding non-epithelial cells, compared to that observed in
other body regions (compare Figure 2.6d and c), may suggest leaching of the stain in
this region ofhigh Pgal expression.
2.2.4.2 Transgenic line K5A1200
Examination of E15.5 embryos from line K5A1200 revealed a more uniform
expression pattern than observed in K5A1100, with the decreased dorsal and ventral
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Figure 2.8 Expression of pgal in K5A1200 embryonic epidermis.
(a) Non-transgenic embryonic skin illustrating the appearance of the dermal and epidermal layers, and
immunostained with anti-K14 antibody to identify the basal epidermis (brown staining), (b) Sagittal section
through bluogal stained E15.5 embryo, pgal expression was visible as thin layer around edge of embryo,
though it was difficult to visualise in the upper dorsal region, consistent with reduced dorsal and ventral
expression evident in wholemount embryos (Figure 2.7). pgal activity was highest in epidermis and
vibrissae follicles of the snout, (c) Magnification of blue-boxed ventral region in (b) showing continuous
epidermal pgal expression. Arrowhead shows region of apparent stain leaching into dermis, (d) Magnification
of boxed area in (c) including a section of reduced epidermal pgal which appeared to exhibit basally-
restricted transgene expression, (e) Magnification of red-boxed snout region of (b) revealing intensely
stained epidermis and surface follicles. Non-staining follicles were likely internal and inaccessible to stain.
Arrows represent extent of apparent stain leaching, (f) Magnification of green-boxed region in (b), showing
apparent staining of all epidermal layers in head region (top of image), and less intense and continuous
staining in ventral trunk. Area between arrowheads in (f) showed stronger expression basally than in
supra-basal layers, possibly suggesting apparent supra-basal pgal expression was artefactual. Wax
sections cut at 10pm and counterstained with haematoxylin and eosin (b-f), except (a), eosin and anti-
K14 antibody. Scale bar = 1600pm (b); 100pm (c,e,f); 20pm (d); 10pm (a).
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(Byrne et al., 1994) (Figure 2.7i(d-f)). Even at E13.5, widespread staining was
evident to the extent that pelage follicles were not obvious, indicating significant
interfollicular staining (Figure 2.7a-c). By late E16.5, staining was uniform except
for a ventral patch, which may have been due to localised reduction in epidermal
permeability at this developmental stage (Figure 2.7h,g). Sagittal sections of E15.5
embryos (Figure 2.8b) revealed that epidermal expression, which was interrupted by
non-staining patches less frequently than in K5A1100, resembled that observed in the
snout region of K5A1100 (Figure 2.8c-e). While [3gal production was visibly most
intense in the basal layer, staining was also present in the supra-basal layers.
Apparent diffusion of bluogal product into the dermis (Figure 2.8c), and tissue
underlying the snout epithelium (Figure 2.8e), where the K5 promoter is unlikely to
be active, suggested the metabolised stain could diffuse beyond its site of production.
Hence, diffusion upwards into the supra-basal epidermis could explain the apparent
epidermal-wide staining observed in K5A1200 embryonic skin. Unfortunately,
K5A1200 embryos were not available at the time of anti-|3gal antibody staining.
2.2.5 Adult expression of K5A1
Although eGFP expression was insufficiently intense to permit genotyping of live
neonate or adult mice using a hand-held UV lamp (Okabe et al., 1997), transgenic
K5A1100,200 mice could be differentiated from non-transgenie littermates on the
basis of eGFP fluorescence in ear-clip biopsies (Figure 2.9). However, in practice,
genotyping was always confirmed by PCR.
Byrne and colleagues demonstrated that the 6.2kb human K5 promoter directed pgal
expression in all examined stratified epithelial tissues, consistent with the expression
profile of the endogenous K5 gene (Byrne and Fuchs, 1993). A subset of these
tissues were taken from K5A1 animals (n = four per line) for detection of Pgal
activity by wholemount xgal staining. Although a minority of the animals may have
been homozygous for K5A1, no significant differences in staining were observed
between mice of the same line. While staining was observed in pinna from both lines







Figure 2.9 Expression of eGFP in K5A1100 and K5A1200 pinna tissue.
Unfixed ear-clips and whole pinnas were examined using fluorescence microscopy for eGFP expression,
(a) Whole pinnas from K5A1200 were easily distinguished from non-transgenic pinnas, while K5A1100
pinnas were only subtly more fluorescent, (b-d) Ear-clips at higher magnification. Although K5A1200 ear-
clips (d) were always unambiguously fluorescent, confident detection of eGFP in K5A1100 ear-clips (c)
required comparison with a non-transgenic sample (b). Scale bar = 400um.
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stained (Figure 2.11a-c), albeit in a non-uniform and apparently variegated manner.
The poor staining in these adult tissues is likely due in large part to the fact that they
are all epidermal tissues possessing a stratum corneum, which constitutes a
significant barrier to penetration by liquids. Such is the relative impermeability of the
epidermal layer that the skin of intact post-El6.5 homozygous ROSA26 embryos,
which express characteristically ubiquitous and high levels of (3gal, fails to stain
significantly after incubation with xgal (data not shown). The reasonable amount of
staining observed in back skin (Figure 2.11) was attributed to unintentional damage
of the epidermal surface by the razor used to depilate the sample. Back skin samples
from transgenic littermates shaved using an electric trimmer showed significantly
reduced staining, with most positive cells clustered along the cut edge. Improved
detection of (Igal expression in epidermal tissues by Byrne and colleagues is
probably a consequence of their methodology, which involved cryosectioning before
staining, thus avoiding the problem of stain penetration (Byrne and Fuchs, 1993).
The lack of detectable staining in the oesophagus in this study (data not shown),
which is known to express endogenous K5 and is readily accessible to the stain, is
consistent with the previous report, in which only a few basal cells were observed to
express the transgene (Byrne and Fuchs, 1993).
The observation that (3gal was produced in significant levels in the pinna of both
lines, and was detectable by wholemount xgal staining, indicated its potential
usefulness as a surrogate tissue in which to evaluate K5 promoter-driven expression
in the K5A1 lines, as well as in other lines discussed subsequently. The low density
of hair follicles in the pinna, and the thin profile of the tissue which presents both
dorsal and ventral surfaces, facilitates efficient stain penetration. Stained pinna were
paraffin embedded and sectioned to determine the localisation of the lacZ signal. The
pinna in cross-section comprises two layers of skin (epidermis and dermis) separated
by a central band of cartilage (Figure 2.10b). Depending on the plane of section,
patches of skeletal muscle can be seen in the dorsal surface. The stratum corneum of
keratin-rich dead squames tended to separate from the epidermal surface during
sectioning, and could normally be seen lying parallel to the surface, to which it often
remained attached at hair follicles.
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Figure 2.10 Expression of pgal in adult K5A1100 pinna.
(a) Wholemount xgal treated pinna showing staining parallel to cut edges where stain can most easily
penetrate tissue. If the level of pgal is sufficient, staining can result from the reagent entering the dorsal
and ventral surfaces, as in the case of the ROSA26 pinna (i). (b) Section through the stained portion of
the pinna, revealing Pgal activity in the epidermis, hair follicles (boxed) and associated sebaceous glands
(arrowhead). Staining was mostly continuous, but non-uniform in intensity. CA = cartilage, DE = dermis,
EP = epidermis, SC = stratum corneum. (d) Magnification of boxed region in (b) showing epidermal
expression continuous with the hair follicle, (f) Arrowheads indicate unstained supra-basal cells, suggesting
expression was basal epidermis-specific, (c) Patches of discontinuous staining co-localise to layer defined
by anti-K14 antibody (brown staining), (e) Magnification of boxed region in (c), showing pgal- and K14-
negative supra-basal cells (arrowheads). Confinement of staining to epidermis was not the result of
incomplete stain penetration, as shown by sectioned ROSA26 pinna 0)- No staining was observed in
non-transgenic littermate (g,h). Wax sections were cut at 10pm and counterstained with haematoxylin
and eosin (b,d,f,h,j), or eosin and anti-K14 antibody (c,e). Scale bar = 1600pm (a,g,i); 100pm (b,h,j);
20pm (c,d,f); 10pm (e).
Figure 2.11 Expression of pgal in adult K5A1200
tissues.
(a) Back skin stained patchily with xgal when depilated
using a razor blade, which presumably damaged
the surface and facilitated stain penetration. Staining
was poor in tail skin (b) and tongue (c), likely in part
due to the impermeability of these tissues, (d) Pinna
showed strong pgal activity parallel to cut edges, (e)
Section through stained portion of pinna revealed
frequent patches of strong staining in epidermis, and
stained sebaceous glands (boxed). Staining which
appeared to descend into the dermis (arrowhead)
implied that xgal signal was more diffuse than the
site of expression it represented, suggesting that apparent pgal activity in supra-basal layers may have
been a visual artefact of high levels of metabolised xgal in basal layer, (g) Magnification of boxed region
in (e) showing unstained supra-basal cells (arrowheads), (f) Region of patchy expression showing co-
localisation of xgal staining with anti-K14 signal (brown staining), (h) Magnification of boxed region in (f)
clearly showing basal location of pgal-positive cells and the presence of non-xgal staining supra-basal
cells (arrowheads). For staining controls, see Figure 2.10(g-j). Wax sections were cut at 10urn and
counterstained with haematoxylin and eosin (e,g), or eosin and anti-K14 antibody (f,h). Scale bar =
1600pm (d); 400pm (a); 200pm (b,c); 100pm (e,f); 20pm (g); 10pm (h).
A transgenic mouse for inducible tracheal lineage analysis
While neither line exhibited uniform production of Pgal in the basal layer, K5A1100
showed lacZ expression in a high proportion of basal epidermal cells, in addition to
the hair follicles and sebaceous glands, known sites of significant K5 expression
(Byrne et al., 1994) (Figure 2.10). Expression mK5A1200 appeared more variegated
than in K5A1100, with more frequent and extensive non-staining regions (Figure
2.1 le), in apparent contrast to the embryonic situation, where interfollicular staining
was markedly more continuous than in the latter line. However, the high intensity of
xgal staining observed in K5A1200 embryos was reflected in adult pinna, with Pgal
activity not obviously restricted to the basal layer of the epidermis (Figure 2.1 lg).
The use of an antibody directed against the K5 binding partner K14 demonstrated
that small groups of lacZ expressing cells were basal (Figure 2.1 lf-h). It is clear that
the subset of epidermal cells expressing the transgene do so at a high level. It seems
likely that, as shown using the anti-Pgal antibody in the vibrissae pad region of
K5A1100 embryos (Figure 2.6e,f), strong Pgal production in the single cell basal
layer of the epidermis, which is in itself only a few cells thick, results in a slightly
diffuse xgal signal not precisely faithful to the pattern in which Pgal is expressed.
The occasional observation that staining can appear to extend into the dermal layer
(Figure 2.8e), in a region sparsely populated with cells, supports the idea that
apparent supra-basal expression in K5A1200 is an xgal artefact resulting from high
levels of Pgal.
2.2.6 Tracheal expression of K5A1
Although the K5A1 lines were generated primarily to confirm that the subcloned K5
promoter was driving transgene expression broadly consistent with published
descriptions (Byrne and Fuchs, 1993; Byrne et al., 1994), tracheas from
K5A1100,200 mice (n = four K5A1 and three non-transgenic tracheas per line) were
examined for Pgal activity in SMGs, as reported by Borthwick and colleagues
(Borthwick et al., 2001) (no eGFP fluorescence was detectable in tracheas).
Wholemount xgal stained tracheas were cut dorsally along the gaps in the cartilage
C-rings, and pinned out to allow visualisation of the ventral surface. Staining was
apparent in a band across the proximal (upper) trachea, consistent with the location
69
A transgenic mousefor inducible tracheal lineage analysis
of tracheal glands (Figure 2.12i,ii(a,b)). Endogenous galactosidase activity was
detected in the thyroid glands, and has been described previously (Borthwick, 1999).
The thyroid glands flank the proximal trachea, resulting in thyroid staining being
visible through the glandular region of pinned out tracheas. This gave the superficial
appearance of intense staining in the tracheas of non-transgenic littermates. While
closer examination revealed thyroid staining was partially responsible for this
observation, stained tracheal glands were apparent in non-transgenic mice (Figure
2.12iii(a,b)). Occasional, weak background staining of SMGs in wild-type tracheas
was also noted by Borthwick (Borthwick, 1999).
Tracheas were sectioned parallel to the proximal-distal axis and the SMGs, most of
which are located between one of the proximal cartilage rings and the luminal
surface, were examined for xgal staining (Figure 2.12i-iii(c-e)). K5A1100 tracheas
demonstrated robust staining in cells lining the majority of glands. Staining appeared
stronger and more widespread than previously reported (Figure 2.12i(h) (Borthwick
et al., 2001). Consistent with the previous study, stained surface epithelial cells were
observed in the proximal trachea (distal to the glandular region), but not in the distal
trachea (Figure 2.12i(a,f,g)). Xgal staining in K5A1200 SMGs was generally at a low
level, though a minority of strongly staining glands were consistently apparent
(Figure 2.12ii(c-e)). Staining in surface epithelial cells was faint and infrequent
proximally, and absent distally (Figure 2.12ii(a,f,g)). The extent of genuine Pgal
activity in K5A1 tracheas became unclear after examination of sectioned non-
transgenic tracheas. While the intensity of staining varied between non-transgenic
tracheas (strong and weaker examples are shown in Figure 2.12iii(c,d and e,
respectively)), it was consistently detected, appearing to localise to the lining of
glands. Unlike in the K5A1 tracheas, no surface epithelial cells were observed to
stain in either proximal or distal regions of non-transgenic tracheas (Figure
2.12iii(f,g)). While staining in K5A1 glands was typically more intense than in non-
transgenic glands, the strongest staining was often found in the basal portions of
gland structures (Figure 2.12i(e),ii(c,d)), while Borthwick and colleagues noted xgal
stained cells primarily in gland ducts just below the tracheal luminal surface (Figure
2.12i(h)) (Borthwick et al., 2001). An anti-Pgal antibody was used on sectioned
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K5A1 tracheas in an attempt to visualise only the bacterial galactosidase. However,
as illustrated previously in Figure 2.6, where only the regions showing the highest
level of xgal staining were positive with the antibody, immunofluorescence on wax
sections was considerably less sensitive than xgal staining, and no signal was
apparent from tracheas of either line (data not shown). The SMG staining patterns
are discussed further in section 2.4.1.3.
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2.3 The transgenic K5 promoter-driven inducible Cre
line, K5CE
The DNA manipulations required to generate the K5CE construct are described in
appendix Al.l and A1.4.
2.3.1 Microinjection of constructs and identification of transgenic
founders
Since no restriction enzymes were predicted to cut pK5CE twice within flanking
vector sequences but not within the construct, as BspHI did in pK5Al, the single
cutter Sfil was used to linearise the vector for microinjection. The microinjection
sessions are summarised in Table 2.1. Founders were identified using primers
specific for the Cre portion of the fusion gene (Figure 2.13). PCRs using myoG
primers were performed separately to ensure the ear-clip genomic DNA preparation
was of sufficient quality (data not shown). The Sfil site separated the 3'eGFP primer
sequence from the 3'neg primer sequence, thus allowing this primer pair to be used
to check genomic genotyping samples for plasmid contamination (the 5'neg and
5'K5 primer sequences were not separated by Sfil digestion and therefore could not
be used for this purpose, Figure 2.13a). No contamination was detected (data not
shown). As for the K5A1 lines, 5'K5 - 5'pos and 3'eGFP - 3'pos reactions
demonstrated the presence of intact transgene termini in all 29 founder animals (data
not shown).
2.3.2 Identification of K5CE lines demonstrating inducible Cre-
mediated recombination
Although the trachea was the site of interest for K5CE expression, it was expected to
be confined to a small subset of SMG and luminal epithelial cells, as observed for the
K5 promoter-driven lacZ transgene (section 2.2.6 and (Borthwick et al., 2001)).
Rather than examine tracheas for low levels of transgene expression, the robust












Figure 2.13 PCR analysis of integrated K5CE transgenes.
(a) Schematic showing the position and orientation of PCR primers on the K5CE construct, including
the sizes of the amplification products. K5 promoter and eGFP represented by black and green bars,
respectively. The integrity-checking PCRs and plasmid contamination control PCRs are as shown for
the K5A1 transgene in Figure 2.3, except for the 5'K5 - 5'neg plasmid contamination control PCR, which
is uninformative in the Sfil linearising digest used, (b) Genomic DNA samples from two positive K5CE
founders used as template in the Cre genotyping reaction (Cre-F - Cre-R) are shown. M = 1 kb ladder.
Map not to scale, fragment sizes in bps.
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which the transgene was active, and thus worthy of further examination. Based on
analysis of the two K5A1 lines previously described, it was anticipated that eGFP
expression would allow expressing lines to be easily identified by ear-clip biopsy
and/or in embryos. However, fluorescence microscopic analysis of ear-clips from
each of the founders did not reveal the presence of eGFP protein (data not shown).
Furthermore, no fluorescence was detected in embryos from 12 independent lines,
despite the fact that litters from at least eight of the lines were confirmed as
containing AGCE-positive embryos (data not shown).
The absence of a visual marker of transgene activity necessitated the use of
approaches to directly evaluate the expression (transcription and/or translation) of the
T2 ....CreER fusion gene. Since the techniques required would not be suitable for
screening all 29 lines generated, seven known transmitting lines were chosen for
further analysis (K5CE100,300,500,600,700,800,1100).
2.3.3 Immunodetection of CreER72 in embryonic epidermis
To evaluate the production of CreER12 protein, hemizygous El5.5 embryos from
each of the lines were sectioned and immunostained with a rabbit polyclonal anti-Cre
antibody. Embryos were used in preference to adult skin because the thin and
hairless skin is easily sectioned, and K5 expression is known to be confined to the
basal epidermis by E15.5, thus providing an expected pattern of expression to
compare against the antibody signal. An embryo known to express the conventional,
non-inducible form of Cre from the bovine K5 promoter in basal epithelia (line
bK5Cre, A. Ramirez, unpublished results, courtesy of D. Melton) was used as a
positive control, since it was recognised that, despite the polyclonal origin of the
antibody, the presence of the ER component may affect its immunoreactivity. While
the bK5Cre embryo exhibited strong fluorescence specific to the basal epidermal
layer, no signal was evident in any of the K5CE embryos (Figure 2.14).
Several explanations, in addition to the obvious interpretation that no protein was
present, could have accounted for this result. As mentioned, the epitopes recognised
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Figure 2.14 Anti-Cre immunofluorescence on K5CE embryonic skin.
E15.5 embryos from seven K5CE lines were sectioned and stained with a polyclonal anti-Cre primary
(1°) antibody and fluorescent secondary antibody. Staining distinguishable from non-transgenic embryos
(h) or transgenic embryos treated only with secondary antibody (g) was not detected in any of the lines.
K5CE1100 is shown to represent the K5CE lines (a-c), although it was the only line showing any potential
expression. A single cell appears positive (arrowhead, b). Failure to detect Cre protein in K5CE lines
was not the result of the technique or reagents, since Cre was detected in identically processed embryos
from line bK5Cre, which expresses conventional (non-fusion) Cre protein from the bovine K5 promoter
(d-f). Wax sections were cut at 7pm. DAPI fluorescence shows cell nuclei. Scale bar = 20pm.
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by the anti-Cre antibody may have been altered or inaccessible on the CreERT2
fusion protein. In the absence of TAM, which stimulates nuclear accumulation of the
fusion protein, CreER12 would have remained cytoplasmic, potentially resulting in a
weak signal compared to nuclear-localised, conventional Cre protein. Indeed, it has
previously been shown using anti-Cre immunofluorescence on sectioned tails from
T2CreER mice before and after systemic TAM administration that, while anti-Cre
signal was low in uninduced tail skin, robust fluorescence was evident in cells in
which TAM-induced nuclear translocation had occurred (Indra et al., 1999).
Alternatively, or additionally, CreER12 production in the K5CE lines may have
occurred at a significantly lower level than that of Cre in bK5Cre, possibly below the
threshold of immunodetection. S. Webb provided some technical assistance with
establishing the anti-Cre immunoassay.
2.3.4 Analysis of K5CE expression in adult skin
In order to determine whether the transgene was being transcribed in any of the
seven lines, RNA was extracted from adult hemizygous backskin and reverse
transcribed to complementary DNA (cDNA) for use as template in PCRs specific for
Cre (Figure 2.15). Robust products were evident from lines
K5CE100,500,600,700,1100, and a faint signal was apparent from K5CE300. No
product was visible from K5CE800, or in non-transgenic controls. The identity of the
Cre amplification products was confirmed by hybridisation with a radiolabelled
internal Cre oligonucleotide (Figure 2.15c). Thus, of seven lines analysed, only one
appeared detectably devoid of CreER72 transcript in skin samples.
2.3.5 A functional assay for inducible Cre-mediated recombination
Given the presence of detectable Cre transcript in six of seven lines tested, a
functional assay was used to evaluate whether this translated into levels of protein
capable of effecting induced recombination at loxP sites. The Cre-dependent lacZ
reporter locus R26R (Soriano, 1999) was introduced into the genome of K5CE mice






Figure 2.15 RT-PCR for expression of CreERT2 in skin of seven K5CE lines.
RNA was isolated from the back skin of mice representing seven K5CE lines. RNA was DNase-treated
before cDNA was prepared and equal amounts used as template in Cre-specific PCRs. (a) Schematic
of CreERT2 portion of the K5CE transgene, showing position of internal Cre oligonucleotide probe (blue
bar) with respect to Cre-specific PCR primers. (b(i)) After 30 cycles, PCR product was generated from
all lines except K5CE800, though signal was very weak in K5CE300. No product was generated by two
non-transgenic littermates (n-t) or by the dH20 control subjected to reverse transcription. Non-transgenic
and dH20 samples used only in PCR step were also negative, while product was generated from K5CE
genomic DNA (gDNA). (ii) RNA and control samples put through the reverse transcription protocol in
absence of reverse transcriptase (RT) enzyme (-RT) were all negative, indicating the absence of
contaminating gDNA. (iii) Using GAPDH primers to control for RNA quality generated comparable PCR
products from all samples, while dH20 controls remained negative, (iv) GAPDH -RT reactions were
negative, (c) RT-PCR products in (b(i)) were transferred to a nylon membrane and hybridised with a
labelled 18mer internal Cre oligonucleotide (a) which confirmed the identity of the PCR product and the
absence of low levels of product in negative controls. M = 1 kb ladder. Map not to scale, fragment sizes
in bps.
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equivalent for all lines, with some involving R26Rtg/wt, and others R26Rtg/'8, animals.
Also, intercrosses were used to increase the proportion of compound K5CEtg R26Rtg
animals obtained, with a concomitant increase in the incidence of homozygosity at
both loci. As a randomly integrated transgene, PCR could not be used to distinguish
animals hemizygous and homozygous for K5CE. While a PCR assay was
subsequently developed to discriminate hemizygosity and homozygosity for the
R26R transgene (chapter 3, Figure 3.3), it was not available at the time of these
experiments.
Since the number of K5CE and R26R loci could influence the frequency of Cre-
mediated activation of Pgal production from R26R, it was important to be aware of
the differences in potential genotype of the animals used in the assay. While this was
less crucial for the K5CE transgene, where hemizygous copy number was likely to
vary by more than two-fold between lines (confirmed in section 2.3.6), doubling the
number of R26R loci would in principle double the cellular targets for Cre action. For
this reason, the probability of hemizygosity and homozygosity for each transgene, of
the animals used from each of the lines, was calculated from known genotypes of
their ancestors (Table 2.2).
Inducible Cre activity was assayed using a method of topical administration modified
from Vasioukhin and colleagues (Vasioukhin et al., 1999) (B. Stripp, personal
communication), exploiting the pinna as an epidermal tissue more accessible to
soluble reagents than the skin, and which was amenable to biopsy analysis. Figure
2.16 shows a schematic of the experiment. Two K5CEtg R26Rtg compound transgenic
animals from each line received topically applied TAM in dimethyl sulphoxide
(DMSO) to both surfaces of the pinna. Two doses of TAM were evaluated, with the
two pinna of each mouse receiving approximately lOmg and 5mg, respectively,
every day for five consecutive days. Ear-clips were taken from both pinna of each
animal on the day following the final treatment, and stained with xgal. In each
experiment, at least one K5CEwt R26Rtg single transgene-positive control animal was
processed identically. One compound transgenic mouse from each line received
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K5CE line K5CE R26R
100
tg/tg 0.33 tg/tg 0.33
tg/wt 0.66
tg/wt 0.66 tg/tg 0.33
tg/wt 0.66
300
tg/tg 0.33 tg/tg 0.33
tg/wt 0.66
tg/wt 0.66 tg/tg 0.33
tg/wt 0.66
500
tg/tg 0.33 tg/tg 0.5
tg/wt 0.5
tg/wt 0.66 tg/tg 0.5
tg/wt 0.5
600
tg/tg 0.33 tg/tg 0.33
tg/wt 0.66
tg/wt 0.66 tg/tg 0.33
tg/wt 0.66
700 tg/wt 1.0 tg/wt 1.0
800
tg/tg 0.33 tg/tg 0.33
tq/wt 0.66
tg/wt 0.66 tg/tg 0.33
tg/wt 0.66
1100 tg/wt 1.0 tg/tg 0.5
tg/wt 0.5
Table 2.2 Predicted frequencies of hemizygosity and homozygosity for the K5CE and R26R
transgenes in compound transgenic mice from seven K5CE lines used in the tamoxifen ear-painting
assay.
The breeding strategies were not equivalent for each of the seven K5CE lines, with the result that mice
homozygous for one or both of the transgenes would be more common for some lines than others.
Since the number of transgenes could theoretically affect the frequency of recombination observed in
response to tamoxifen (TAM) treatment, it was desirable to know the hemizygosity/homozygosity status
of the mice used from each line in the TAM ear-painting assay. However, no simple means of
assessing the hemizygosity/homozygosity status of individual mice was available at the time of the
experiment. Therefore, breeding records were used to predict probabilities of transgene inheritance
(assuming Mendelian inheritance, and that the transgenes were unlinked) at each of the crosses used
in the generation of the litters from each line used in the assay. For each line, final probabilities of
hemizygosity and homozygosity for the K5CE transgene are shown, where 1.0 is 100% probability of
the genotype shown. For each K5CE genotype (tg/wt or tg/tg), the probability of tg/wt or tg/tg for R26R
is shown. Since only compound transgenic mice should show Cre-dependent recombination, mice
carrying only one of the transgenes, and non-transgenic mice, are excluded.
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Figure 2.16 Tamoxifen ear-painting regime used to identify functionally expressing K5CE lines.
Of the three K5Clzg R26P!'1 compound transgenic mice from each of seven K5CE lines used in the ear-
painting assay, two received two different concentrations of topically administered tamoxifen (TAM) in
dimethyl sulphoxide (DMSO) to each pinna for five consecutive days. The third animal received DMSO
alone to both pinna. In each experiment, at least one K5CE R26R19 mouse received TAM as per the
K.5CE!9 R26R/ animals. 50pl of solution was applied using a micropipette, and a cotton bud stripped of
most of the cotton was used to "paint" the solution over dorsal (outside) and ventral (inside) surfaces of
the pinna. Two ear-clips were taken from each pinna on the day following the final treatment, and fixed
before xgal staining. Stained ear-clips were examined wholemount prior to sectioning (Figure 2.17).
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DMSO in the absence of TAM. No adverse effects on the health of the animals were
observed.
Wholemount stained earclips were inspected for the presence of |3gal positive cells
(Figure 2.17). Stained cells were evident in ear-clips from all K5CE lines except
K5CE800, the only line which appeared completely negative for K5CE transcription
by RT-PCR (see Figure 2.15). K5CE100,300,500 all exhibited low numbers of
stained cells, which appeared marginally more frequent in K5CE300 than in
K5CE100,500 (Figure 2.17a-d(i), K5CE500 not included). However, approximately
equal numbers of stained cells were present in both DMSO and TAM treated ear-
clips from these lines, indicating insignificant inducibility of recombinase activity.
Contrastingly, significant numbers of xgal stained cells were visible in ear-clips from
K5CE600,700,1100 animals treated with TAM (Figure 2.17e-j). Both ears from each
mouse showed a comparable amount of staining, though difficulties in accurate TAM
administration prevented conclusions being drawn regarding dosage (discussed in
section 2.4.2.2), and the extent was similar in both TAM treated mice from each line
(data not shown). Table 2.2 shows that the observed activity in K5CE600,700,1100
T2
compared to K5CE100,300,500, which all expressed CreER transcript (see Figure
2.15), was not the result of increased probability of homozygosity of either transgene
in the former lines. Overall, the frequency of staining observed was
K5CE600<1100< 700. While significantly more Pgal positive cells were present after
TAM treatment than after application of DMSO alone, more stained cells were
apparent in ear-clips from the DMSO control mice of lines K5CE600,700,1100 than
in the TAM or DMSO treated ear-clips from the remaining lines. Given the complete
absence of detectable xgal staining in the TAM treated K5CEHl R26Rtg controls
(Figure 2.17k(i)), and in all ear-clips from K5CE800 (not shown), this indicated a
"background leakiness" of TAM-independent Ore activity which correlated with the
potential for inducible activity. Although the ER component of CreER72 had been
modified to reduce its sensitivity to endogenous oestrogen (Feil et al., 1997), the
CreER72 fusion protein, and analogous constructs, are known to mediate a low
frequency of recombination in the absence of exogenous inducing agents
(Vasioukhin et al., 1999; Kellendonk et al., 1999; Weber et al., 2001).
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Figure 2.17 Results of functional assay for Cre-mediated recombination after topical application of
tamoxifen to mouse pinna (continued from previous page).
Representative wholemount and sectioned ear-clips are shown for K5C£'9 R26R*g animals from five K5CE lines (a-
j(i-iii)), plus a K5CE* R26R'9 control (k(i-iii)). Sections are shown at x10 magnification (a-k(ii)), which reveals the general
frequency of staining, with boxed regions magnified to x63 (a-k(iii)) to demonstrate epidermal localisation of pgal-
positive cells. Staining was equivalent after treatment with 5mg or 10mg tamoxifen (TAM). For each line, the TAM and
DMSO treated ear-clips exhibiting the most extensive staining are shown. K5CE500.800 are not included because
K5CE500 showed very similar staining to K5CE100, and no staining was evident in K5CE800. Infrequent stained cells
were visible on whole mount ear-clips from K5CE100,300 (arrowheads, a-d(i)). While slightly more cells were evident
on the latter, there was no obvious difference between the TAM and DMSO treated ear-clips of either line. No (3gal-
positive cells were encountered during sectioning of K5CE100 earclips (a,b(i,ii)), though stained hair follicle ceils were
detected on a TAM treated K5CE300 section (d(i,ii)). DMSO treated ear-clips from K5CE600,700,1100 showed similar
background of uninduced recombination (e,g,i(i)) with stained cells visible in sections from K5CE600.1100 (e,i(ii,iii)).
After TAM treatment, significantly elevated numbers of stained cells were observed in all three lines (f,h,j(i-iii)). As
confirmed by anti-K14 antibody staining on K5CE600 sections, (igal-positive cells were generally confined to the basal
epidermis, however an apparently supra-basal stained cell was evident (arrowhead, j(iii)). No figal activity was detected
in K5CE"^ R26Ftg ear-clips treated with TAM (k(i-iii)). Wax sections were cut at 10pm and counterstained with
haematoxylin and eosin, except (f(ii,iii)), haematoxylin and anti-K14 antibody. Scale bar = 400pm (a-k(i)); 50pm (a-
k(ii)); 20pm (a-k(iii)).
A transgenic mousefor inducible tracheal lineage analysis
Sectioning of the stained ear-clips revealed Pgal to be mostly confined to the basal
epidermal layer in K5CE600,700,1100 (Figure 2.17e-j(ii-iii)), indicating that
differentiation of recombined basal cells into supra-basal descendants had not
occurred in during the 5-day experiment. Due to the low frequency of stained cells
on K5CE100,500,800 ear-clips, and on DMSO-treated ear-clips from lines
K5CE600,700,1100, few or no stained cells were encountered upon sectioning of
these tissues. Despite a low incidence of (3gal expression in K5CE300, xgal stained
hair follicles were apparent in one ear-clip section (Figure 2.17d(iii)). Anti-K14
immunostaining of a TAM treated K5CE600 ear-clip provided additional
confirmation of the basal location of Pgal expressing cells (Figure 2.17f(ii,iii)).
The unambiguous correlation between TAM treatment and the number of cells
exhibiting Pgal activity detected after pinna biopsy, strongly suggested that xgal
staining was the result of induced Cre activity facilitating transcription of lacZ from
recombined R26R loci. An association between Pgal production following TAM
administration, and excision of the floxed component of the R26R transgene, was
subsequently demonstrated using a PCR assay (chapter 3, Figure 3.10).
2.3.6 Determination of relative transgene copy number
Although six of seven K5CE lines expressed the CreER72 transcript, only three lines
demonstrated inducible recombinase activity. Given this apparent lack of a clear
T2
correlation between transcription and translation of CreER (assuming that the
inability to detect recombinase activity reflected an absence of CreER12 protein),
variation in K5CE transgene copy number between the lines was assessed to
determine whether this was a more useful predictor of functional K5CE lines. This
was achieved by Southern hybridisation of Bglll digested genomic DNA (gDNA)
with a radiolabelled Cre-specific PCR probe (Figure 2.18). Densitometric
quantification of signal intensities was achieved using a phosphorimager. As a result
of the difference in specific activities of the Cre and CFTR probes, evident from
Figure 2.18d(ii), accurate determination of absolute copy number, by assuming the
CFTR signal was representative of two gene copies and comparing with Cre signal,
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Figure 2.18 Relative transgene copy number analysis
of seven K5CE lines.
Genomic DNA (gDNA) from mice representing seven
K5CE lines, plus non-transgenic (n-t) littermate gDNA,
was digested with Bglll, transferred to a nylon '
membrane, and hybridised with probes specific for Cre
and CFTR. CFTR was used as a known single-copy
gene with which to normalise Cre hybridisation results
for differences in DNA loading, (a) Map of Sfil linearised
K5CE construct showing position of Cre-F - Cre-R2
PCR primers, within the Cre portion of CreERT2, with
respect to Bglll restriction sites. The Cre PCR product
was predicted to hybridise specifically to the 221 Obp
Bglll fragment (shown in green), (b) Bglll digest of
pK5CE, confirming predicted restriction pattern (16bp
fragment too small to visualise). Digestion of pK5-
eGFP confirms that 2.2kb and 0.6kb fragments arise
from subcloned CreERT2 element, (c) Map of Bglll and
Hindlll sites surrounding exon 10 (Ex 10) of CFTR on
chromosome 6. The CFTR probe was a 1244bp Hindlll fragment (shown in blue), which is bisected by
a Bglll site. Thus, the probe was predicted to hybridise to 1259bp and 869bp Bglll fragments, with which
it contains 901 bp and 343bp of complementarity, respectively (brackets), (d) Bglll digested gDNA was
separated on 1.8% gel, which revealed comparable loading of samples (i). (ii) Phosphorimager representation
of membrane after hybridisation with radiolabelled Cre PCR probe and CFTR restriction fragment probe.
Cre signal was robust in all K5CE samples (no signal evident in n-t control), but both CFTR fragments
appeared faint, (e) Densitometric analysis was performed by dividing each Cre value by the corresponding
1.2kb CFTR value. The ratio was then simplified by setting the lowest value (K5CE1100) to 1, adjusting
the others proportionally, and rounding off (Adj.). This does not indicate absolute transgene copy numbers,
but reflects the fold difference in relative numbers between lines. M = 1kb ladder. Map not to scale,
fragment sizes in bps. Bracketed fragment sizes indicate proportion of total fragment size.
K5CE Cre/
Line Cre CFTR CFTR Adj.
n-t 6887.68 8955.67 0.8 -
100 19281.21 10921.46 1.8 1
300 31591.99 13480.22 2.3 1
500 1595074.8 14434.65 11.1 7
600 53724.28 12641.39 4.2 3
700 21862.52 10635.87 2.1 1
800 48663.77 8902.74 5.5 3
1100 13991.98 8466.66 1.7 1
A transgenic mousefor inducible tracheal lineage analysis
was not valid. However, after normalisation of the Cre hybridisation signal from
each line with the corresponding CFTR signal, which controlled for discrepancies in
DNA loading and lane-specific background hybridisation, values representing
approximate fold differences in copy number were obtained (Figure 2.18e). Four of
the lines (K5CE100,300,700,1100) were observed to have approximately equal
numbers of transgenes, with two lines exhibiting 3-fold higher numbers
(.K5CE600,800). The remaining line (K5CE500) was calculated to carry 7-fold more
copies than the four lowest copy number lines. F. Kilanowski provided some
technical assistance with the radioactive work.
2.3.7 Analysis of K5CE expression in the trachea
Having identified three K5CE lines in which epidermal activation of a ubiquitous
reporter transgene could be induced through the administration of exogenous ligand,
it was desirable to determine whether the K5CE transgene was expressed in the
trachea. RNA samples were prepared from K5CE600,700,1100 tracheas, as well as
from non-transgenic control and bK5Cre tracheas. The bK5Cre line had previously
been used in anti-Cre immunofluorescence experiments as a positive control known
to express Cre in basal epithelia, Figure 2.14. The bovine K5 promoter driving
expression of Cre in bK5Cre had been reported to drive weak expression of a bK5-
lacZ construct in embryonic trachea, though no Pgal had been detected in adult
trachea (Ramirez et al., 1994). While a low level of Cre-dependent reporter activity
had previously been reported in the trachea of bK5Cre mice, the pattern of
recombination or Cre expression had not been characterised (Brakebusch et al.,
2000).
Oesophagus and thyroid tissue was carefully removed from tracheas to minimise
contamination of the tracheal RNA, as at least oesophagus is known to express
endogenous K5, though it has been shown that oesophageal Pgal activity was poor in
two independent K5-lacZ transgenic lines (Byrne and Fuchs, 1993). RT-PCR was
performed using Cre primers as described in Figure 2.15 (Figure 2.19). Cre transcript
was detected in tracheas from all three lines after 45 cycles of PCR, though notably
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more product was generated from bK5Cre tracheal RNA. No product was visible in
non-transgenic controls. The identity of the Cre amplification product was confirmed
by hybridisation with a radiolabelled internal Cre oligonucleotide (Figure 2.19c).
Detectable expression of CreER72 in the trachea of each of the three lines,
K5CE600,700,1100, which demonstrated TAM inducible activity of CreER72
















Figure 2.19 RT-PCR for expression of CreER72 in trachea of three K5CE lines.
RNA was obtained from tracheas of the three K5CE lines which demonstrated significant inducible Cre
activity in the tamoxifen ear-painting assay (K5CE600,700,1100). Care was taken to remove thyroid and
oesophagus tissue from tracheas prior to RNA extraction. RNA was DNase-treated before cDNA was
prepared and equal amounts used as template in Crie-specific PCRs. bK5Cre tracheal RNA was included
to assess whether this line expressed the transgene in the trachea, (a) Schematic of CreER72 portion
of the K5CE transgene, showing position of internal Cre oligonucleotide probe (blue bar) with respect
to Cre-specific PCR primers. (b(i)) At 45 cycles, PCR product was visible in three K5CE lines, though
the bK5Cre sample produced a stronger product. No product was generated by non-transgenic (n-t)
littermates or by the dH20 control subjected to reverse transcription. Non-transgenic and dH20 samples
used only in PCR step were also negative, while product was generated from K5CE genomic DNA
(gDNA). (ii) RNA and control samples put through reverse transcription in absence of reverse transcriptase
(RT) enzyme (-RT) were all negative, indicating the absence of contaminating gDNA. (iii) Using GAPDH
primers to control for RNA quality generated comparable PCR products from all samples, while dH20
controls remained negative, (iv) GAPDH -RT reactions were negative, (c) RT-PCR products in (b(i)) were
transferred to a nylon membrane and hybridised with a labelled 18mer internal Cre oligonucleotide (a)
which confirmed the identity of the PCR product and the absence of low levels of product in negative
controls. M = 1 kb ladder. Map not to scale, fragment sizes in bps.
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2.4 Discussion
The generation and analysis of a novel transgenic line (K5CE) designed to permit
temporal induction of lineage marking within a subset of tracheal basal cells, thereby
circumventing ambiguities arising from potential developmental or adult steady-state
transgene expression, has been described. A range of techniques has been employed
in order to select potentially useful K5CE lines. This was preceded by a description
of reporter expression in two K5A1 lines, produced to allow the evaluation of the
subcloned human K5 promoter which drives expression of a fusion gene encoding an
inducible Cre protein in K5CE.
2.4.1 The transgenic K5 promoter-driven control line, K5A1
2.4.1.1 Expression ofeGFP
Two of four K5A1 lines demonstrated detectable transgene expression. In the
expressing lines, patterns of eGFP production, in embryonic skin and adult pinna,
and Pgal activity, in embryonic and adult basal epidermis, were broadly consistent
with reports in which the transgenic behaviour of the 6.2kb human K5 promoter was
well characterised, and shown to be largely faithful to that of the endogenous K5
gene (Byrne and Fuchs, 1993; Byrne et al., 1994). The absence of detectable eGFP in
adult tissues other than the pinna is likely the result of insufficient translation of
eGFP from the IRES sequence to permit visualisation of eGFP signal above high
levels of autofluorescence. Problems associated with the expression of downstream
sequences in bicistronic constructs containing IRESs are not uncommon, and are
discussed further in chapter 5 section 5.5.5. However it has recently been reported
that, even in mice where eGFP is expressed directly from the K5 promoter, sensitive
and consistent detection of specific fluorescence requires the use of anti-eGFP
antibodies (Schoch et al., 2003).
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2.4.1.2 Expression of (3gal
Subtle differences in the timing of the onset of K5-driven Pgal expression, where
K5A1100 and K5A1200 appeared "late" and "early", respectively, by comparison
with the description of Byrne and colleagues (Byrne et al., 1994), may have been
simply due to several hours difference in developmental age of embryos representing
the same day of embryonic development. Alternatively, epigenetic factors
responsible for the mosaic expression, evident to varying extents in both lines, may
also have perturbed the precise temporal regulation of transgene activation.
Variegated expression of transgenes in a population of equivalent transgene-bearing
cells is not uncommon, though it is not well understood, and has been variously
attributed to integration within pericentromeric chromatin (Festenstein et al., 1996;
Milot et al., 1996; Dobie et al., 1996), epigenetic effects on high copy number arrays
(Garrick et al., 1998; Lau et al., 1999), and the prokaryotic origin of certain
transgenes (Clark et al., 1997), particularly lacZ (Cui et al., 1994). Unanticipated
expression of lacZ constructs in transgenic mice is discussed further in chapter 5
section 5.5.6.
Of particular interest is the observation that a lacZ transgene driven by the bK5
promoter, also used in the bK5Cre mouse, was expressed in a consistently variegated
fashion, in a manner similar to lines K5A1100,200 (Ramirez et al., 2001). The
reproducibly mosaic expression pattern in animals bearing this transgene provided
the authors with a means to investigate the effects of several parameters on the extent
of observed variegation. While there was some evidence that pericentromeric
integration sites could mediate variegation, it was apparent that mosaic expression
also occurred from transgenes integrated far from the centromeric heterochromatin.
Using a Cre/loxP approach to reduce the number of transgene copies within an
integrated array did not have an effect on the proportion of expressing cells,
suggesting that, at least in that system, repeat induced gene silencing was
unnecessary for transgene repression. Given the non-mosaic expression of cDNAs
from the bK5 promoter, including cyclin D1 (Robles et al., 1996), IGF-1
(PiGiovanni et al., 2000), leptin, (Larcher et al., 2001), and E2F1/4 (Wang et al.,
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2000), the authors speculated that the prokaryotic lacZ sequence was responsible for
the variegated expression (Ramirez et al., 2001). While this is consistent with the
observations of Clark and colleagues regarding transgenic expression of prokaryotic
reporter sequences, the same group also noted a similar effect using mammalian
cDNAs, concluding that such intron-less sequences were unable to attenuate the
formation of local repressive chromatin structures (Clark et al., 1997). Reports of
non-mosaic bK5-driven expression of the prokaryotic, intron-less Cre gene
((Brakebusch et al., 2000; Berton et al., 2003) and A. Ramirez, unpublished results)
indicate that susceptibility to variegation is not a feature of all prokaryotic sequences.
Severe repression of a lacZ transgene expressed from the human K18 promoter
(Thorey et al., 1993) may imply that the mechanisms resulting in mosaic expression
are particularly stimulated by keratin promoter-/acZ constructs. Despite the
observations of Ramirez and colleagues (Ramirez et al., 2001), no variegation was
reported for the human K5 promoter-driven lacZ mice characterised by Byrne and
co-workers (Byrne and Fuchs, 1993; Byrne et al., 1994): however, the fact that only
two of nine Pgal-producing lines were selected for further analysis may suggest sub-
optimal pgal expression was observed in some of the remaining lines. Depending on
the relative influence of the lacZ sequence and position effect on expression, non-
mosaic K5A1 lines may have been obtained had more than four founders been
created. Nevertheless, differences in construction of the Yi5-lacZ (Byrne and Fuchs,
1993) and K5A1 transgenes, including the amount of flanking vector sequence,
cannot be discounted as factors that may have influenced the uniformity of
expression.
While (3gal activity appeared confined to the basal epidermal layer in K5A1100,
bluogal stain was noted to be present throughout K5A1200 embryonic and adult
pinna epidermis, though staining often appeared more intense basally, and non-
stained supra-basal cells were occasionally visible. Despite a similar pattern of
staining in K5A1100 vibrissae pad epidermis, anti-Pgal immunofluorescence detected
pgal only in the basal layer. Ramirez and colleagues reported precisely the same
observation in their most highly expressing bK5-/acZ lines, and suggested that
persistence of (3gal below the threshold of immunodetection, in cells migrating
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upwards from the basal layer, might account for the disparity in histochemical and
immunofluorescence data (Ramirez et al., 1994). An analogous process is thought to
explain the appearance of basal cell-specific keratin filaments in supra-basal cells
lacking the corresponding mRNAs (Schweizer et al., 1988), though keratin filaments
are likely to be significantly more durable than pgal (Lersch et al., 1989). The
authors conceded that, due to an absence of supra-basal xgal staining in some highly
expressing lines, a low level of inappropriate transgene expression in supra-basal
layers of those lines exhibiting supra-basal xgal staining, could not be discounted
(Ramirez et al., 1994). This could occur if the promoter component of the
microinjected transgene had undergone degradation or re-arrangement prior to
integration. It has been shown that a truncated 90bp version of the 6.2kb human K5
promoter is still competent to direct largely keratinocyte-specific expression, but that
differentiation specificity switches from basal to supra-basal cells, implying the
presence of elements promoting basal specificity, and suppressing supra-basal
specificity, in the remainder of the promoter fragment (Byrne and Fuchs, 1993). Loss
of the latter regulatory sequences would result in pan-epidermal expression.
Although intact K5A1 transgene 5' termini were shown to be present in both
K5A1100,200 founders, this does not preclude 5' degradation in a subset of transgene
copies. While the persistence of basally-produced Pgal, or misexpression of Pgal
production, could underlie this observation in either this study or that of Ramirez and
colleagues (Ramirez et al., 1994), examination of bluogal stained and sectioned
embryos and adult pinna from K5A1 lines suggested leaching of metabolised bluogal
precipitate from the basal epidermal layer, and outer follicle layer, into surrounding
tissues including the supra-basal epidermal layers, is the most likely explanation. It
would be desirable to probe K5A1200 expression with the anti-Pgal antibody to
determine whether the immunofluorescence signal was basal layer-specific. The
occasional difficulty in designating stained cells as basal or supra-basal is a
consequence of the fine profile of embryonic, and adult pinna, epidermis, the same
property which renders them conveniently more permeable to fixing and staining
reagents than other adult epidermal tissues.
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2.4.1.3 Endogenous (3gaI expression in tracheal submucosal glands
Upon examination of K5A1 tracheas to determine whether |3gal expression in these
lines recapitulated the SMG duct expression described by Borthwick and co-workers
(Borthwick et al, 2001), xgal staining was consistently localised to the proximal
trachea. However, a similar pattern, albeit less intense, was observed in stained non-
transgenic littermate tracheas. The results of SMG staining are difficult to interpret.
While low levels of endogenous staining were observed during analysis of
ROSHPd/wild-type chimaeric SMGs (Borthwick, 1999), non-specific glandular
staining was not reported when K5-lacZ expression was detected in SMG ducts
(Borthwick et al., 2001). However, it has since become apparent that endogenous
tracheal xgal staining can be problematic, and results from a reaction between
mucous and the strongly negatively-charged xgal (S. Randell, personal
communication). Similarly, endogenous activity in thyroid glands is due to
thyroglobulin. While Borthwick and colleagues reported K5 promoter-directed (3gal
expression primarily in gland duct cells proximal to the tracheal luminal surface
(Borthwick et al., 2001), staining in K5A1 glands appeared more distal (that is,
further from the tracheal luminal surface). Particularly in K5A1200, patches of
staining which were more intense than observed in non-transgenic glands appeared
localised to regions previously shown to produce mucous (Borthwick, 1999),
suggesting it may represent endogenous rather than transgene-specific activity.
Alternatively, the more intense and widespread staining in K5A1 SMGs could
indicate that tracheal activity of the K5 promoter is higher in these lines than in the
single line examined by Borthwick and colleagues (Borthwick et al., 2001), which
was one of the well characterised lines produced by Byrne and co-workers (Byrne
and Fuchs, 1993), though the latter group did not report any tracheal expression.
Although Borthwick and colleagues confirmed the presence of K5 protein-expressing
cells in tracheal SMGs by immunofluorescence (Borthwick et al., 2001), until
recently the possibility remained that the tracheal (3gal activity they observed was
confined to the single transgenic line used in that study (though the fact that this line
was one of two previously shown to express pgal in an identical, K5-faithful pattern
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(Byrne and Fuchs, 1993), might suggest that the tracheal expression would have been
shared between the lines). However, Schoch and colleagues recently generated a K5-
eGFP mouse, using the same configuration of promoter and intron elements used in
the K5A1 lines, which expressed eGFP in tracheal gland duct and surface epithelial
cells near gland duct openings in the upper trachea, and in systematically arrayed
foci in the lower trachea centred over cartilage-intercartilage junctions (Schoch et al.,
2003). This pattern is reminiscent of the distribution of Pgal-positive cells in the K5-
lacZ trachea, and the subsequently discovered BrdU LRCs (Borthwick et al., 2001).
That K5 promoter-directed transgene expression to SMG ducts has now been
observed in two independent lines carrying different expressed sequences suggests
that a subset of cells in the proximal trachea represent a bona fide site of K5
promoter activity. If this is the case, then, given the apparently K5-specific basal
epidermal Pgal expression observed in the K5A1 lines, they are likely to also
demonstrate the appropriate SMG expression. While some of the SMG staining
observed was thus likely to have been the result of K5A1 activity, the unexpectedly
high levels of glandular staining probably reflected a degree of endogenous staining.
Attempts to specifically detect Pgal by reducing the xgal incubation temperature
either had no effect or completely eliminated staining, and anti-Pgal antibodies were
insufficiently sensitive on wax sections to be informative (data not shown). A better
approach may have been to increase the pH of the xgal staining solution into the
alkaline range, though this technique was designed to minimise the activity of
endogenous lysosomal Pgal which has an acidic pH optimum (Weiss et al., 1999),
whereas some of the mucous found in SMGs are neutral in pH. At any rate, these
observations underlined the importance of including non-transgenic littermate
control samples in all subsequent tracheal xgal staining experiments.
Although apparent endogenous xgal staining undermined the certainty with which
K5 promoter-directed Pgal expression in SMGs could be identified, the K5A1 lines
were nevertheless useful in demonstrating appropriate activity of the subcloned K5
promoter at least in epidermis, from which SMG expression might reasonably be
extrapolated on the basis of similar transgenic lines employing the K5 promoter
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(Byrne and Fuchs, 1993; Borthwick et al., 2001; Schoch et al., 2003). While anti-
Pgal immunodetection would be required to definitively confirm basal cell-specific
expression in K5A1200, the potential lack of fidelity for basal cells may not affect
SMG expression, if it is the presence of basal layer-specific promoter elements that
drive tracheal expression. Of course, transgene expression in SMGs of the two K5A1
lines was only important in its capacity to predict equivalent expression of the
]2CreER fusion gene in the K5CE lines where, in the absence of visible eGFP
fluorescence, the expression profile of the transgene is more difficult to ascertain.
Given that considerably more K5CE than K5A1 lines were produced (29 to 4,
respectively), the frequency of K5CE lines showing appropriate K5 promoter-
directed expression should be correspondingly greater.
While it was recognised that the occurrence of significant levels of endogenous
staining in tracheas lacking the K5A1 transgene could potentially complicate the
results of Pgal-based lineage analysis in experiments using K5CEtg R26R'8 mice, it
was envisioned that a marked lineage would be identifiable on the basis of the
strength, consistency, and pattern of staining from the ubiquitous promoter of the
R26R conditional reporter. It has previously been shown that ROSA26-derived SMGs
were unambiguously distinguishable from neighbouring, endogenously staining
wild-type-derived SMGs in chimaeric tracheas (Borthwick, 1999).
2.4.2 Identification of K5CE lines demonstrating inducible Cre-
mediated recombination
Expression analysis data on the seven K5CE lines selected for further study is
summarised in Table 2.3. That such an extensive analysis was warranted, using
several approaches, was partly due to the absence of eGFP signal either in embryos
or adult tissues. IRES-dependent gene expression in bicistronic constructs is known
to be unpredictable, and is discussed further in chapter 5 section 5.5.5. While, in
principle, a functioning IRES-eGFP might have permitted the tissue-specific activity
of the transgene to be visually assessed, abrogating the need for RT-PCR analysis,

















100 1 + - N/D
300 1 + - N/D
500 7 + - N/D
600 3 + + +
700 1 + + +
800 3 - - N/D
1100 1 + + +
Table 2.3 Summary of expression analysis on seven K5CE lines.
N/D = not determined.
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sufficient to be visually detectable above background autofluorescence in adult
tissues, including the trachea. Nevertheless, eGFP in embryonic skin would have
proved a useful initial screen for expressing lines.
Despite the absence of eGFP expression, the fact that the easily accessible epidermis
is the primary site of K5 expression could still be exploited in the identification of
lines expressing the K5CE transgene. It was reasoned that, if the tracheal SMGs were
a genuine site of K5 promoter activity, then the most effective strategy to select
useful lines would be to identify those demonstrating functional expression of the
inducible Cre protein in the epidermis, before evaluating tracheal expression in this
smaller subset of lines.
2.4.2.1 Epidermal expression of CreER12 transcript
To that end, transcription of CreER72 in back skin was evaluated by RT-PCR. Since
it was not feasible to analyse mice derived from all 29 founders, seven known
transmitting lines derived from female founders crossed with R26R males, were
examined. All but one of the lines generated a Cre-specific PCR product. Although
the product generated from line K5CE300 appeared significantly less than that from
the five remaining expressing lines, and despite using equal amounts of cDNA
template in each PCR, the use of a saturating number of thermal cycles in the
GAPDH positive control reaction masked any evidence of technical inaccuracies,
preventing the confident inference of relative transcript levels between the lines.
Thus, the lines were simply considered either to express the transgene
(K5CE100,300,500,600,700,1100) or not (.K5CE800). While it had been anticipated
that the RT-PCR experiment would have excluded several lines from evaluation in
the subsequent, significantly more laborious, functional assay, only K5CE800 was
shown to be negative for CreER72 transcription at the number of PCR cycles used. It
was decided to include K5CE800 as an additional negative control.
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2.4.2.2 Tamoxifen-inducible recombination in adult epidermis
The functional assay for TAM-inducible recombination involved a modification of
the topical administration of TAM described by Vasioukhin and colleagues
(Vasioukhin et al., 1999) (B. Stripp, personal communication). TAM was used,
rather than its significantly more expensive metabolite OHT, which have both been
shown to be similarly effective at inducing Cre activity (Danielian et al., 1998;
Metzger and Chambon, 2001). DMSO was used as the solvent for its known
penetration enhancing properties (Caspers et al., 2002). The assay demonstrated an
association between the application of TAM and production of basal cell-localised
Pgal, as detected by xgal staining. Formal proof that (3gal activity after TAM
administration resulted from recombination at R26R loci was subsequently shown by
PCR (chapter 3, Figure 3.10). Although the results of this assay were unambiguous
in indicating inducible Cre-mediated recombination in three of the seven lines
evaluated, problems with TAM solubility prevented inferences being confidently
made into the relative recombination efficiencies of the different lines, and any
differences resulting from the two TAM concentrations used. Although not
mentioned in reports describing TAM inducible activation of Cre fusion proteins,
many researchers have anecdotally reported difficulties in obtaining solutions of
TAM or OHT in oil (with or without ethanol), which is normally used as the carrier
for the more common systemic administration (L. Bugeon, G. McLean, personal
communications). Similar problems were encountered with DMSO in this
experiment. At the concentrations used, TAM in DMSO was an opaque, paste-like
suspension (previously noted by B. Stripp, personal communication). It proved
impossible to dispense the entire volume, or prevent some of the suspension from
remaining on the cotton bud used to "paint" the suspension over the pinna. Thus
administered doses were not accurate, though approximately equivalent staining
between mice, and between the pinna of individual mice, of the same line suggested
that the general differences in staining between lines, as detected by visual
inspection, might reflect genuine differences in protein activity. Because of the
solubility issue, it is unclear whether the degree of recombination observed in lines
K5CE600,700,1100 was maximal, or was limited by levels of ligand or by expression
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from the K5 promoter. In the absence of informative anti-Cre immunofluoresence
data, it is not known whether the K5CE lines share the variegated expression of the
K5A1 lines.
Low levels of recombination mediated by CreER fusions in the absence of inducer,
as observed in this experiment, have previously been reported (Vasioukhin et al.,
1999; Hayashi and McMahon, 2002). In response to speculation that this background
activity might result from proteolytic cleavage of the linker joining the Cre and ER
domains, leading to unregulated Cre activity, a fusion protein was created in which
Cre was flanked at both amino- and carboxy-terminal ends by mutated mouse ERs
(MerCreMer, (Zhang et al., 1996)). This resulted in negligible ligand-independent
recombinase activity, though there was disagreement over whether this reflected an
overall reduction in inducible activity of the bulky protein (Verrou et al., 1999;
Kellendonk et al., 1999). More recently, an enhanced PR-regulated Cre was
produced in which a reduction in the length of the Cre-PR linker, and removal of a
cryptic splice donor site in the 3' of the Cre portion, effectively eliminated
background activity without affecting the maximum induced activity (Cre*PR,
(Wunderlich et al., 2001)). When Cre*PR was compared in vitro with CrePRl, the
former demonstrated approximately 50-fold lower background activity, a
significantly expanded range of inducibility, and enhanced dose-response
characteristics. If the activity profile of Cre*PR is recapitulated in transgenic mice,
then it will be the construct of choice for studies requiring inducible site-specific
recombinase activity. However, because of the relatively low number of SMG cells
expected to express the transgene, the observed level of uninduced recombination
appeared unlikely to be problematic in this study.
2.4.2.3 Functional expression of CreER72 did not correlate with transgene
copy number
It is intriguing that, while expression of CreER72 was detected in six of seven lines,
only three of the expressing lines demonstrated inducible Cre-mediated
recombination. It was shown that differences in recombinational activity were not
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likely to be due to increased levels ofR26R, or K5CE, homozygosity in certain lines.
Due to the non-quantitative RT-PCR protocol used, observed recombination rates
could not be confidently related to transcript levels. Thus, it may simply have been
that differences in transcriptional activity not accurately reflected by the RT-PCR
data were responsible for proportionally different levels of CreERT2 protein. It would
be desirable to assess transcription levels by quantitative or semi-quantitative RT-
PCR to address this. One means by which apparently equal transgene expression, as
determined by quantitative RT-PCR, could translate into variation in protein activity
would be if deletions or other deleterious re-arrangements had occurred within
transgene loci in a subset of transgenic lines. Multimeric transgene arrays can form
inverted repeat structures if transgenes are arranged in head-to-head or tail-to-tail
configurations. Such structures have been shown to be unstable and prone to high
levels of re-arrangement, including partial deletions (Collick et al., 1996). Since the
RT-PCR primers used amplified only a part of the Cre portion of the CreER72
transcript, it would not reveal deletions outside this region, such as in the ER domain.
In this way, apparently similar levels of CreER72 transcription could result in
markedly different levels of functional protein. Since higher copy number arrays are
more likely to contain inverted repeat structures (Collick et al., 1996), and are thus
more susceptible to this form of structural instability than lower copy number arrays,
this would be consistent with the apparent absence of a proportional relationship
between transgene copy number and functional protein in the K5CE lines. The
highest copy number line (K5CE500) harboured approximately seven-fold more
copies than the lowest copy number lines (K5CE100,300,700,1100), yet showed no
increase in recombination above background levels in response to TAM, despite
demonstrating transcription of CreER12. Two of the lines which demonstrated
significant inducible recombination carried the least transgene copies
(K5CE700,1100), while the remaining functional line carried approximately three¬
fold more (.K5CE600), equal to another line which showed neither transcription of
CreER12, nor induced or uninduced Cre activity (K5CE800).
The proposed mechanism of transgene array instability would not explain an
observed inverse correlation between copy number/transcription and protein levels in
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transgenic lines carrying the MerCreMer inducible Cre fusion protein (Verrou et al.,
1999). A line carrying many transgene copies and expressing high levels of mRNA
did not generate detectable protein until some copies (or a transgene locus) were lost
through segregation, which coincided with high levels of protein production (L.
Bugeon, personal communication). Whether the lack of inducible recombinase
activity in some lines which expressed CreER72 was a result of low or absent protein
levels, or was indicative of mutations in the CreER72 gene, could be investigated by
in situ immunodetection or Western blotting of tissue extracts using an anti-Cre
antibody known to bind the CreER12 fusion protein. Such an antibody exists
(Doerflinger et al., 2003), but failed to detect protein in the skin of K5CE mice in
preliminary experiments (data not shown). Conventional Cre protein in bK5Cre skin
was also not detected, indicating that a technical issue, rather than the absence of
TO
CreER protein or the inability of the antibody to bind the fusion protein, was
responsible. While the antibody could indicate the presence or absence of the protein,
it could also be used to assess its inducibility by immunostaining after TAM
administration, either in primary cultures derived from transgenic mice, or in tissue
sections from animals recently treated with TAM (Indra et al., 1999), and
determining the sub-cellular localisation of the protein.
2.4.2.4 Tracheal expression of CreER72 transcript
Evaluation of tracheal CreER72 expression by RT-PCR was limited to the three lines
showing activity of CreER12 in pinna epidermis (K5CE600,700,1100). While a
product was generated from the bK5Cre sample at 30 PCR cycles (data not shown),
45 cycles were required to detect transcript in the K5CE lines. Although tracheal
expression of bK5 promoter-driven transcripts has been alluded to in several reports
(Ramirez et al., 1994; Brakebusch et al., 2000), it has not been characterised. The
bK5Cre mouse is described further in chapters 3 and 4. While the RT-PCR was not
quantitative, the absence of detectable amplification product from all three K5CE
tracheal samples at 30 cycles, compared to robust products from equivalent amounts
of skin cDNA template, was consistent with the expectation that the K5 promoter is
active at a low level overall in the trachea, which could be a consequence of high-
104
A transgenic mousefor inducible tracheal lineage analysis
level expression in a small subset of tracheal cells. Preliminary attempts to detect
T2CreER protein using anti-Cre antibodies on tracheal sections were unsuccessful, as
predicted by the failure of these antibodies to bind the fusion protein in skin sections,
despite the presence of functional protein as revealed by the TAM ear-painting assay.
However, the K5-specific expression pattern demonstrated by the subcloned K5
promoter in the K5A1 lines, in combination with the functional expression data and
apparent tracheal transcription of CreER72, suggested that lines K5CE600,700,1100
were likely to be suitable for their intended purpose of investigating lineage arising
from the K5 promoter-expressing cells of the adult tracheal SMG ducts.
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A preliminary investigation ofcell lineage in regenerating tracheal epithelium
3.1 Introduction
The generation of a transgenic mouse designed to facilitate monitoring of the lineage
arising from a putative population of tracheal stem cells was described in chapter 2.
The identification of the submucosal gland (SMG) duct as a possible stem cell niche
was based on observations that, following long-term bromodeoxyuridine (BrdU)
labelling and an appropriate washout period, label-retaining cells (LRCs) were
preferentially localised to SMG ducts in the proximal trachea, and to systematically
arrayed foci more distally (Borthwick et al., 2001). Unlike in rapidly renewing
systems such as the epidermis (Bickenbach, 1981; Lavker and Sun, 1983), where
stem cells are constantly dividing to replenish the layers lost through desquamation,
the basal rate of mitosis in steady-state airways is extremely low (Evans and Shami,
1989). Since cell division is a prerequisite for nuclear incorporation of a pulsed label,
the identification of LRCs in the similarly quiescent cornea had previously been
achieved by induced epithelial injury to stimulate stem cell recruitment (Cotsarelis et
al, 1989).
3.1.1 A model for putative tracheal stem cells in submucosal gland
ducts
Borthwick and colleagues applied the same approach to the trachea, using two
sources of injury in parallel experiments (Borthwick et al., 2001): intratracheal
instillation of polidocanol (POL), a detergent clinically used as a sclerosing agent
and to facilitate gene transfer to airways (Parsons et al., 1998), and SO2, a well-
studied model of pulmonary epithelial injury (Lamb and Reid, 1968). While the two
methods differed in the nature of the damage caused to the epithelial layer, the BrdU
labelling index of viable surface epithelial cells 24 hours after treatment exceeded
50% in each case, compared to 1.3% in undamaged trachea. Repair was rapid, with a
columnar layer evident within 3 days of both treatments, and re-establishment of a
fully ciliated epithelium by 7 days. After four weeks of repeated tracheal damage
combined with frequent BrdU injections, tracheas from mice killed 3, 6, 21, and 95
days after the final injury were examined for incorporated label. At the 3 and 6 day
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timepoints, many labelled cells were detected throughout the tracheal surface and
gland system, though densely stained cells appeared to be preferentially localised to
the SMG ducts and surface clusters in both the proximal and distal trachea. By 21
days after damage, the overall BrdU staining was markedly weaker, though the
labelling index still exceeded 30%. Cells exhibiting intense staining were localised to
the SMG ducts in upper trachea, whereas in the glandless lower trachea, they were
predominantly basal and were arranged in foci, which tended to correspond with
cartilage-intercartilage junctions.
Closer examination of the proximal trachea from 21 and 95 day timepoint animals
revealed that labelled cells were concentrated in gland ducts and the immediately
adjacent tracheal luminal surface epithelium (Borthwick, 1999). Three zones of
LRCs could be recognised on the basis of staining intensity and morphology. The
most heavily labelled cells were morphologically simple (by light microscopy) and
found at the base of the SMG duct (zone one). Slightly less-heavily stained basal
cells, extending from the top of the ciliated duct into the adjacent tracheal epithelium,
comprised zone two. Zone three described cells in a finite region of luminal
epithelium beyond zone two. These cells exhibited weaker staining than those of
zones one and two, and were of intermediate morphology, lacking contact either with
the luminal surface or the basal lamina. This situation appeared to show parallels
with the corneal epithelium, in which stem cells in the adjacent limbal region give
rise to transit amplifying (TA) cells which migrate through the basal layer, dividing
to produce further TA cells and supra-basal, differentiated daughter cells (Lehrer et
al., 1998). Since the intensity of retained label within a cell should, in principle,
correlate inversely with the frequency with which it has divided, a model was
proposed whereby the most densely staining cells of the SMG duct represent tracheal
stem cells (Figure 3.1). In response to tracheal epithelial injury, these cells would
give rise to a TA population, corresponding to the less intensely staining cells of
zones two and three, which would migrate into, and repopulate, the neighbouring
epithelium.
108
Figure 3.1 Three zone model for label retention around the submucosal gland duct (modified from
Borthwick, 1999).
(i) Zone one - intensely-labelled stem cells in the submucosal gland duct divide to self-renew and produce
early transit amplifying (TA) cells, (ii) Zone two - early basal TA cells migrate towards the surface
epithelium, dividing to produce late TA cells and differentiated cell types, (iii) Zone three - late TA cells
of intermediate morphology migrate further from ductal opening, dividing to produce further late TA cells
and differentiated cell types.
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3.1.2 Do these cells contribute to repair of the tracheal
epithelium?
While LRCs have been shown to correspond to tissue-specific stem cells in several
other systems such as the epidermis (Bickenbach, 1981), corneal epithelium
(Cotsarelis et al., 1989), and hair follicle (Cotsarelis et al., 1990), and the localisation
of LRCs to tracheal gland ducts is consistent with observations from other epithelia
in which stem cells have been found in specialised, generally well protected niches
spatially proximal to their more differentiated progeny (Cotsarelis et al., 1989), these
combined observations remain circumstantial, and do not directly indicate a
relationship between the SMG duct LRCs and the cells of the reconstituted epithelial
layer. Label-retention studies are often combined with in vitro clonogenic assays,
which measure the capacity of candidate stem cells to form large, self-renewing
clones (Morris and Potten, 1994; Oshima et al., 2001). While these studies are useful
in revealing the potential potency of subpopulations of cells, they do not indicate
progenitorial behaviour of those cells in the context of a renewing or regenerating
tissue.
An elegant means to test the model would be to mark the putative stem cells of the
SMG ducts and follow their descendents, if any, in response to induced injury. As
discussed in chapter 2, due to the spatial coincidence of keratin-rich cells with
tracheal LRCs, in particular the ability of the human K5 promoter to drive Pgal
expression in a pattern apparently consistent with these cells (Borthwick et al.,
2001), and given the precedents for the presence of specific keratins to distinguish
stem cells from their differentiated derivatives (Schermer et al., 1986; Lyle et al.,
1998), it was hypothesised that K5 might represent a marker for this putative stem
cell niche (Borthwick et al., 2001). To test this hypothesis, and thus to potentially
test the model, transgenic mice carrying a human K5 promoter-driven fusion gene
encoding an inducible Cre protein were generated (K5CE, chapter 2). When
combined with the ubiquitously expressed Cre reporter allele R26R, permanent
marking of lineages arising from K5 expressing cells can be temporally regulated
through the administration of the exogenous ligand tamoxifen (TAM).
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This bipartite genetic approach to lineage analysis was used for two reasons pertinent
to the context in which lineage was to be tracked. Firstly, the permanence, in
principle, of the marking that should be achieved using a ubiquitously expressed
reporter, appeared to be a necessary feature of the strategy. This is because the small
number of high K5 promoter-expressing, keratin-rich cells within the tracheal
epithelium and gland ducts implies that, if these cells are indeed stem or progenitor
cells, then their immediately differentiated progeny have ceased K5 expression. As a
result, alternative strategies, for example the retrospective laacZ technique (Bonnerot
and Nicolas, 1993), in which the reporter remains under the transcriptional regulation
of the promoter that drives its expression within the progenitors, would not allow
lineage to be followed outside the putative stem cell population. Secondly, an
inducible, rather than a constitutively active, form of Cre was used to circumvent
problems arising from the potential precocious activation of the reporter prior to the
onset of the experiment. Since ubiquitous, permanent marking of lineage would be
activated in any cell in which the K5 promoter became switched on, K5 expression in
developmental precursors of the adult trachea, should it occur, would result in an
entirely marked, and thus uninformative, adult tissue. Similarly, if the high K5
expressing population has a role in the maintenance of the steady-state adult tracheal
epithelium, the extent of marked cells resulting from constitutive Cre activity could
be uninterpretable. The inducible system would prevent lineages being marked until
the desired moment, permitting cell fates to be tracked through time by examining
tissue at various timepoints after the known induction of reporter activation.
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3.1.3 Aims
As a preliminary investigation into the ability of the K5CE mouse to facilitate
inducible marking of the high K5-expressing population within adult SMG ducts,
K5CE'8 R26R'8 animals were injected with TAM to stimulate systemic Cre-mediated
activation of the ubiquitous reporter. This was preceded by intratracheal instillation
of POL as described previously (Borthwick, 1999; Borthwick et al., 2001), to
stimulate epithelial repair with the concomitant recruitment of stem cells. Tracheas
were removed at various timepoints and xgal stained to visualise patterns of figal-
positive cells.
In order to validate the requirement for an inducible recombinase, the pattern of (3gal
expression from R26R was determined in tracheas from mice in which the bovine K5
promoter directs expression of constitutive (non-inducible) Cre (hK5Cre, A.
Ramirez, unpublished results). A low level of Cre-dependent reporter activity had
previously been reported in the trachea of bK5Cre mice (Brakebusch et al., 2000),
but the pattern of recombination or Cre expression had not been characterised. The
use of bK5Cre tracheal RNA in a Cre-specific RT-PCR suggested Cre transcript may
be present at higher levels than in corresponding samples from human K5 promoter-
driven K5CE lines (chapter 2, section 2.3.7). Thus it was anticipated that, if the bK5
promoter mirrored its human counterpart's ability to direct expression within the
putative stem cell niche, and indeed if the K5-expressing cells of the SMG duct were
in fact airway progenitors, then constitutive Cre activity in the adult trachea would
lead to an uninformatively high level of reporter activation.
In fact, as shown in Figure 3.2, while significant [3gal activity was apparent in
bk5Cre's R26R'8 tracheas, staining was not as widespread as anticipated, and
certainly suggested Cre-mediated recombination resulting from potential bK5
promoter activity in tracheal precursors during development had not occurred. The
patches of ftgal expression appeared sufficiently small and discrete that available
bK5Cre's R26Rtg mice were used in a pilot study to evaluate their suitability in
monitoring lineage patterns during tracheal repair. It was anticipated that, if the bK5-
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expressing cells were progenitors capable of repopulating the damaged airway, more
Pgal-positive cells would be present in a repaired, than in a steady-state, epithelium.
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Results
3.2 Evaluation of the bK5Cre mouse for monitoring
cell lineage in regenerating tracheal epithelium
3.2.1 /3gal expression in bK5Cretg R26Rtg compound transgenic
mice
Since it was first shown to drive appropriate cell type-specific expression in vitro
(Casatorres et al., 1994), and in a pattern broadly consistent with endogenous K5 in
vivo (using lacZ, (Ramirez et al., 1994)), the 5.3kb bovine K5 promoter has been
used to drive basal-specific epithelial expression of a range of transgenes, including
Myc (Rounbehler et al., 2001), E2F4 (Wang et al., 2000), IGF-1 (DiGiovanni et al.,
2000), and Cre (Brakebusch et al., 2000; Berton et al., 2003).
To verify that the bK5Cre transgene would effect appropriate basal epithelial
activation of the R26R allele, bK5Cre mice were crossed with R26R mice.
Compound transgenic progeny were analysed, and bK5Cre'8 R26Rtg males were
crossed with non-transgenic CD1 females to obtain compound transgenic embryos.
Such embryos showed widespread activation of (3gal expression, which increased
markedly from E14.5 to El5.5 (Figure 3.2a,b). A lag in the extent of flgal-activity
compared to equivalent stage K5A1 embryos (chapter 2, section 2.2.4), in which (3gal
was expressed directly from the human K5 promoter, was likely due to the time
taken for Cre protein to effect recombination at R26R alleles, and for Pgal to
subsequently accumulate. Sectioned xgal stained E15.5 skin revealed intense staining
in supra-basal layers, while staining in the basal layer, the site of Cre production
(shown previously, Figure 2.14), was variegated (Figure 3.2e). Although the bK5
promoter has been reported to drive mosaic expression of a lacZ transgene (Ramirez
et al., 2001), expression of Cre has not been reported to be mosaic ((Brakebusch et
al., 2000; Berton et al., 2003) and A. Ramirez, unpublished observations), and
immunodetected Cre protein in El5.5 epidermis was not noticeably variegated
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(chapter 2, Figure 2.14). Interestingly, a similar heterogeneity in basal epidermal
staining was noted in adult bK5Cre's R26R'S skin (A. Ramirez, unpublished results),
and was interpreted as indicating that, while Cre production is specific to basal cells,
these cells have differentiated into supra-basal derivatives by the time Cre has caused
activation of pgal expression from R26R. Despite these observations, xgal stained
adult pinna in this study demonstrated intense and continuous Pgal activity
throughout all epidermal layers, including the outermost stratum corneum, and in
hair follicles and associated sebaceous glands (Figure 3.2f).
Unexpectedly, a proportion of bK5Cre's R26R'8 compound transgenic embryos and
adults were found to exhibit a strikingly different Pgal expression profile, which did
not reflect K5 production. Further investigation, described in chapter 4, revealed the
cause of this phenomenon, and such animals were excluded from the studies
discussed in this chapter. However, the necessary but unanticipated exclusion of
these animals meant that a limited number of suitable bK5Cre's R26R'8 mice were
available for the experiment described in section 3.2.3.
In reports of mice expressing Pgal (Ramirez et al., 1994), cyclin D1 (Robles et al.,
1996) and Cre (Brakebusch et al., 2000) from the bK5 promoter, expression of the
transgene (in the case of Cre, expression of a Cre-dependent reporter) in the trachea
was mentioned but not described. That Cre transcript was detected in bK5Cre adult
tracheal RNA at 30 cycles of RT-PCR (data not shown), compared to 45 cycles
required for its detection in three K5CE lines (chapter 2, Figure 2.3.7), supported
these observations of bK5 promoter activity within the trachea. Regardless of
whether the transgene was expressed in tracheal precursors during development, it
was thought that if the detected expression of constitutive Cre in adult, steady-state
trachea was occurring in stem cells, proposed to express the human K5 promoter,
then the degree of pre-existing reporter activation would render the system useless
for following specific lineages. To demonstrate this, and with the intention of
validating the choice of a temporally regulated system, adult bK5Cre's R26R'S
tracheas (n = 3) were xgal stained. Significant Pgal activity was observed throughout
the luminal surface of all three tracheas, though minor variation was apparent in the
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Figure 3.2 pgal expression in bK5Cre'° R26R? transgenic mice.
(a,b) pgal activity in bKSCre19 R26FP E14.5 and E15.5 compound transgenic embryos, respectively. (c,d)
No staining was observed in single transgene-positive bK5Cre R26R'9 embryos, (e) pgal activity in
E15.5 epidermis. Staining was uniform throughout the supra-basal layers, though was patchier in the
basal layer, stained brown with anti-K14 antibody, (f) Xgal stained adult pinna showing intense staining
throughout the epidermis, including the dead squames of the stratum comeum (arrowhead). Hair follicles
and associated sebaceous glands showed strong pgal expression, (g) Trachea from bK5Cre9 R26R!3
mouse showing distinctive, strong staining in the larynx at the proximal end of the trachea (arrowheads),
with stained cells distributed over the luminal surface for the length of the trachea. Excluding the larynx,
staining was typically more intense in the region corresponding to the submucosal glands (SMGs). No
significant endogenous, background glandular staining was apparent in the three tracheas examined.
Scale bar = 1600pm (a-d,g); 100pm (f); 10pm (e).
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overall intensity of staining, representing differences in the frequency of (3gal-
positive cells. The trachea exhibiting staining intermediate between the three
examined is shown in Figure 3.2g. The larynx was consistently observed to stain
heavily. On the luminal surface, the most intense staining corresponded to the region
of the tracheal glands.
Although bK5Cre's R26Rtg tracheas demonstrated significant xgal staining which was
clearly not endogenous background activity (described previously, chapter 2, section
2.4.1.3), it was evidently not the result of activation of R26R activity in tracheal
precursors during development, which would have been expected to result in
extensive or ubiquitous Pgal expression. Indeed, the moderate level of staining did
not obviously exclude the bK5Cretg R26Rtg mouse from being informative with
regard to tracheal lineage patterns. Particularly, the fact that the glandular proximal
trachea showed the highest levels of xgal staining within the luminal surface,
suggested that the bK5 promoter may have been most active in the SMGs, as is the
case for its human counterpart (Borthwick et al., 2001). For these reasons, the
usefulness of bK5Cretg R26Rtg mice for tracing lineage in regenerating tracheal
epithelium was evaluated in parallel with analogous experiments involving the K5CE
mouse (section 3.3).
The R26R status (hemizygous or homozygous) of the animals used in the following
studies was determined using a PCR specific to the wild-type R26R (ROSA26) locus
in conjunction with the /acZ-specific PCR described in chapter 2, Figure 2.3 (Figure
3.3).
3.2.2 Intratracheal instillation ofpolidocanol to damage tracheal
epithelium
Prior to undertaking the tracheal injury protocol on the limited number of suitable
bK5Cretg R26Rtg animals available for the lineage study, a 24 hour POL damage (and
PBS control) timepoint was performed on wild-type animals (n = 3 per treatment) to

















Figure 3.3 PCR assay for the discrimination of mice hemizygous
and homozygous for R26R.
(a) Schematic of the R26R (ROSA26) locus showing the
position of PCR primers (R26F2 - R523, Soriano, 1999) within
the genomic sequence flanking the R26R construct. The
primers are only able to amplify a product (602bp) from the
wild-type (w-t) locus. R26R (lacZ)-specific primers (lacZF -
lacZR) are also shown. SA (splice acceptor), AAA (triple
polyadenylation sequence), bpA (polyadenylation sequence).M
= 1 kb ladder. Map not to scale, fragment sizes in bps. (b) The
R26R hemizygote sample (hem) is positive in both the lacZ-
specific and R26R locus-specific PCRs. Amplification only in
the /acZ-specific PCR indicates a homozygote (horn, no wild-
type R26R loci). Wild-type samples typically produced a
stronger signal in the R26R locus-specific PCR. myoG-specific







Figure 3.4 Apparatus for tracheal instillation of PBS or polidocanol into anaesthetised mice (diagram
modified from Davidson, 2000).
See chapter 7 (section 7.10) for details of method.
PBS POL
Figure 3.5 Polidocanol-induced damage of tracheal epithelium after 24 hours.
10ptl 2% polidocanol (POL) in PBS, or PBS alone, was administered to wild-type mice by direct tracheal
instillation. Tracheas were removed after 24 hours and sectioned for analysis of damage. (a,c) Submucosal
gland (SMG) regions shown at two different magnifications after treatment with PBS alone. The epithelial
layer was intact. (b,d) Equivalent images to (a,b) for trachea receiving POL. The epithelium had been
removed, and detached material could be seen in the tracheal lumen (arrowheads). (e,f) Distal tracheal
luminal surface following PBS or POL treatment, respectively. Arrowheads in (f) indicate remaining basal
epithelial cells. Scale bar = 100pm (a-d); 50pm (e,f).
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were obtained. Intratracheal instillation was achieved by placing an anaesthetised
mouse in the apparatus depicted in Figure 3.4. A narrow-gauge, flexible micropipette
tip was used to dispense 10pi of 2% POL in PBS (or PBS alone) to the top of the
trachea. S. Webb provided technical assistance with establishing the reproducibility
of this technique.
After approximately 24 hours the mice were culled and the tracheas sectioned for
analysis of epithelial injury (Figure 3.5). As expected, while PBS treated tracheas
displayed an intact epithelial layer, POL had stripped superficial columnar cells from
the full length of the tracheal surface, though some basal cells closely adherent to the
underlying lamina were seen to persist. Material presumably consisting of detached
epithelial cells was occasionally observed in the tracheal lumen. This study
confirmed that the intended epithelial injury could be reproducibly obtained using the
apparatus and technique described.
3.2.3 Analysis of/3gal expression in repairing bK5Cret9 R26Rt9
tracheal epithelium
To investigate whether the bK5Cre line could be used to monitor lineage in
regenerating tracheal epithelium, 13 bK5Cres R26R'S adult compound transgenic
mice, and four adult bK5Crewt R26R'S mice, were split into four groups to be culled
at different timepoints after intratracheal instillation of POL or PBS. Table 3.1 shows
the distribution of genotypes and treatments between the groups. The limited
availability of useable bK5Cre'8 R26R'S mice (see section 3.2.1) prevented the use of
equal numbers between the groups. The timepoints used were (after treatment), +1
day (d), +3d, +7d and +20d. Few stained cells were expected to be seen in animals
receiving POL at +ld due to removal of the epithelial cells. The epithelial layer
should be largely restored by +3d, and completely by +7d (Borthwick et al., 2001),
thus these timepoints were expected to be informative if the bK5Cre transgene was
active in epithelial progenitors. At +20d, the epithelium should have returned to the
steady-state.
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Timepoint Mouse Genotype Treatment Ave. stained Ave. cells
number (POL/PBS) cells per block
bK5Cre R26R SMGs distal SMGs distal
100 tg/wt tg/wt PBS 36.0 7.0 2.6 2.3
+1d 130 POL 0 0 - -
616 wt/wt tg/tg 0 0 - -
102 PBS 13.5 2.0 2.5 2.0
127 tg/wt tg/wt 63.5 7.0 5.1 2.3
+3d 103 36.0 6.5 3.0 1.6
128 POL 71.0 21.0 4.4 3.5
613 wt/wt tg/tg 0 0 - -
104 PBS 47.0 8.0 4.5 2.0
129 tg/wt tg/wt 83.5 36.5 5.1 3.8
+7d 105 81.5 65.0 5.6 5.7
131 POL 75.0 75.0 10.0 8.8
794 wt/wt tg/tg 0 0 - -
134 PBS 24.5 6.5 3.5 2.5
+20d 118 tg/wt tg/wt 87.0 4.5 7.9 2.3
135 POL 8.5 6.5 2.4 2.6
615 wt/wt tg/tg 0 0 - -
Table 3.1 Summary of experiment to evaluate the bK5Cre mouse for tracing lineage in the
regenerating tracheal epithelium.
For each trachea, stained cells were counted in submucosal gland (SMG) and distal tracheal regions
on a total of four microscopic fields per region, on two different sections. Averaged values are shown
for the number of stained cells and the number of cells per continuous stained block of cells, and reveal
significant variation between tracheas, including those of equivalent genotype, receiving the same
treatment, and taken at the same timepoint. tg/wt = hemizygous, tg/tg = homozygous, wt/wt =
transgene-negative. POL = polidocanol.
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3.2.3.1 Unanticipated variation in tracheal figai expression between individual
bK5Cret9 R26Rtg mice
Examples of wholemount and sectioned xgal stained tracheas are presented in Figure
3.6. The range of variation in tracheal expression of Pgal between individual animals,
irrespective of treatment, was considerably greater than suggested by the initial
analysis of three untreated bK5Cre's R26R'8 tracheas (section 3.2.1). The extent of
variation, represented by the number of xgal stained cells counted, is apparent in
Table 3.1. As a result of this variation, any increase in the number of Pgal-positive
cells during the period of epithelial regeneration following POL treatment was
masked by pre-existing differences in |3gal expression inherent to the individual
animals. The most informative POL and PBS treated tracheas from each timepoint,
usually those exhibiting the most staining, are shown in Figure 3.6. Many of the
tracheas that are not shown displayed low levels of pgal activity, with xgal stain
appearing faint on sections, though they were consistently distinguishable from
bK5Crewt R26Rtg tracheas. This heterogeneity in Pgal expression was intriguing, as it
did not correlate with the number of transgene copies (all compound transgenic
animals were hemizygous for both transgenes), or the age or sex of the animals.
Fixing and staining was performed identically, using the same xgal preparation,
making it unlikely that the differences were due to technical factors. Also, variation
in staining distribution and intensity was not an artefact of endogenous galactosidase
activity, as determined by its appearance, and by comparison with control (bK5Crewt
R26Rts) tracheas stained concurrently (for example, Figure 3.6i).
In the absence of a visually discernible correlation between the extent of xgal
staining observed in tracheas, and the treatments and timepoints pertaining to each
trachea, the numbers of stained cells and blocks of continuous stained cells were
counted on two SMG sections and two distal tracheal sections, for each trachea.
Averaged counts, represented as the total number of stained cells and the number of
cells per block, are recorded in Table 3.1 and indicate the wide variation in Pgal
expression apparent even between transgenically-identical mice which received the
same treatment and were killed at the same timepoint. Standard analysis of variance
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(ANOVA) confirmed that variation in the numbers of stained cells and blocks
observed between individual animals was significantly greater than the residual
variation between replicate observations from each trachea, allowing averaged values
to be used in the subsequent analysis. This indicated an overall marginally significant
(p<0.05) increase in the total number of stained cells and stained cells per block after
POL treatment compared to PBS treatment. However, the importance of this result is
unclear given the absence of statistically significant differences in the numbers of
stained cells observed in POL treated tracheas between the various timepoints at
which tracheas were examined (n = two per +3d, +7d, and +20d timepoint).
Statistical analysis was performed by A. Carothers.
3.2.3.2 Clonal expansion from bK5Cre-expressing progenitors?
Despite the lack of clear evidence, in terms of total numbers of marked cells, for
clonal expansion originating in hK5Oe-expressing cells during re-epithelialisation,
examination of sectioned tracheas revealed intriguing staining patterns (Figure 3.6).
The pattern of xgal staining within SMG ducts, indicative of bK5 promoter
expressing cells and their descendents, suggested the bK5 promoter was active in the
cells previously shown to express the human K5 promoter (Borthwick et al., 2001).
Particularly, the SMG duct shown in Figure 3.6a(iii) is reminiscent of the SMG duct
containing cells expressing Pgal from the human K5 promoter (chapter 2, Figure
2.12(i)h). This is supported by the fact that staining within the tracheal lumen was
consistently significantly more widespread and intense in the region corresponding to
the SMGs, than more distally. The majority of stained cells were found in continuous
stained blocks of cells interspersed with non-stained blocks (for example, Figure
3.6c(ii)), consistent with the notion of clonal expansion of marked cells. The most
encouraging observation with regard to the hypothesis that K5-expressing epithelial
progenitors are present within SMG ducts, was numerous examples of apparent
continuous marked lineage extending from gland duct cells to the overlying surface
epithelium (Figure 3.6d(iii),f(iii,vi,viii),h(v)). Interestingly, two of the best examples
of this were located in discrete glands, one or two intercartilaginous spaces distal to
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continuity of stained cells connecting the gland duct to the tracheal surface was only
observed in POL treated tracheas, the significance of this was unclear, and may
simply have been the result of a chance increase in the frequency of sections passing
directly through gland ducts in POL compared to PBS treated tracheas. Close spatial
correlations between staining in glands and in a discrete portion of directly overlying
surface epithelium were frequently observed in both POL and PBS treated tracheas
(Figure 3.6h(iii) and c,e(ii), respectively), and were interpreted as likely representing
direct gland-surface lineage relationships existing on another plane of sectioning.
Serial sectioning would be required to determine whether this was the case.
3.2.3.3 Variation in the staining and distribution of submucosal glands
between individual bK5Cret9 R26Rtg mice
The distribution of |3gal activity within the glandular region of bK5Cre'8 R26R'S
tracheas was intriguing. While in some tracheas, staining was apparent throughout
many of the glands within the glandular region (for example, Figure 3.6c(ii)),
staining appeared to be confined to few glands in the glandular region of other
tracheas (for example, Figure 3.6h(ii)). While this variation in the extent of staining
within the glandular regions of different tracheas may seem to raise the issue of
endogenous galactosidase activity, it must be stressed that such non-specific staining
as described in chapter 2 section 2.4.1.3 did not appear to occur at appreciable levels
within this experiment. Furthermore, staining in surface epithelial cells, which as
described was often continuous with stained gland cells, was not observed to result
from non-specific sources in any of the experiments performed for this thesis. Thus,
it may be that K5-expressing cells do not exist within all glands, and that the
proportion of glands containing these cells may vary between individual animals.
The existence of variation in tracheal characteristics between individual animals used
in the study, as previously described in terms of marked differences in staining
frequency in genotypically equivalent and identically treated animals, was further
supported by the appearance of numerous, intensely staining foci in the wholemount
trachea of (PBS treated) mouse 129 (Figure 3.6e(i)). While similar foci were evident
in wholemount tracheas from many of the mice, and corresponded to SMGs, the
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mouse 129 trachea was distinctive due the high number and widespread distribution
of the foci, which extended into the distal trachea. Figure 3.7a confirms the presence
of distal glands in the trachea of mouse 129, with a gland positioned in the seventh
intercartilage space distal to the main gland block. However, no obvious relationship
between the stained distal gland and the local epithelial layer was apparent.
3.2.3.4 Absence of lineage patterns in the distal trachea
The patterns of staining in the generally glandless distal trachea were less
informative than in proximal regions. Staining was consistently less intense and
appeared more scattered, with fewer and smaller blocks of continuous staining. If the
bK5 promoter recapitulates the expression from the human K5 promoter, which was
shown to express in a pattern consistent with LRCs, found to be localised to
cartilage-intercartilage junctions in the distal trachea, then it might be expected that
staining would be concentrated in these regions. While small blocks of staining were
occasionally detected at these sites (Figure 3.6h,e(iv)), they were not the exclusive
sites of distal Pgal activity (Figure 3.6e,f(iv)). It may be that the proposed
progenitorial role of high K5-expressing basal cells is diminished in the distal
trachea, as discussed in section 3.4.1.
3.2.3.5 /3gal expression in both columnar and basal epithelial cells
Stained epithelial blocks in the proximal glandular region were examined at high
power magnification to determine whether they contained multiple cell types, based
on morphology, which would indicate multipotency of the progenitors. Due to the
relative thickness of the sections (10pm), the presence of several layers of cells
reduced the clarity with which individual cells could be visualised. Staining
corresponding to basal cells could be detected at the edges of, and separate from,
blocks of stained columnar cells (Figure 3.7b). However, the POL treatment is
known to leave some basal cells attached to the luminal surface, and it is known that
a subset of surface basal cells, particularly near gland duct openings, show high
levels of (human) K5 promoter activity (Borthwick et al., 2001; Schoch et al., 2003).
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For these reasons, it could not be said with certainty whether the basal cells observed
were part of, and thus potentially clonally related to, an adjacent stained block also
containing columnar cells, or whether they were bK5 promoter-expressing cells




Figure 3.7 Further observations from tracheal epithelial lineage marking using bK5Crelg R26FI" mice.
(a(i)) Longitudinal section through mouse 129 trachea showing xgal stained proximal submucosal glands
(SMGs), stained epithelial cells, and stained distal glands. The proximal (P) - distal (D) axis is shown,
(ii) Higher magnification of boxed region in (a(i)) showing stained distal gland overlying cartilage-
intercartilage junction. Apparent epithelial damage over the gland, possibly resulting from incomplete
repair of distal epithelium at +7d timepoint, or mechanical damaged caused when the trachea was opened
for wholemount inspection, prevented the detection of a potential correlation between staining in the
gland and overlying surface epithelium, (b) High magnification of proximal tracheal epithelium from mouse
105 (i,ii) and 128 (iii), showing staining corresponding to the expected position of basal epithelial cells
(arrowheads). Scale bar = 100pm (a(i)); 50pm (a(ii)); 10pm (b(i-iii)).
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3.3 Evaluation of the K5CE mouse for monitoring cell
lineage in regenerating tracheal epithelium
3.3.1 Analysis of /3gaI expression in repairing K5CEtg R26Rt9
tracheal epithelium
Although three potentially useful K5CE lines had been identified in the experiments
described in chapter 2 section 2.3, time constraints and mouse availability dictated
that only line K5CE1100 would be assessed for its ability to facilitate inducible
marking of the putative tracheal stem cell population. Nine K5CE'S R26R'S adult
compound transgenic mice, and three each of adult mice carrying either the K5CE or
R26R transgenes, were split into three timepoint groups. All mice carrying the R26R
allele were confirmed to be homozygous by PCR (data not shown). Although a
similar assay was not available for the K5CE transgene, breeding records were used
(as described previously, chapter 2, Table 2.2) to calculate that all K5CE'8 animals
had a 0.61:0.39 probability of being hemizygous:homozygous. The timepoints (+7d,
+20d, +30d) differed from those used in the previous experiment, since it was known
that induction of lineage marking by repetitive TAM administration would take
several days, and that damage had to be effected prior to reporter activation (B.
Stripp, personal communication). A timeline for the experiment is shown in Figure
3.8. All animals received intratracheal instillation of POL followed immediately with
an intraperitoneal injection of 4mg TAM in com oil, or oil alone (+0d). The mice
received further injections of TAM or oil on +ld and +2d, and were killed on +7d,
+20d, and +30d.
This protocol unexpectedly resulted in significant mortality, with three animals
failing to emerge from anaesthesia. Two more mice died subsequently, on +3d and
+5d. Several of the remaining mice appeared "hunched", and all animals were
monitored closely for any further deterioration in their condition for the duration of
the study. The unexpected loss of one third of the experimental animals prior to the
first timepoint prompted a reallocation of animals between timepoint groups in order
to minimise the effect on the results. The final timepoint groups are shown in Table
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3.2, including the treatment administered to each mouse, and the prematurely
deceased mice. As a result of the reallocation, no control animals (genetic or
treatment) were present in the +30d group, the K5CEtg R26Rwt control was absent
from the +20d group, and only one TAM treated K5CEtg R26Rtg mouse was available
in the +7d group.
At each timepoint, pinna and tail skin, in addition to the trachea, were taken from
mice as positive controls for systemic action of administered TAM. Representative
stained tissues are shown in Figure 3.9, and the results are summarised in Table 3.2.
No staining above endogenous levels (which were minimal in this experiment) was
observed in the tracheas of any of the animals, as shown in TAM treated K5CEtg
R26Rtg tracheas from each timepoint (Figure 3.9a-c(i)), and genetic and treatment
control tracheas (+20d, Figure 3.9d,e(i)). Sectioning of the tracheas revealed that,
while some degree of epithelial repair had occurred, it was variable between animals
and appeared impaired relative to that observed in the previously described
experiment involving the bK5Cre mice (compare Figure 3.9a-e(ii) with Figure
3.6d,f,h,i(ii)).
Examination of the pinna and tail skin indicated that recombination as a result of
systemic TAM activity had occurred. At +7d (Figure 3.9a(iii,iv)), low-level staining
in pinna was apparent, and had increased markedly by +20d (Figure 3.9b(iii-v)), with
staining evident in both basal and supra-basal cells, indicating differentiation of cells
in which the recombination event had occurred. Scattered flgal expression was also
apparent in tail skin (Figure 3.9b(vi-v)). Large blocks of staining at were apparent in
pinna at +30d (Figure 3.9c(iii-v)), and in some cases stained supra-basal cells lay
over Pgal-negative basal cells, suggesting that some CreERT2-producing cells had
begun to differentiate before |3gal expression had been activated from R26R. An
increased frequency of stained cells within tail skin was noted at +30d, with Pgal
activity evident in all epidermal layers (Figure 3.9c(vi-vii)). Although stained cells
were observed in oil treated K5CEtg R26Rtg pinna, they were extremely infrequent
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898+ua wt/wt tg/tg N/A N/A N/A
Table 3.2 Summary of experiment to evaluate the K5CE mouse for tracing lineage in the regenerating
tracheal epithelium.
Ail animals received polidocanol on +0d. Superscript after mouse numbers indicates day of premature
death. +++,++,+ indicates high, moderate, and low level staining, respectively, compared to equivalent
tissue from other animals. LI indicates very low-level staining resulting from ligand-independent activity
of CreER12. tg = transgene-positive, tg/tg = homozygous, wt/wt = transgene-negative. TAM =
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Figure 3.8 Timeline of experiment to evaluate the K5CE mouse for tracing lineage in the regenerating
tracheal epithelium.
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observed in tail skin from these mice, or in pinna or tail skin of TAM treated K5CEwt
R26R'8 mice (Figure 3.9e).
The observed Pgal activity in epidermal tissues suggested that the apparent absence
of Cre-mediated Pgal expression from R26R within tracheas was not due to a failure
in achieving systemic TAM administration. Alternative explanations are considered
in section 3.4.2.
3.3.2 Tamoxifen-induced xgal staining results from excision within
the R26R allele
Although the Pgal activity in K5CE'8 R26Rtg tissue, observed to correlate with TAM
administration in experiments described in this chapter and in chapter 2 (section
2.3.5), had been assumed to be the result Cre-mediated site-specific recombination at
R26R alleles, this had not been demonstrated directly. To this end, a PCR assay was
developed in which a primer pair separated by the floxed NEO cassette of the R26R
construct, could only amplify a product after excision of the intervening sequence
(Figure 3.10a). The lacZ4 primer was designed by Rijnkels and Rosen, who also
noted that DNA extracted from fixed tissue, as used here, can only support PCR
amplification of fragments of up to approximately 800bp (Rijnkels and Rosen, 2001).
This dictated that only the post-recombination amplification product could be
obtained. The PCR assay was validated using DNA templates containing known
recombined R26R alleles: bK5Cretg R26Rtg pinna DNA in which the epidermal cells
carry recombined copies, and DNA carrying entirely recombined copies (the two
right-most lanes on Figure 3.10b, respectively), the source of which is detailed in
chapter 4.
DNA extracted from fixed and stained pinna tissue from mice 819, 820, 788, 828 and
905 (see Table 3.2) was used as template in the reaction (Figure 3.10b). Both stained
and non-stained pinna tissue from mice 819 and 820 was used, to check that
incomplete staining of pinna from these mice (Figure 3.9a-c(iii)) was the result of
incomplete stain penetration, rather than regional activation of Pgal expression.
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Though very faint, a product corresponding to that seen in the positive controls was
observed in both 819 samples, the "stained" 820 sample, and sample 788. No product
could be visualised from samples 828 and 905, or from K5CEwt R26Rtg mice, or
K5CEtg R26R'8 mice not exposed to TAM. Since the PCR products were difficult to
visualise directly, hybridisation with a loxP sequence-specific oligonucleotide probe
confirmed the presence of all products, plus a faint product from the "non-stained"
820 sample (Figure 3.10c). This indicated that Cre-mediated recombination had
occurred throughout TAM treated K5CEtg R26Rtg pinna, despite staining being
restricted to regions of high stain accessibility. Other than the positive controls, no
additional samples yielded PCR products.
PCR on template mixtures containing varying proportions of unrecombined and
recombined R26R alleles were performed to assess the sensitivity of the PCR assay
(Figure 3.10d). A product was faintly visible when 10% of R26R loci were
recombined, but not when only 5% were recombined, suggesting that recombination
in pinna resulting from systemic TAM administration exceeded 5%.
137






Table 3.2 for details





!S £ x05 It "O
0.5kb-
0.4kb-j«KM»
m mm mm «M» Me. UNfr #1Rfe mm.
Figure 3.10 Tamoxifen-induced pgal activity correlates with recombination at R26R alleles.
(a) Schematic of the R26R allele before and after Cre-mediated recombination, which results in the loss of the floxed
NEO cassette. Primers for detecting the recombined allele are positioned in the splice acceptor (SA) and the 5' of
lacZ. PCR amplification only occurred from the recombined allele, when the region between the primers is reduced
from approximately 2500bp to approximately 350bp. The loxP sites are represented by red triangles. The position of
an oligonucleotide probe consisting of the 34bp loxP sequence is shown by a green bar. bpA (polyadenylation
sequence), AAA (triple polyadenylation sequence). Map not to scale, fragment sizes in bps. (b) 5921R - lacZ4 PCR
on pinna DNA of five mice following tracheal damage and tamoxifen treatment. The band apparent in every lane is
the PCR primers. Although barely visible in the figure, a PCR product was observed on the original photograph in
lanes corresponding to mice 819, 820, 788. "s" and "ns" after the mouse number indicates DNA from stained and non-
stained region of pinna, respectively. No visible product was generated from mice 828 and 905, or dH20, or untreated
K5CE!9 R26&m or K5C&* R26Rm controls. Robust product was amplified from DNA from pinna showing epidermal
staining (bK5Cre's R26R/"*). and ubiquitous staining ("100% recomb.", all R26R alleles recombined). (c) To verify the
presence and identity of the weak PCR products, the bands were transferred to a nylon membrane and hybridised
with a labelled oligonucleotide specific for the loxP sequence. Only samples 819, 820, 788 and the positive controls
hybridised with the probe, (d) Genomic DNA containing 100% recombined R26R loci was mixed with DNA in which
all R26R loci were unrecombined (R26R""ec) at the ratios shown (5%-95%), and used as template in 5921R - lacZ4
PCR. 10% recombined R26R loci was the lowest ratio which produced a visible product. M = 1kb ladder.
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3.4 Discussion
Putative airway stem cells have previously been identified, on account of their long-
term label-retaining characteristics, to reside in and around SMG ducts in the upper
trachea, and at positions corresponding to cartilage-intercartilage junctions in the
lower trachea (Borthwick et al., 2001). In common with known stem cell niches in
several other epithelial tissues, the SMG duct represents a well protected
compartment distinct from, but spatially proximal to, the differentiated cell
population (the luminal surface epithelium) (Cotsarelis et al., 1989). In addition to
appearing morphologically undifferentiated, consistent with the expected "primitive"
phenotype (Cotsarelis et al., 1989), the LRCs were observed to be spatially
coincident with cells expressing high levels of keratin proteins, and which expressed
a lacZ transgene driven by the human K5 promoter (Borthwick et al., 2001). The
expression, or otherwise, of specific keratins has previously been found to
distinguish stem cells from their more differentiated progeny (Schermer et al., 1986;
Lyle et al., 1998). To test the hypothesis that the high K5 promoter-expressing
population represented tracheal progenitors, a transgenic mouse designed to permit
temporally controllable activation of permanent lineage marking within the high K5-
expressing cells was created (.K5CE, chapter 2). A preliminary experiment to
evaluate the usefulness of one of the K5CE lines in marking the lineage arising from
the putative stem cell niche in response to tracheal epithelial injury, has been
described. An inducible system was used to prevent unanticipated precocious activity
of the Cre transgene resulting in widespread, uninterpretable reporter expression. In
attempting to validate this decision, it was observed that a constitutive (non-
inducible) system (bK5Cre) effected less extensive reporter activity than had been
anticipated, and thus might be of use for the same purpose. A pilot study using the
bK5Cre mouse has been described.
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3.4.1 Constitutive lineage marking: bK5Cre x R26R
Prior to the studies described in section 3.2, the pattern of tracheal expression from
the bovine K5 promoter was not known. In fact, the precise distribution of bK5
promoter-expressing cells remains unknown, since the xgal staining of cells observed
in bK5Cre'8 R26Rtg mice did not distinguish between such cells and their progeny.
However, it is clear that the bK5 promoter is active in a subset of cells throughout the
tracheal luminal epithelium, and in the SMGs. The presence of staining in untreated
and PBS treated tracheas suggested that, if the bK5 promoter was active in
progenitor cells, then these cells had a role in the steady-state trachea, regardless of
any involvement in epithelial regeneration. Support for the notion that bK5
promoter-expressing cells had progenitorial capacity derived from the observation on
tracheal sections that (3gal-positive cells were arranged into continuous stained
blocks, consistent with clonal expansion. Despite the moderate level of staining
displayed by untreated tracheas (Figure 3.2g), it was anticipated that recruitment of
stem cells during repair of induced epithelial damage would result in a detectable
overall increase in the number of stained cells. However, when stained wholemount
POL and PBS treated tracheas from the various timepoints were compared, although
large differences in the intensity and extent of staining were apparent, the variation
did not obviously correlate with the treatment received or the timepoints at which the
tracheas were taken. Although a marginally statistically significant correlation
between POL treatment and an increase in the frequency of stained cells and the size
of stained blocks was detected, consistent with the stimulation of bK5 promoter-
expressing progenitors, there was no significant effect relating to the time at which
POL-treated tracheas were collected (after the +ld timepoint, when no epithelial
cells were present in the POL treated trachea). This may have been because, since
reconstitution of the columnar layer was largely complete by the +3d timepoint, no
further expansion of stained blocks occurred. Interestingly, in a recent report by
Hong and colleagues (Hong et al., 2003), discussed in section 3.4.3, the size of
stained groups of tracheal epithelial cells was noted to continue to increase following
the return of the epithelium to its normal composition after damage.
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In the absence of a correlation between the individual-specific variation in tracheal
staining and factors such as age or sex, or the likely influence of technical issues or
endogenous enzyme activity, it may be that genetic background differences underlie
the inconsistencies in the frequency of pgal-positive cells. This could occur by
modulation of the number or distribution of bK5 promoter-expressing putative
progenitor cells. The unusual frequency and distribution of SMGs in the trachea of
mouse 129 (Figure 3.6e and Figure 3.7a) may argue in favour of segregating genetic
elements affecting patterns of xgal staining, since SMG distribution in the mouse is
known to differ between inbred strains (Borthwick, 1999), and the location of at least
one genetic determinant has been elucidated (Innes and Dorin, 2001). Since complete
breeding records were not available for the bK5Cre or R26R mice, the possible
sources of genetic variability cannot be identified. However, the combining of
genetic backgrounds from two separate transgenic lines will undoubtedly have
resulted in an outbred genotype. Given the time required to make the animals
congenic through backcrossing, the use of large numbers of animals per treatment
and timepoint group may be the only feasible means of revealing statistically
meaningful trends.
One other point to consider as regards detecting differences in the frequency of
marked cells in repaired compared to undamaged epithelia, is that is that there is no
internal control for tracheal damage. Since, as determined by earlier work, a
columnar layer is expected to be reconstituted within three days of POL treatment
(Borthwick et al., 2001), an efficiently regenerated epithelium should appear
superficially indistinguishable from an unsuccessfully damaged one. While instances
of poor or negligible epithelial injury in this experiment cannot be excluded, the
tracheal damage protocol had previously been shown to effective and reproducible
(section 3.2.2).
Regardless of actual numbers of stained cells, the patterns of apparent lineage
revealed on tracheal sections, irrespective of treatment, were intriguing. Numerous
examples of continuously stained epithelial blocks extending from gland ducts to the
epithelial surface, occasionally on either side of the gland duct opening (for example,
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Figure 3.6f(vi)), were noted. This pattern is precisely what would have been
predicted by the model based on SMG duct LRC data (Borthwick, 1999) (Figure
3.11), assuming that the K5-expressing cells correspond to the LRCs (and that LRCs
do, in fact, represent progenitors), or that an overlap between these populations
exists. Serial sectioning would have been useful in allowing indirect spatial
relationships between stained glands and local epithelial blocks to be clarified. The
apparent involvement of (bK5-expressing) SMG duct progenitors in steady-state
epithelial maintenance is consistent with observations from the tracheas of
aggregation chimaeric R OSA2<5: wild-type mice (Borthwick, 1999). SMGs were
found to be either entirely derived from ROSA26 cells, or wild-type cells, indicative
of their clonal origin. Interestingly, whenever a ROSA26-derived gland was found in
a tracheal glandular region also containing (3gal-negative wild-type glands, a finite
region of surface epithelium surrounding the ROSA26 gland shared its xgal stained
phenotype, suggestive of a lineage relationship.
While high magnification examination of proximal tracheal stained cell blocks
appeared to reveal the presence of basal cells as well as columnar cells, the intensity
of staining meant that basal cells could only be discriminated when they occurred
against a background of unstained columnar cells, either at the edge of, or separate
from, stained blocks. Certain cells within groups of stained basal cells not associated
with columnar stained blocks or SMG duct lineages were likely bK5 promoter-
expressing cells, possibly with unipotent differentiation potential to give rise to
adjacent stained basal cells, as has been described (Hong et ah, 2003). When stained
basal cells were detected adjacent to stained columnar blocks, it was unclear whether
they represented the furthest extent of a lineage block, whether they gave rise to the
block, or whether they were unrelated to the block. The use of cell type-specific
markers such as Griffonia simplicifolia isolectin B4 (GSI-B4) for basal cells (Shimizu
et al., 1991), and antibodies against Clara cell secretory protein (CCSP) for columnar
secretory cells and acetylated tubulin for ciliated cells (Hong et al., 2003), would be
an obvious next step in evaluating the cellular composition of stained blocks.
However, inferences regarding the multipotency of the progentitors from which these





Figure 3.11 Observed apparent lineage patterns are consistent with predictions of the three zone label
retention model.
Apparent patterns of cell lineage connecting the submucosal gland (SMG) duct with the surface epithelium
resemble the migration of cells described by the model based on tracheal label retention data (Borthwick,
1999). (a) The three zone model of label retention (annotated in Figure 3.1). (b,c) Cre-mediated activation
of permanent pgal expression in a bovine K5 promoter-expressing SMG duct cell could result in observed
xgal staining patterns (for example, Figure 3.6f(iii,vi,viii)) during steady-state replenishment (b), or after
damage-induced repair (c), of tracheal surface epithelium.
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established. Examination of serial sections would assist greatly in this regard, and
would be essential in determining the likely origin of many stained blocks which, on
the limited number of sections analysed in this pilot study, did not display a clear
relationship with the underlying SMGs. The use of anti-Cre with anti-(3gal antibodies
may prove an elegant means of identifying the cellular source of stained blocks
(preliminary attempts at this were unsuccessful, data not shown). Examination of
xgal stained and/or immunostained wholemount tracheas using Optical Projection
Tomography (OPT) (Sharpe et al., 2002) would allow visualisation of clones in three
dimensions, and could be used to produce virtual tissue sections. Also, given that a
columnar layer is largely reconstituted within three days of POL damage, but is still
absent after 24 hours, the inclusion of a +2d timepoint would provide a valuable
"snapshot" of lineage patterns during the early repair phase, and may yield clues as
to the origin of marked blocks. These techniques and modifications to the
experimental protocol would also be relevant within the context of a successful
inducible lineage marking study.
While the bK5Cre'8 R26Rtg mice undoubtedly provided tantalising hints as to
possible lineage relationships, at least in the upper trachea, it may be that the sheer
frequency of stained cells would continue to prove an impediment to the confident
identification of clonal lineages. Elimination of ambiguities of this sort was the
rationale behind the construction of the inducible K5CE mouse, the preliminary
evaluation of which is discussed in section 3.4.2.
Despite previous observations that (human) K5 promoter-driven transgene activity
(Schoch et al., 2003) was localised to epithelial foci corresponding to underlying
cartilage-intercartilage junctions in the distal trachea, an analogous pattern of xgal
staining was not observed in this study. The absence of large stained blocks of cells,
and of discernible patterns in the distribution of those cells which did stain, in the
distal trachea is consistent with the notion that related, but likely different, lineage
systems operate in the proximal and distal tracheal zones. It has been speculated that
cell renewal in the upper trachea relies more on gland duct and surface basal cell
progenitors, whereas the glandless lower trachea, which contains slightly more Clara
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cells than the upper trachea (Pack et al., 1981), may utilise a Clara cell based lineage
system (Schoch et al., 2003).
3.4.2 Inducible lineage marking: K5CE x R26R
The preliminary experiment permitted by time on one of the three functional K5CE
lines described in chapter 2 section 2.3 was disappointing in that no induction of Pgal
expression was evident in the tracheal epithelium, despite activation of the R26R
allele in epidermal tissues. While not informative with regard to tracheal lineage
patterns, the experiment is included to demonstrate the general experimental design
which would be followed if time was available to repeat the study, as this result does
not invalidate the strategy, or the use of K5CE mice for this purpose, which merit
further evaluation. Moreover, the experiment was valuable in suggesting useful
modifications to a range ofparameters.
Given the rapid and generally complete re-epithelialisation observed after POL-
induced damage of bK5Cre'8 R26R'8 tracheas, the variable and apparently impaired
epithelial restoration which occurred in the K5CE'8 R26R'8 tracheas was presumed to
relate to the poor condition of many of the animals following consecutive treatment
with POL and TAM or oil. While such a compromised epithelial repair context is
clearly not an ideal situation in which to monitor lineage patterns, there is no obvious
reason why induced lineage marking could not have been activated in the repair that
did occur. As a result of the unexpected mortality and morbidity observed (both in
TAM and oil alone treated animals), a repeat of this experiment would necessitate a
revised protocol, likely separating the tracheal damage and the TAM administration
onto different days. Such a strategy was used successfully, albeit with a different
damaging agent, by Hong and co-workers (Hong et al., 2003), discussed in section
3.4.3.
Before any repeat of this experiment is undertaken, further efforts should be made to
establish whether lines K5CE600,700,1100 express the CreER72 transgene in the
SMG ducts and surface basal epithelial foci, as expected of the human K5 promoter.
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In a preliminary experiment, an antibody previously described to bind the CreER12
fusion protein (Doerflinger et al., 2003) showed no binding to sectioned K5CE or
bK5Cre tracheas. Its failure to bind the latter, which clearly contains Cre protein,
rendered the experiment uninformative. It may prove useful to induce nuclear
localisation of the CreER12 protein by TAM treatment prior to immunodetection,
since this has been shown to increase the intensity of the signal (Indra et al., 1999).
Previous efforts to demonstrate SMG duct expression from the /acZ-expressing
K5A1 lines were hindered by apparent endogenous galactosidase activity, levels of
which were high in that experiment (chapter 2, section 2.2.6). In situ hybridisation to
12the CreER transcript would be an alternative means of evaluating expression of the
K5CE transgene. If it can be unambiguously shown that K5CE tracheas do not
express CreER12 appropriately, then the experiment is clearly destined to fail.
However, all three functional lines need to be rigorously analysed to determine
whether the tracheal CreER72 expression detected by RT-PCR is reflected in an
• T9 • ■> •
appropriate pattern of CreER protein. The need to test all three lines is emphasised
by the experience of Schoch and colleagues, who found levels of K5 promoter-driven
eGFP to vary between tracheas of different lines (Schoch et al., 2003).
While the successful induction of CreER12 activity in examined epidermal tissues
validated the TAM preparation and route of administration, and could be interpreted
as indicating the absence of CreER12 protein in the trachea, it may simply have been
that the dosage, or the timing or frequency of administration, was not appropriate for
targeting the relatively few cells expected to produce the protein in the trachea.
These parameters should be experimentally investigated, as should alternative modes
of delivery, such as topical application by intratracheal instillation or nebulisation. In
addition to TAM, its metabolite 4-hydroxytamoxifen (OHT) could be used. While
several reports describe similar results using both OHT and TAM (Danielian et al.,
1998; Metzger and Chambon, 2001), OHT has appeared more effective in at least
one study (Zhang et al., 1996). Comparative evaluation of inducible Cre activity in
each line may be more easily achieved ex vivo, administering ligand to injured
tracheas maintained in a tracheal culture system (Scott et al., 2000).
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3.4.3 Validation of an inducible approach to tracheal epithelial
lineage marking
A recent study by Hong and colleagues revealed multipotent differentiation potential
of tracheal basal cells in response to naphthalene-induced ablation of secretory
(Clara) cells (Hong et al., 2003). This experiment also demonstrated proof of
principle for inducible recombinase-mediated lineage analysis in the regenerating
tracheal epithelium. Systemic naphthalene had previously been shown to stimulate
proliferation of neuroendocrine cells (Hong et al., 2001), and of a pollutant-resistant
subpopulation of Clara cell secretory protein (CCSP)-expressing cells associated
with either the neuroepithelial body (NEB) (Reynolds et al., 2000a) or the
bronchoalveolar duct junction (BADJ) (Giangreco et al., 2002), in the distal airways.
More recently, bronchial epithelial cells that assumed a K14-expressing phenotype
following injury were shown to exhibit multipotent differentation potential (Hong et
al, unpublished results). In the most recent study the authors determined that in the
steady-state trachea, a subset of tracheal basal cells were immunoreactive for K14,
and were usually found in small clusters associated with epithelial regions above
cartilage rings (exactly how this distribution differs from the cartilage-intercartilage
junction distribution described for K5 promoter-driven transgene expression, is
unclear) (Hong et al., 2003). However, in response to naphthalene-induced ablation
of Clara cells, basal cell hyperplasia was observed, and was associated with
expression of K14 in virtually all basal cells. The correlation between restoration of a
Clara cell-containing pseudostratified epithelium, and regression of the hyperplastic
K14-expressing basal cells, was suggestive of a progenitor-progeny relationship.
To determine the differentiation potential of tracheal basal cells, the authors used a
bipartite transgenic lineage marking approach analogous to the K5CE R26R strategy
attempted in this study (Hong et al., 2003). Using mice harbouring a K14 promoter-
driven inducible Cre transgene (CreERTAM, (Vasioukhin et al., 1999)) in combination
with the R26R transgene, naphthalene treatment was followed two days later by
TAM administration, resulting in apparently clonal clusters of xgal stained cells
throughout the tracheal epithelium by day six. The (3gal-positive clusters were
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enlarged in tracheas taken at 21 days, at which time the epithelium had returned to its
normal composition, and were observed to have increased further in size by day 43.
Analysis of the phenotypes of cells present within the stained clusters revealed that
while some clusters contained only basal cells, indicative of a unipotent progenitor,
the majority of clusters harboured multiple (basal, columnar, ciliated) cell types,
revealing the existence of K14-positive basal cells capable of multipotent
differentiation following secretory cell depletion. The authors did not conduct
lineage marking on undamaged mice, so the contribution of these cells to steady-state
maintenance of the tracheal epithelium is unclear.
The basal phenotype of the progenitors identified after Clara cell ablation is
consistent with several previous studies suggesting that basal cells represent airway
progenitors (Inayama et al., 1988; Breuer et al., 1990; Ford and Terzaghi-Howe,
1992b; Shimizu et al., 1994; Engelhardt et al., 1995). Since K14 is generally co-
expressed with K5 (Byrne and Fuchs, 1993), marked cells might have been expected
within SMGs, however none were observed (Hong et al., 2003). The authors
speculated that this may have resulted from the low frequency with which lineage
marking was activated, or the lack of injury among epithelial cells of the SMG. The
latter explanation is consistent with the established notion that the selectivity of
injury towards specific airway epithelial cell types is an important determinant of
progenitor cell activation. It has been shown that secretory cells of both the proximal
and distal airway epithelium of rats act as the main progenitors for replacement of
the epithelium in response to oxidant-induced injury to terminally differentiated
ciliated cells, while basal cells were implicated in the steady-state maintenance of
this tissue (Evans et al., 1976; Evans et al., 1986). As mentioned, naphthalene-
induced ablation of secretory cells was accompanied by proliferation of
neuroendocrine cells and a naphthalene resistant population of Clara cells in the
bronchioles (Reynolds et al., 2000a; Hong et al., 2001; Giangreco et al., 2002), and
K14-positive basal cells in the tracheobronchial epithelium ((Hong et al., 2003) and
Hong et al, unpublished results). Epithelial damage resulting from exposure to POL
or SO2, both of which remove columnar cells and, to varying extents, basal cells,
stimulates slow-cycling basal cells to take up a nuclear label (Borthwick et al.,
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2001). Thus, it is conceivable that the mode of damage effected by naphthalene was
not appropriate for the stimulation of the putative SMG duct progenitors.
3.4.4 Further evidence ofprogenitorial capacity amongst tracheal
basal cells
Despite the absence of marked lineage within SMG ducts in the study of Hong and
co-workers (Hong et al., 2003), recent experiments by Schoch and colleagues have
provided additional support for the notion that the K5-positive basal cells postulated
to equal tracheal LRCs (Borthwick et al., 2001), have progenitor-like characteristics
(Schoch et al., 2003). Examination of a transgenic mouse expressing eGFP from the
human K5 promoter revealed a distribution of eGFP-positive basal cells which
corresponded with the pattern of LRCs noted previously (Borthwick et al., 2001;
Schoch et al., 2003): eGFP expression was focussed on tracheal gland ducts and the
surrounding surface epithelium in the upper airway, and to systematically arrayed
foci centred over cartilage-intercartilage junctions in the lower airway. The K5-eGFP
mice were crossed with ROSA26 mice such that the resulting compound transgenic
animals expressed eGFP in a subset of tracheal basal cells, and (3gal in all cells.
Tracheal epithelial cell preparations were generated from K5-eGFP1" ROSA26's mice,
and the eGFP-expressing subset purified by flow cytometry. The colony forming
efficiency (CFE) of the eGFP-positive fraction compared to the eGFP-negative
fraction was compared by seeding the cells in an air-liquid interface cell culture
system which supported secretory and ciliated cell differentiation, and staining with
xgal to reveal ROSA26-&QxivQ& colonies. The eGFP-positive population showed a
consistently greater CFE than the eGFP-negative population. While the average
difference in CFE was 4.5-fold, the eGFP-positive population exhibited a 12-fold
higher CFE specifically for large colonies (>100 cells).
These results demonstrated a diverse progenitorial capacity amongst different
tracheal epithelial cell types, and even within the basal compartment. Of course,
while ex vivo clonogenic assays have proved useful for identifying putative stem
cells (Jones and Watt, 1993; Rochat et al., 1994), they represent an inherently
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artificial context in which to analyse the potency of cell populations, and should
ideally be interpreted as indicative of a given cell's proliferative potential, rather than
its behaviour or function within its native physiological situation. Nevertheless, the
enhanced clonogenic properties of the eGFP-positive cells is consistent with the
notion that a high K5 promoter-expressing subset of tracheal basal cells, thought to
correspond to LRCs, may represent the stem or early TA progenitor population.
These findings support further attempts to mark the lineage of the high K5-
expressing population in vivo using the K5CE mouse, which has the potential to
indicate the physiological role of these cells, including those of the SMG duct.
Additionally, the K5-eGFP mice could be used in a repeat of the original BrdU label-
retaining experiment (Borthwick et al., 2001) to determine whether the high K5-
expressing population are in fact LRCs.
3.4.5 Are submucosal gland duct progenitors involved in steady-
state maintenance of the tracheal epithelium?
While the lineage marking experiment of Hong and colleagues employed a selective
mode of airway damage to reveal multipotency of a subset of tracheal basal cells,
which may otherwise have been obscured by contributions from the secretory cell
pool (Hong et al., 2003), the tracheal injury used in the label-retention experiments
of Borthwick and co-workers was simply a means to stimulate proliferation of stem
cells which might normally act in steady-state maintenance of the tracheal epithelium
(Borthwick, 1999; Borthwick et al., 2001). Borthwick cites several pieces of
evidence for the involvement of the SMG duct LRCs in steady-state epithelial
renewal (Borthwick, 1999), including the observation that cells from all three of the
LRC zones (Figure 3.1) undergo mitosis in steady-state human bronchial SMGs
(Leigh, 1995), the presence of (a low number of) LRCs in the corresponding regions
of undamaged tracheas (Borthwick, 1999), and the correlation between SMG and
overlying epithelial origin in chimaeric tracheas (Borthwick, 1999). Preliminary
lineage analysis using the bK5Cre mouse (section 3.2.3) would appear to further
support the argument for a role of (b)K5 promoter-expressing SMG duct cells in
steady-state tracheal maintenance, consistent with the concept of a functional
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relationship between the glands and the surface epithelium resulting from the
developmental derivation of SMGs from overlying epithelial cells (Thurlbeck et al.,
1961; Engelhardt et al., 1995). However, more confident identification of clonal
relationships within renewing or regenerating tracheal epithelium should be obtained
through the use of the inducible lineage marking system, an approach recently
validated (Hong et al., 2003).
3.4.6 Future directions
3.4.6.1 Further evaluation of the inducible Cre transgenic lines
Given the preliminary nature, necessitated by time, of the experiments described in
this chapter, further evaluation of inducible Cre lines K5CE600,700,1100 is a
priority, and efforts to this end are underway. The demonstration of human K5
promoter-driven transgene expression within SMG ducts (Schoch et al., 2003) is
positive with regard to the prospects for CreER12 expression within the same cells of
K5CE mice. The recent report describing inducible lineage marking of K14
promoter-expressing cells in the trachea (Hong et al., 2003) is encouraging from a
proof of principle perspective, but could also be considered to render the K5CE
mouse redundant, since K14 is generally regarded as the co-expressed partner of K5
(Byrne and Fuchs, 1993). However, the issue of K5 promoter-expressing progenitors
within the SMG duct was not resolved using the K\4-CreERTAM mouse, as no
marked cells were evident within SMGs (Hong et al., 2003). While this could have
been an effect of the selectivity of the injury induced by naphthalene, or could have
resulted from the overall low frequency of marked cells, it is possible that the K14
promoter did not reflect endogenous K14 activity in the gland ducts. Alternatively, it
may be that the previously identified K5 promoter-expressing cells of the SMG duct
are a separate population from those shown to express K14 protein (Borthwick et al.,
2001): K5 is known to partner with K15 in certain epithelia (Lloyd et al., 1995) and
in oocytes (Gallicano, 2001). Intriguingly, K15 is considered a marker for human
hair follicle stem cells (Lyle et al., 1998), and it may be interesting to check for its
presence in tracheal epithelia. Since K5 and K14 are therefore not exclusively co-
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expressed, the K5CE mouse may prove useful in revealing lineages arising from K5
promoter-expressing cells in which the K14 promoter is not active. Also, the K5CE
mouse would be necessary to demonstrate an in vivo, physiologic progenitor role for
the K5 promoter-expressing cells of the SMG duct, since the demonstration of an
elevated in vitro CFE amongst K5 promoter-expressing tracheal basal cells did not
distinguish between SMG duct and surface epithelial basal cells (Schoch et al.,
2003).
If further evaluation of the K5CE lines demonstrates their suitability for inducible
marking of lineages arising from the high K5-expressing cells of SMG ducts, then it
would be interesting to monitor their contribution to airway restoration in a range of
injury contexts. In addition to POL and SO2, NO2- and 03-induced oxidative damage
has been used to specifically injure ciliated cells (Evans et al., 1976), and bleomycin
is known to cause damage to both epithelial airway cells and endothelial alveolar
cells (Kotton et al., 2001). Naphthalene has been used to specifically ablate Clara
cells (Stripp et al., 1995), while portions of airway epithelium have been completely
denuded using mechanical techniques (Shimizu et al., 1994). Observing lineage
patterns arising in response to a variety of airway damage scenarios should provide
valuable clues as to functional redundancies and potential hierarchies of progenitor
or stem cell utilisation in the respiratory epithelium.
3.4.6.2 Inducible lineage analysis of other airway populations
The successful demonstration of the inducible lineage marking strategy in adult
airways ((Hong et al., 2003) and Hong et al, unpublished results) could be usefully
extended to other cell types known to be involved in airway kinetics. For example,
Clara cells and the naphthalene-resistant subset of Clara-like cells are defined by
their expression of Clara cell secretory protein (CCSP) (Hong et al., 2001). Likewise,
pulmonary neuroendocrine cells (PNECs) are identified by their expression of
calcitonin gene-related peptide (CGRP) (Hong et al., 2001). Using the promoters of
the CCSP and CGRP genes to drive expression of an inducible recombinase should
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facilitate further elucidation of the potency of these cell types, and their contribution
to airway maintenance and regeneration.
3.4.6.3 Further experiments using the constitutive Cre transgenic line
The bovine K5 promoter-driven constitutive Cre line (bK5Cre) appeared to reflect
the SMG duct expression of the human K5 promoter, and could therefore be useful
for following the lineage of these cells, particularly in the event that the K5CE lines
prove refractory to attempts at inducing lineage marking. Although, as anticipated,
the generally high frequency of marked cells prevented the unambiguous
identification of clonally marked blocks, potentially interesting patterns of cell
lineage were observed. Further investigation of lineage patterns arising from
hK5Cre-expressing cells might be more informative in the context of aggregation
chimaeras containing hKSCre'8 R26Rtg compound transgenic cells and wild-type
cells. This should reduce the frequency of marked lineages, increasing the confidence
with which blocks could be identified as being of clonal origin. Alternatively, should
further analysis reveal that the human K5 promoter does not drive expression of the
CreERn transgene in the tracheas of the three potentially useful K5CE lines,
expression of the fusion gene from the bovine K5 promoter would be a suitable
alternative.
3.4.6.4 Do circulating stem cells respond to tracheal injury?
While current research continues to support the notion of region-specific stem cells
within the various compartments of the airway (Borthwick et al., 2001; Hong et al.,
2001; Giangreco et al., 2002; Schoch et al., 2003; Hong et al., 2003), it is important
to consider the potential contribution from circulating bone marrow (BM)-derived
stem cells. These cells could be useful for ex vivo gene therapy, since they offer the
prospect of genetic manipulation before engraftment in a range of tissues. This would
circumvent potential difficulties in targeting therapies at tissue-resident airway stem
cells, which may prove inaccessible to luminally-delivered gene therapy vectors
because of their proposed localisation to basal positions in the proximal tracheal
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surface epithelium and gland ducts. Efforts are currently underway to evaluate the
involvement ofBM-derived cells after airway epithelial injury.
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4.1 Introduction
In the course of studies into cell lineage in the mouse airway (chapter 3), marked
inconsistencies in (3gal expression were detected in the tracheas and other tissues of
bK5Cre's R26R'8 compound transgenic mice (section 3.2.1). This is a separate
observation from that regarding the described variation in frequency and intensity of
xgal staining in tracheas from bK5Cre'8 R26R'8 animals (discussed in section 3.4.1).
While some mice displayed, as expected, Pgal expression in basal epithelial cells and
their supra-basal daughter cells, other animals exhibited universal Pgal production,
indicating constitutive recombination of the R26R allele.
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4.1.1 Aims
This chapter demonstrates the alternate expression patterns observed and investigates
the molecular basis for this phenomenon.
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4.2 Results
4.2.1 Alternate patterns of recombination in bK5Cret9 R26Rtg mice
correlate with the sex of the bK5Cre transgene donor parent
As demonstrated in chapter 3, the bK5Cre transgene, when combined with the R26R
conditional reporter allele, causes expression of (3gal in the basal cells of epithelial
tissues (Figure 3.2). This is due to a permanent genetic rearrangement within the
R26R allele and, because of the ubiquitously active nature of the ROSA26 locus, all
descendants of bK5 promoter-expressing cells express the reporter. In the skin, the
entire epidermis including hair follicles and sebaceous glands becomes marked, as
K5-positive basal epidermal cells divide to produce daughters which populate the
supra-basal layers. This is shown in pinna section (Figure 4.Id), which also reveals
that the dermis remains entirely unstained after xgal treatment. As shown previously
in chapter 3, (3gal is consistently and strongly expressed in the larynx at the proximal
extent of the trachea, and to a more variable degree in the epithelial layer of the
tracheal lumen, and the SMGs (Figure 4.1a).
However in some first generation litters inheriting both the bK5Cre transgene and the
R26R locus, all animals staining after xgal treatment exhibited ubiquitous expression
of (3gal (Figure 4.1b,e), reminiscent of the ROSA26 phenotype (Figure 4.1c,f), which
would depend upon universal recombination of R26R. Intercrosses between
bK5Cretg/wt R26Rtg/wt compound hemizygous animals that displayed K5-derived |3gal
expression consistently resulted in litters composed of ubiquitously staining animals,
plus a minority of non-staining animals: such litters were devoid of animals
exhibiting a K5-derived pattern of recombination.
In an effort to elucidate the pattern of segregation of the ubiquitously staining
phenotype, embryonic litters were collected from crosses between several
bK5Cretg/wt and R26Rtg/wt single transgene-positive, hemizygous mice (Table 4.1).
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Figure 4.1 The pattern of Cre-mediated recombination differed depending on the sex of the bK5Cre
transgene-transmitting parent.
Xgal-stained wholemount tracheas (a,b) and sectioned pinna (d,e) of mice resulting from reciprocal
bK5Cre x R26R crosses. Corresponding ROSA26 tissues are included for comparison (c,f). (a,d) bK5Cne'g
R26R'g tissue from bK5Cre male x R26R female cross, (a) R26R recombination was strongest at the
proximal end of the trachea, with less intense staining in the luminal surface, (d) Staining was confined
to the epidermis of the pinna, including in the hair follicles which descend into the dermis. (b,e) bK5Cre>g
R26Rg tissue from bK5Cre female x R26R male cross, (b) The trachea showed complete recombination
of R26R, mirrored in the pinna (e), where an intensely stained layer of cartilage is flanked by the more
weakly staining dermis, (b) and (e) exhibit comparable staining to the ROSA26 tissues (c,f). Scale bar



































Total 0(0) 5,5,1 (11) 6,3,4 (13)
Table 4.1 Genotype-phenotype correlations in embryonic offspring of reciprocal bK5Cre'a/m x R26Rtg/wt
crosses.
Three litters from both types of cross were obtained: 9-, 7-, and 6-embryo litters from bK5Cre'a/wt male x
R26RtgM female crosses and 11-, 8-, and 5-embryo litters from bK5Cre'3/wt female x R26Rla/wt male
crosses. For each of the four possible embryonic genotypes, the number of mice from each of the three
litters displaying a K5-derived or a ubiquitous |3gal expression pattern, or no (3gal expression, are
recorded. The number of embryos showing each phenotype were totalled and revealed an expected
ratio of approximately 1:3 between K5-derived expression™ expression from the bK5Cretg/w' male x
R26RtB/wt female crosses, with xgal staining embryos corresponding to those genotyped as compound
transgenic. The bK5Cre'a/wt female x R26Rta/wt male crosses generated no embryos exhibiting a K5-
derived xgal staining pattern, and the ratio of ubiquitous expression™ expression was approximately
1:1. Amongst the embryos showing ubiquitous (3gal expression, approximately half were compound





Primary 1 0 47
Mature 15 21 7
Antral 15 20 5
Primary 0 0 39
non-transgenic Mature 0 0 21
Antral 0 0 16
Table 4.2 Numbers of DAPI-positive oocytes displaying anti-Cre signal in bK5Cre'g/wtand non-
transgenic ovaries.
DAPI-positive oocytes were scored for anti-Cre fluorescence (nuclear or nucleolar), and categorised by
follicle stage. "Primary" follicles were small and surrounded by a single layer of follicle cells (Figure
4.7). "Mature" follicles were all follicles developmentally intermediate between primary follicles and
"antral" follicles (not equal to the "mature follicle" annotated in Figure 4.7). "Antral" follicles were defined
as those displaying large antral spaces (approximately corresponding to all stages subsequent to the
"secondary oocyte" pictured in Figure 4.7). However, due to potential misrepresentation of follicle
stages as a result of the plane of section viewed, these categorisations were not strict, particularly
between the mature and antral follicles. Also, it is possible that the single bK5Cre anti-Cre-positive













Figure 4.2 Universal recombination of R26R in offspring from bK5Cre females does not require transmission
of bK5Cre.
(a) Xgal stained E13.5 embryos from a cross between a R26Rt9/wt male and bK5Cre'9/wt female, (b)
Genotyping of embryos for the R26R and bK5Cre transgenes revealed that ubiquitously stained embryo
(ii) did not carry the bK5Cre transgene. Genotypes are bKSCre19 R26R® (i), bK5CreM R26R!9 (ii), bK5CreM
R26Rm (non-transgenic, iii). Myogenin (myoG) primers were used as an internal PCR control, (c) A sagittal
section through an xgal stained embryo showing ubiquitous expression of pgal (lack of internal staining
was due to incomplete xgal stain penetration). Compare with epidermal-specific staining in an bK5Cre'9
R26Rtg embryo from a cross between a R26R female and bK5Cre male, chapter 3, Figure 3.2a,b,e. M
= 1kb ladder, n-t = non-transgenic. Scale bar = 800^m (c).
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Xgal staining of resulting embryos revealed that the universal activation of R26R
occurred only when the bK5Cre transgene was carried by the female parent.
Furthermore, genotyping of the embryos revealed that this staining pattern was not
dependant on inheritance of bK5Cre (Figure 4.2).
4.2.2 Cre activity in bK5Cre oocytes causes universal
recombination in the subsequent generation
That universal recombination of R26R was apparent only in progeny descended from
bK5Cre females, combined with the observation that the bK5Cre transgene was not
required to mediate this event in the offspring, suggested that recombination was
occurring at the beginning of embryonic development, and being propagated through
subsequent cell division. Accumulation of Cre protein within oocytes would explain
these findings, with persistence of protein into the early zygote necessary to effect
the observed recombination of paternally-derived R26R alleles in MT5Cre-negative
offspring.
To investigate this, immunofluorescence detection of Cre protein was performed on
sectioned ovaries from three hemizygous bK5Cre mice (Figure 4.3). As it was
anticipated that Cre protein would be abundant immediately preceding fertilisation,
the animals were first superovulated to elevate the proportion of mature oocytes.
Highly fluorescing foci were observed in bK5Cre oocytes (Figure 4.3d-f), but were
absent in non-transgenic oocytes (Figure 4.31). Serial sections revealed a correlation
between DAPI fluorescent staining of chromatin and anti-Cre fluorescence,
indicating that Cre was localised to the oocyte nucleus (Figure 4.4). The spatial
relationship between the Cre signal and the chromatin conformation of a subset of
oocytes revealed the protein to be particularly abundant in nucleoli (Figure 4.3c,f). S.
Webb provided some technical assistance with establishing the anti-Cre
immunoassay.
The fact that all embryos inheriting a R26R allele from crosses between R26Rtg/wt
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Figure 4.4 Immunofluorescence analysis of serial sections revealed a correlation between nuclear DAPI
staining and anti-Cre signal.
Corresponding fields of view from four consecutive serial sections of a bK5Cre ovary, imaged for DAPI (a,c,e,g) and
anti-Cre signal (b,d,f,h). Excluding the central primary follicle, four mature follicles are visible, numbered (Mv). As the
sections are examined in turn for anti-Cre fluorescence from (b) to (h), the nuclei of all four oocytes are revealed as
positive, in the order that they have been numbered. Careful examination of the DAPI images reveals an association
between the respective peaks of anti-Cre fluorescence and the appearance of DAPI-stained chromatin in the same
oocyte. This indicated that Cre protein was localised to oocyte nuclei. Thus, DAPI signal was used as a control,
indicating in which oocytes the plane of section had bisected the nucleus. Accordingly, scoring of Cre-positive nuclei
was limited to these oocytes. Scale bar = 20nm.
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that all fertilisable oocytes within bK5Cre ovaries produced Cre protein. To quantify
this, Cre-positive oocytes were counted on 31 ovary sections from three hemizygous
bK5Cre animals (Table 4.2): since the plane of section through an oocyte often did
not pass through its nucleus, Cre-positive oocytes were scored per DAPI-positive
oocyte (Figure 4.4). Excluding the immature oocytes of primary follicles, the nuclei
of 86% of oocytes contained detectable amounts of Cre protein. In 58% of Cre-
positive oocytes, the protein was noted to be concentrated in the nucleoli, with a
reduced intensity of fluorescence in the surrounding nucleus. However it is likely
that in many or all of the remaining 42%, the plane of section had simply not entered
nucleoli. In most cases where DAPI-positive oocytes appeared to lack Cre protein,
only a small number of DAPI staining foci were observed, suggesting the plane of
section was through the edge of the nucleus where Cre levels may be low, and did
not bisect nucleoli (Figure 4.3g,j). Of 48 DAPI-positive primary follicles examined,
only one contained an apparently Cre-positive oocyte. However, classification of this
follicle as primary, based on its relatively small size and single layer of surrounding
follicle cells, may have been incorrect, as both follicle size and structure can be
misrepresented by the plane of section. Alternatively, this oocyte may have been at
the transition between the primary follicle and double-layered stages, during which
Cre protein begins accumulating prior to the first meiotic division (see section 4.3.2).
As a control, 16 ovary sections from three non-transgenic mice were examined for
fluorescent nuclei. Of 37 non-primary follicles observed, none exhibited nuclear
fluorescence.
4.2.3 Cre protein mediates recombination of R26R within oocytes
To further confirm the presence of Cre protein in bK5Cre oocytes, and to
demonstrate that the levels of Cre produced were sufficient to effect recombination
of R26R, ovaries from bK5Cre'g/wt R26Rtg/wt compound hemizygous mice were
stained with xgal. In order to firstly demonstrate transcriptional activity of the R26R
allele in oocytes, ovaries from mice produced by crossing a R26Rtg/wt male with a
bK5Cretg/wt female, and thus being universally recombined at R26R, were xgal
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stained and sectioned (Figure 4.5a). As expected, the ovary exhibited widespread,
albeit non-uniform, production of (3gal. While all oocytes demonstrated expression
from the recombined R26R allele, they differed in ooplasmic staining intensity, and
many contained a discrete spot of intense xgal staining.
In ovaries from compound hemizygous mice in which the bK5Cre transgene was
inherited paternally, xgal staining was confined to oocytes (Figure 4.5b). Although
general ooplasmic staining was less intense than in ovaries carrying a universally
recombined R26R allele, many oocytes contained a similar spot of intense xgal
staining (Figure 4.5c). This distinctive staining pattern, which was also visible in
wholemount ovaries (Figure 4.5d), was not observed in single transgene-positive
bK5Crewt R26R'S mice (Figure 4.5e), or in non-transgenic mice. Staining foci did not
appear to coincide with known sub-cellular structures (J. McNeilly, personal
communication) and, as is shown clearly on Figure 4.5c, were distinct from the
nucleus.
Figure 4.6 shows schematically how Cre activity in the female germline could result
in the genotype-phenotype correlation presented in Table 4.1 for a cross between a












Figure 4.6 Cre activity in the female germline causes zygotic recombination of paternally-derived R26R
alleles.
A cross between a R26Rtg/wt male and a bK5Cretg/wt female is represented. As shown, it is assumed that
the bK5Cre allele had integrated onto a chromosome other than chromosome 6, where R26R is located
(however for this cross, the genotype-phenotype correlation should be the same if the transgenes are
located on homologous chromosomes). The potential male and female gametes are phowm as are the
genotypes of the four theoretical progeny, representing four genotypic classes: bK5CregR26Rg: bK5Cre9
R26R :bK5Cre R26Rg:bK5CrewlR26Rwt (non-transgenic), at a ratio of 1:1:1:1. The Cre protein within
both female gametes, including that not transmitting the bK5Cre transgene, is thought to persist into the
early zygote, resulting in the recombination-mediated activation of figal expression in all zygotes inheriting
the R26R allele (50%). In these animals, this permanent genetic change is inherited by all cells, resulting
in ubiquitous |5gal expression. In a cross where the female also carried the R26R allele, recombination
would occur in all R26R-positive oocytes prior to ovulation (not shown).
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4.3 Discussion
The bK5Cre line of mice used in chapter 3 to study cell lineage in the tracheal
epithelium displayed alternate patterns of recombination of floxed alleles which was
found to be determined by the mode of inheritance of the transgene: the paternally-
inherited transgene caused basal epithelia-specific recombination typical of the bK5
promoter, while its unanticipated activity in the female germline resulted in universal
excision of floxed sequences in the subsequent generation. Since accumulation of
Cre protein in the maternal oocytes was apparently responsible for this phenomenon,
further discussion of these results would be usefully informed by a basic review of
oocyte development in the mouse.
4.3.1 Murine oogenesis in brief
Figure 4.7 shows a composite drawing of the mouse ovary including all the stages of
oogenesis, from the primordial germ cells which appear at 8 days gestation, to the
mature antral follicles which are first seen at approximately 17 days after birth.
Primary oocytes are present in the adult ovary, and are initially distinguished by their
single, loose layer of squamous follicle cells, and slightly enlarged nucleus compared
to adjacent cells. As the oocyte develops, the nucleus continues to grow, and the
single layer of follicle cells becomes cuboidal, producing the distinctive primary
follicle. Over time, the follicle cells surrounding the primary oocyte become multi-
layered, fluid-filled antral spaces begin to form, and single or multiple nucleoli
appear as RNA production increases markedly. As the antra start to appear more
distinct, recombination and segregation of alleles occurs as the oocyte undergoes the
first meiotic division, resulting in the formation of the first polar body and leaving a
secondary oocyte. The second meiotic division begins immediately in the maturing
follicle with the oocyte, coated in cumulus cells, suspended in the single fused
antrum. Flowever in the swollen, mature follicle, the secondary oocyte nucleus
remains arrested in metaphase, which does not resume until fertilisation. Finally, a





































Figure 4.7 Development of the mouse oocyte (modified from Rugh, 1990).
Composite drawing showing all stages of oocyte development from primordial oocyte to mature antral
follicle and corpus luteum.
See section 4.3.1.
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stimulate a large number of follicles to synchronously mature, before triggering their
release. In experiments described here, the ovaries were removed after administration
of human chorionic gonadatrophin (hCG), but before the predicted onset of
ovulation.
4.3.2 Accumulation of Cre protein precedes the first meiotic
division
The observation that all i?2<5i?-positive offspring derived from bK5Cre females
stained ubiquitously with xgal, regardless of whether they also inherited the bK5Cre
transgene, suggested that Cre protein was being produced in all oocytes, rather than
in merely a subset. Since the female parents were hemizygous for bK5Cre, only
approximately half of fertilised oocytes would be expected to carry the transgene: in
the remainder, bK5Cre would have been lost to the polar body during the first
meiotic division. Thus, the presence of Cre protein in all fertilised oocytes would
necessitate its synthesis prior to the first meiotic division, when all oocytes contain
the bK5Cre transgene. This is supported by anti-Cre immunofluorescence data and
xgal detection of R26R recombination, revealing the presence and activity of Cre in
relatively small oocytes lacking antra (Figure 4.4b, Figure 4.5b). The alternative
explanation, that Cre protein is synthesised in follicle cells and transported into the
oocyte, is not supported, as no Cre-positive follicle cells were detected.
That the paternally-derived R26R allele is universally recombined by Cre protein
produced in the female germline indicates that maternally-derived Cre must persist
until male and female pronuclei fuse following fertilisation. Although this has not
been directly demonstrated, the use of ovaries from superovulated mice revealed that
Cre protein was clearly abundant in the oocytes of late stage follicles, and thus would
likely be present at fertilisation. Xgal staining of two-cell embryos has previously
been used to demonstrate zygotic recombination of paternally-derived alleles by Cre
produced in oocytes from mice carrying a ubiquitously-expressed Cre transgene
(Sakai and Miyazaki, 1997). This technique, or anti-Cre immunofluorescence, could
be usefully employed on two-cell embryos resulting from crosses between R26R
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males and bK5Cre females to prove that Cre protein is present and active in the early
embryo.
4.3.3 Nucleolar accumulation of Cre protein does not prevent
access to genomic loci
The immunofluoresence data presented reveals a marked sub-nuclear accumulation
of Cre protein. In a proportion of oocytes, a ring of DAPI fluorescent staining
encircled the region of high anti-Cre fluorescence. Oocytes in which the nucleoli are
surrounded by a ring of Hoechst-positive chromatin ("surrounded nucleolus, SN"-
type) have previously been described and distinguished from "non-surrounded
nucleolus (NSN)" -type oocytes, in which the chromatin is organised into discrete
spots which do not delineate the nucleolar border (Debey et al., 1993). Both
chromatin configurations are represented in Figure 4.3c,f and b,e, respectively: the
spatial relationship between the SN-type oocyte's rings of DAPI fluorescence and the
foci of intense anti-Cre signal indicated that the sub-nuclear compartment exhibiting
elevated levels of Cre protein was the nucleolus.
The significance of this observation, and the means by which it occurs, is unclear.
The Cre gene within the bK5Cre construct bears an exogenous nuclear localisation
signal (NLS) (A. Ramirez, personal communication). NLS-Cre has been reported to
mediate a 2-fold increase in recombinational excision of floxed sequences, compared
to wild-type Cre (Gu et al., 1993). However, a subsequent study found that the same
NLS had no effect on nuclear accumulation of Cre protein, attributing this to the
efficient import facilitated by the protein's endogenous nuclear targeting
determinants (Le et al., 1999). Targeting of Cre to nucleoli was not reported, though
the nuclear activity of the somatic cells in which those experiments were conducted
is likely to have been considerably different from the situation in the developing
oocyte. Despite this, the concentration of Cre within the DNA-poor nucleolus is
counter-intuitive. In the absence of an obvious role within, or means of targeting, the
nucleolus, the apparent accumulation of Cre there may be an artefact resulting from
high expression of the prokaryotic protein.
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Despite its apparent accumulation within nucleoli, Cre protein clearly had access to
the R26R locus of genomic DNA, as demonstrated by xgal staining of oocytes from
compound transgenic mice carrying a paternally-derived bK5Cre transgene. The
staining pattern was characterised by faint, generalised ooplasmic staining and single
or, less commonly, multiple intense, discrete foci of staining within the ooplasm.
These staining spots could be seen on wholemount ovaries, and sectioning revealed
they did not coincide with obvious sub-cellular structures. Similar spots, albeit
against a background of stronger ooplasmic staining, were also observed in
homozygous ROSA26 ovaries, and in ovaries containing universally recombined
R26R alleles from mice with bK5Cre mothers, but not in single transgene-positive
mice carrying entirely unrecombined R26R alleles. Similar foci of xgal staining have
been reported in ROSA26 preimplantation embryos, and were not found to be
associated with distinct cytoplasmic organelles by electron microscopy (Neganova et
al., 2001). The authors speculated that the sub-cellular localisation of xgal precipitate
might reflect an involvement of the ROSA26 locus in RNA or protein distribution.
Alternatively, the staining spots may represent figal aggregates produced as the
oocyte attempts to remove the foreign protein, as they have been observed in other
transgenic lines expressing (3gal in oocytes (G. Wei, personal communication).
4.3.4 Does expression from the bK5 promoter in oocytes reflect
endogenous K5 production?
It was initially imagined that the activity of the bK5Cre transgene in oocytes was
ectopic, the likely result ofposition effect on the transgene in the particular line used.
However, analysis of another bK5Cre line has revealed universal recombination of
floxed alleles following bK5Cre transmission through the female germline, albeit
with a lower penetrance than the line used in these studies (A. Ramirez, unpublished
results). In the other bK5Cre line, 21% of offspring inheriting only the reporter gene
showed complete recombination, with no recombination detected in the remainder,
while 17% inheriting both transgenes showed complete recombination, the remaining
83% exhibiting tissue-specific recombination (A. Ramirez, unpublished results). This
suggests that expression of bK5 promoter-driven transgenes in oocytes might be
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representative of endogenous K5 transcription. Although K5 activity is generally
regarded as being restricted to epithelia (Byrne and Fuchs, 1993), and contrary to
reports describing the absence of intermediate filaments from mammalian embryos
prior to the 8-cell stage (Chisholm and Houliston, 1987), several keratins including
K5 have been detected in mouse oocytes and early embryos (Lehtonen, 1987;
Gallicano et al., 1994). It appears that K5, and its apparent oocyte partner K15, are
maternally synthesised during oogenesis and stored in cytoskeletal sheets until
required at the morula or blastula stage when they would function by binding to
desmosomes (Gallicano, 2001). If expression of the bK5Cre transgene in oocytes is a
consequence of endogenous K5 promoter activity, then the apparent absence of K14
protein in oocytes (Gallicano, 2001) may explain why constitutive recombination of
floxed alleles in the female germline has not been reported for mice in which Cre has
been introduced to the genomic K14 locus (Huelsken et ah, 2001). Mice expressing
Cre from the K15 promoter have not been described.
Despite this, other studies using Cre transgenes driven by K5-derived promoters
(both bovine and human) make no mention of constitutive recombination of floxed
alleles in progeny born of K5-Cre mothers: although only male mice carrying Cre
downstream of a 14kb human K5 promoter were used in matings by Tarutani and
colleagues (Tarutani et al., 1997) and Gao and co-workers (Gao et al., 2002), while
the sex of the K5-Cre transgene-bearing mice used by Suzuki and colleagues (Suzuki
et al., 2003) was not specified, no evidence of expression within the female germline
was apparently observed (J. Takeda, personal communication). In another study, the
absence of such a phenomenon in experiments using the same 5.2kb bovine K5
promoter as used here is not informative, as no attempt was made to activate the
inducible version of Cre in transgenic mothers (Zhou et al., 2002). The detection of
Cre activity in the oocytes of two independent lines of bK5Cre mice suggests that
genomic position effect on the randomly integrated transgenes is unlikely to be
entirely responsible. That such an expression profile is representative of the
endogenous K5 gene is supported by reports of K5 protein within oocytes (Gallicano
et al., 1994). In light of this, it is surprising that the more extensive promoter region
(14kb of human sequence, compared to 5.2kb of bovine sequence used here), which
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one would expect to drive a more faithful pattern of expression, apparently fails to
emulate the female germline-specific phenomenon described herein. This effect may
therefore be a characteristic feature of the bK5Cre construct used in these studies.
Although several transgenic mice have been generated which express Cre in their
oocytes, using either strong ubiquitous promoters (Schwenk et al., 1995; Lakso et al.,
1996; Sakai and Miyazaki, 1997; Lallemand et al., 1998) or regulatory elements
from known oocyte-expressed genes (Lewandoski et al., 1997; de Vries et al., 2000)
it would appear that only one other line exists in which paternal transmission results
in a tissue-specific recombination pattern and maternal transmission produces
constitutive recombination in offspring, independent of inheritance of the Cre
transgene. However the unanticipated expression of Cre within the oocytes of this
line, in which the transgene is driven by elements of the rat prostate-specific
probasin gene promoter, only achieved constitutive recombination in 47% of
offspring (Wu et al., 2001). Thus the bK5Cre line described here, which effects
universal recombination in 100% of offspring when bK5Cre is present in the female
parent, offers both basal epithelia-specific and ubiquitous recombination of floxed
alleles, simply by changing the parent carrying the Cre transgene.
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5.1 Introduction
5.1.1 Gene correction
"Gene correction", also known as "targeted gene repair", describes the ability of a
range of small molecule reagents to permanently and site-specifically effect small-
scale sequence alterations at genomic loci, and is a conceptually more elegant
approach to the established complementation approach of gene therapy. The direct
correction of a genetic defect at its native chromosomal location offers several
advantages over the addition of an exogenous functional copy of the mutant gene.
The repaired gene would remain under the regulation of its endogenous control
elements, including 5', 3' and intronic sequences typically absent from cDNA-based
gene therapy vectors, restoring the precise physiological expression characteristics of
the normal gene. Since gene correction reagents act site-specifically and introduce no
exogenous DNA into the genome, there is little risk of insertional mutagenesis as has
been observed with integrating viral vectors (Hacein-Bey-Abina et al., 2003). Also,
the permanent nature of the sequence alteration should circumvent the need for
repeated administration, which in the case of adenoviral vectors can lead to severe
inflammatory responses (Thomas et al., 2003). Unlike complementation strategies,
gene correction approaches are applicable to dominant-negative, gain-of-function
mutations, since repair should simultaneously reduce the amount of deleterious
protein and increase the proportion of functional protein. If the permanent genetic
"fix" promised by gene repair techniques could be delivered to the stem cells of the
target tissue, and then by propagation to all the differentiated cells, a single-dose
gene therapy could be realised.
Gene correction has been achieved through the use of several types of small
molecule reagents. The most prolific of these are modified oligonucleotides
pioneered by Kmiec and colleagues, which have evolved from RNA/DNA
oligonucleotides (RDOs or "chimeraplasts") to single-stranded oligonucleotides
(SSOs) (Liu et al., 2003). Other systems include small DNA fragments (SDFs)
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(Gruenert et al., 2003), triplex-forming oligonucleotides (TFOs) (Seidman and
Glazer, 2003), and a recently recognised property of adeno-associated virus (AAV)
(Inoue et al., 2001). The two systems which were under investigation in the
laboratory when this project was undertaken, RDOs and SDFs, will be briefly
introduced.
5.1.2 RNA/DNA oligonucleotides
The original RDO design was a single-stranded, self-complementary oligonucleotide
of approximately 70-80 bases, which adopted a double-hairpin conformation through
intra-molecular base-pairing (Kmiec, 2003) (Figure 5.1a). The sequence of the paired
strands was complementary to the target sequence, except for the position
corresponding to the mutation, to facilitate homologous pairing. One strand
contained RNA bases, modified to resist nuclease digestion, which were believed to
enhance pairing of the molecule with the target sequence (Kotani et ah, 1996).
Additional stability was provided by 4-thymine loops at either end of the molecule,
and one of the phosphodiester bonds was left unligated to allow the molecule to
become intertwined with the target helix. Although the mechanism of action has not
been determined, the molecule was postulated to act by mimicking a mismatched
base pair at the site of the mutation, inducing the recruitment of cellular DNA repair
proteins to resolve the mismatch and thus alter the target sequence (Kmiec, 1999)
(Figure 5.1b).
The range of experimental systems, genetic targets, molecule designs, and associated
experimental parameters used in different studies have meant that meaningful
comparisons between the correction frequencies achieved have been difficult to
make. However, there has clearly been great variation in reported efficiencies. While
many groups have persistently failed to achieve any RDO-mediated correction (van
der Steege et al., 2001), there have been some notable successes. Kren and
colleagues reported a single nucleotide conversion efficiency of 43% in cultured
hepatocytes (Kren et al., 1997), and subsequently achieved conversion of 40% of
factor IX loci in rat liver in vivo (Kren et al., 1998). The single base pair mutation
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introduced into the factor IX gene was associated with prolonged blood coagulation.
Also in rat liver, insertion of a single nucleotide was achieved at a frequency of
approximately 20% at the UDP-glucuronosyltransferase gene, resulting in reduced
serum bilirubin levels (Kren et al., 1999). In a mouse over expressing human apoE2,
the dysfunctional version of the apoE protein responsible for premature
artherosclerosis, approximately 25% of APOE2 was converted to the APOE3 form
(Tagalakis et al., 2001), and such a change was shown to have effects at the protein
level in vitro. Other reports of functional in vivo correction, albeit demonstrating
more modest efficiencies, include the detection of wild-type dystrophin fibres in the
mdx mouse (Rando et al., 2000) and GRMD dog (Bartlett et al., 2000) models of
muscular dystrophy, and the production of melanin pigment in albino melanocytes
(Alexeev et al., 2000).
Several explanations have been forwarded for the variability in observed correction
rates, including the differential recombination and repair activities of different cell
types (Santana et al., 1998) and the efficiency with which targeting molecules are
delivered to the nucleus (Thorpe et al., 2002b). Another issue has been the quality
and purity of RDO syntheses (Liu et al., 2003; Manzano et al., 2003). The latter
factor, combined with the high cost of producing complex RDO molecules, led to the
experimental deconstruction of RDO functionality. It was discovered that single-
stranded oligonucleotides (SSOs) comprising 25-90 nucleotides of DNA protectively
capped with modified RNA nucleotides (Igoucheva et al., 2001) or phosphorothioate
linkages (Gamper et al., 2000) could effect sequence-specific modifications with
similar frequencies to RDOs (Figure 5.1a(ii,iii),c). Moreover, in experiments
demonstrating both episomal and chromosomal correction of a defective lacZ gene
by two different lengths of sense and antisense SSOs, no correction was effected by a
corresponding RDO (Nickerson and Colledge, 2003).
Recent work has concentrated on the use of SSOs, though reported efficiencies of
correction are modest compared to the previously described in vivo work using
RDOs. Correction of the a-D-glucosidase gene was achieved in cultured cells at
frequencies of between 1.5-5%, reflected by increases of approximately 0.5-4% in
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enzyme activity, with sense SSOs showing higher corrective activities than antisense
versions (Lu et al., 2003). The latter observation contrasts with reports of higher
conversion rates being mediated by antisense than sense SSOs (Igoucheva et al.,
2001; Nickerson and Colledge, 2003). While the binding of antisense SSOs to the
nontranscribed strand would not be destabilised by transcription, as might occur in
the case of sense SSOs, the conflicting results might reflect an influence of DNA
replication, with the polarity of the process favouring sense or antisense SSOs at
different loci (Liu et al., 2003). Attempts to identify cellular factors which influence
correction frequencies are now being conducted in yeast. For example
overexpression of RAD51, which codes for a strand transferase protein known to be
involved in recombination reactions, has been shown to enhance both episomal and
chromosomal SSO-mediated gene repair (Liu et al., 2002). This is consistent with the
results of Thorpe and colleagues using mammalian cell lines, who observed
significant levels of RDO-mediated correction only in a cell line overexpressing
RAD51 (Thorpe et al., 2002b). Further dissection of the endogenous mechanisms
involved in mediating the activities of SSOs should enhance the utility of this
technique.
5.1.3 small DNA fragments
SDFs are typically 400-800bp single- or double-stranded PCR products derived from
the wild-type version of the mutated target sequence, and have been shown to
mediate gene correction through a poorly-understood process termed small fragment
homologous replacement (SFHR). It has been postulated that the absence of
sequence non-homologous to the target (except for the mismatched base(s)) is
responsible for the levels of recombination observed (Goncz et al., 1998), in contrast
to the infrequent homologous replacement achieved using much longer classical
targeting vectors which contain significant regions of non-homology, such as
selectable markers (Deng and Capecchi, 1992).
Unlike RDOs, the action of which has so far been limited to single base conversions
and insertions, the ability of SDFs to mediate the insertion or deletion of multiple
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bases has been demonstrated: both insertion and deletion of 3bp corresponding to the
AF508 mutation in the cystic fibrosis transmembrane conductance regulator (CFTR)
gene has been achieved in cultured epithelial cells (Kunzelmann et al., 1996; Goncz
et al., 1998). These studies also revealed that an independent single base pair
conversion could be introduced concomitantly with the primary insertion or deletion.
In addition to DNA- and RNA-based methods of detection, correction within 1-10%
of transfected cells was confirmed functionally using electrophysiological
measurements (Kunzelmann et al., 1996).
In primary myoblast cultures from the mdx mouse model of Duchenne muscular
dystrophy, multiple applications of wild-type SDF resulted in conversion at 15-20%
of loci as revealed by PCR-restriction fragment length polymorphism (RFLP), but no
corresponding transcript or protein was detected (Kapsa et al., 2001). However,
SDF-mediated correction of episomally-maintained mutant eGFP (Thorpe et al.,
2002b) or lacZ (Nickerson and Colledge, 2003) constructs has been functionally
demonstrated in a range of cell lines. Reduced levels of SDF-mediated correction
were apparent at chromosomally-integrated versions of the same mutant reporters
(Thorpe et al., 2002a; Nickerson and Colledge, 2003), the eGFP study implicating
poor nuclear delivery using polyethylenimine transfection (Thorpe et al., 2002a). The
influence of the delivery method on the level of correction achieved has been
revealed by other studies, and emphasises the importance of factors other than the
molecule design in affecting the experimental outcome (Colosimo et al., 2001;
Sangiuolo et al., 2002).
To date, only two studies have demonstrated SFHR in vivo. Intratracheal delivery of
mutagenic SDFs to wild-type mice was shown to result in the expression of AF508
Cftr mRNA within airway and lung cells (Goncz et al., 2001), though levels of
conversion were not quantified. Injection of SDFs into dystrophic mdx muscle
achieved low levels of correction which lasted for three weeks, though no dystrophin
fibres were evident (Kapsa et al., 2001). The elucidation of the molecular basis of
SFHR, for example through the use of cell lines deficient in recombination,
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replication or repair proteins, should permit the further development of SDF
technology.
5.1.4 Evaluating gene correction in vivo; limitations of current
systems
The development of gene correction modalities has taken place throughout a range of
systems, both in vitro and in vivo, and has employed a range of experimental
readouts, both sequence-based and functional. Cultured cells undoubtedly provide a
technically simpler means of delivering, evaluating the performance of, and
ultimately gaining an insight into the actions of gene correction molecules. Efficient
sequence-specific modification in cultured cells would be of significant value in a
range of applications, for example ex vivo gene therapy of cultured progenitor cells.
However, an ex vivo approach may not be applicable to all genetic diseases, therefore
gene correction must aim to effect repair in somatic tissue. Animal models are thus
essential for addressing issues specific to in vivo gene correction, such as mode of
delivery, dosage, and route of administration, in addition to the general question of
molecule design.
Many studies have relied on DNA-based means of detecting and measuring sequence
alterations, including sequencing of the target site, allele-specific PCR, and
diagnostic restriction digests. Indeed, some reports have been criticised for
employing PCR-based methods of detection found to be potentially artefactual
(Zhang et al., 1998). Far more elegant and convincing are functional assays of gene
correction, of which there are several examples, where the induced sequence
alteration results in an experimentally detectable change in protein activity. These
have often targeted specific genes in animal models of disease, such as the
dystrophin gene in the mdx mouse (Rando, 2002; Bertoni and Rando, 2002) and the
GRMD dog (Bartlett et al., 2000), both of which are deficient in dystrophin protein.
In these studies, dystrophin-positive fibres were detected by immunohistochemistry
after injection of RDOs into muscle. While a demonstration that correction achieved
at the genomic level translates into the production of protein is convincing evidence
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that the gene correction phenomenon is real, the most compelling data are those
revealing physiological consequences of gene repair. In the Gunn rat model of
Crigler-Najjar syndrome type I, correction of the causative single base deletion
within the UGT1A1 gene was, in addition to a battery of DNA-based methods,
demonstrated by a persistent drop in serum bilirubin levels and the appearance of
glucuronidated bilirubin species (Kren et al., 1999).
While undoubtedly elegant, and demonstrative of the potential therapeutic
applicability of gene correction strategies, one limitation of these functional and
physiologic rescue-type approaches is that the efficacy of the gene correction system
is assayed only in the target tissue. In the previous example, the evidence of
functional correction applied only to the liver, where UGT1A1 is expressed.
Likewise, prolonged coagulation indicative of reduced coagulant activity after
targeted mutagenesis of the factor IX gene in rats is informative only about the
activity of RDOs in hepatocytes. Another important study, in which correction of the
tyrosinase gene by topical and intradermal application of RDOs to the skin of albino
mice was confirmed by the production of pigmented hairs (Alexeev et al., 2000), is
indicative solely of their ability to mediate gene repair in melanogenic cells.
In addition to the anatomically restricted nature of data derived from these types of
functional assays, many of the techniques involved, including
immunohistochemistry, western blotting, and blood sampling for high performance
liquid chromatography (HPLC) analysis or enzymatic assays, are relatively laborious
and time-consuming, in common with some of the DNA and RNA based methods of
detection, such as DNA sequencing, RT-PCR, southern blotting, colony
hybridisation and RFLP analysis. As a result, these methods are not ideal for large
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An in vivo model providing a functional, yet technically simple readout of correction
frequency, facilitating the further development and optimisation of gene correction
molecules in a physiological context, would be a major asset to gene correction
researchers. This chapter describes the generation and analysis of a transgenic mouse
carrying a mutated, correctable reporter gene, with the intention that it should permit
the rapid histochemical detection and quantification of correction events occurring
upon administration of gene correction molecules. While the respiratory tissues are
of most relevance to CF research, the main interest in the laboratory in which this
work was undertaken, there was no advantage in restricting the utility of such a
model to particular anatomical regions. Thus, a ubiquitously active promoter was
chosen to drive expression of the transgene, such that the model would be suitable
for the investigation of factors influencing gene correction efficiency in all tissues.
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5.2 The transgenic mutated reporter line, R26X
The inactivated reporter transgene R26X, and the cloning strategy used to create it, is
depicted in Figure 5.2. Briefly, the construct consists of a mutagenised bacterial lacZ
gene positioned downstream of the R26 promoter fragment, which has been reported
to drive ubiquitous expression (Kisseberth et al., 1999). An internal ribosome entry
site (IRES) 3' of the lacZ sequence is juxtaposed with the gene encoding the
enhanced green fluorescent protein (eGFP). While (3gal activity should be dependent
on correction of the mutation within lacZ, eGFP should be produced constitutively,
and should serve to indicate expression of the transgene. It was recognised that the
designed non-functionality of the truncated pgal produced by R26X would hinder
efforts to validate the construct. In order to better evaluate promoter activity in cell
culture and predict the behaviour of the R26X construct in transgenic mice, a non-
mutated version of the transgene, R26Z, was created. While only the production of
R26X is described, both transgenes were constructed identically and in parallel,
except for the initial mutagenesis step, which was omitted in the production of R26Z.
The DNA manipulations involved in the generation of these constructs are described
in detail in appendix A2. The intermediates in vector construction are named in
Figure 5.2 to allow referencing.
5.2.1 Site-directed mutagenesis of lacZ
The commercial mammalian reporter plasmid pCMV(3 (Clontech) containing the E.
coli lacZ gene downstream of the human cytomegalovirus (CMV) promoter was
selected as the parental plasmid for the generation of R26X. A PCR-based site-
directed mutagenesis protocol (see chapter 7, section 7.4) was used to introduce a C
to T susbstitution at position 1126 of lacZ, designed to result in an arginine (CGA) to
stop (opal, UGA) mutation at amino acid position 376 (R376X) (Figure 5.3a).












Figure 5.2 Cloning strategy to generate R26X transgenic mice.
Construct elements are represented by the following: CMV promoter (black triangle); R26 promoter (pink
triangle); lacZ gene (blue rectangle); IRES-eGFP (white rectangle-green rectangle); R376X nonsense
mutation (red spot). Intermediates in vector construction are named to allow reference in main text. R26Z
mice were created identically, except for omission of the mutagenesis step.
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on xgal transformation plates, while every white colony analysed had undergone
deletions in the promoter region. This suggested that the mammalian CMV promoter
is active, and that the induced stop codon undergoes partial suppression, in bacteria.
The presence of the mutation was checked by RFLP, as the R376X mutation
produces a novel endonuclease product owing to the loss of a Tfil recognition site
(Figure 5.3a,c). The mutation was confirmed by DNA sequencing (Figure 5.3b
"R376X").
After transfection into COS-7 cells, the mutated pCMVR376X plasmid (see Figure
5.2) showed no Pgal activity by xgal staining (demonstrated subsequently, Figure
5.4), confirming the functional consequences of the mutation. In an attempt to induce
readthrough of the premature stop codon, thereby validating the integrity of the
mutagenised sequence, COS-7 cells transfected with pCMVR376X were incubated
with varying concentrations of G-418. This aminoglycoside antibiotic has previously
been shown to suppress premature stop codons in CFTR, with full-length protein
produced to 35% of wild-type levels (Howard et al, 1996). Translational
readthrough was assessed by visual inspection of xgal stained cells, though no Pgal
activity was detected, the apparent condition of the cells suggesting a toxic effect of
G-418 (data not shown).
To confirm the absence of additional lacZ mutations in pCMVR376X, the gene was
sequenced. Eight sense and eight antisense primers were used to span the
approximately 3.1kb gene, with no section receiving less than 2x coverage, and a
contig was assembled from overlapping reads. Regions of ambiguous sequence were
repeated, and the entire sequence was compared to Clontech's published pCMVP
sequence. Other than the designed mutation, two other mismatches were detected.
However, the mismatches were again found after sequencing of the relevant regions
of non-mutated pCMVP, indicating either errors in the Clontech data, or accumulated
base changes since the plasmid was obtained (Figure 5.3b). Both sequence alterations
are predicted to be silent, and they do not ablate Pgal enzyme activity as shown by
the production of functional Pgal from pCMVP in transfections (see Figure 5.4).
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Figure 5.3 Site-directed mutagenesis of lacZ.
(a) C to T substitution at the first position of codon 376
converts an arginine to a stop with a concomitant
elimination of a Tfil restriction site (GAWTC). (b) Aligning
the mutagenised lacZ (lacZ R376X) contig with the lacZ
sequence from Clontech's pCMVp data (/acZ Clontech)
revealed three mismatches, including the induced R376X
mutation. Sequencing the corresponding regions of wild-
type lacZ in pCMVp revealed the two unanticipated
mismatched base pairs to also be present in pCMVp,
indicating either errors in the Clontech data, or
accumulated base changes since the plasmid was
acquired. In the latter case, neither change is predicted
to alter the amino acid sequence. The mismatched bases
are shown at the centre of the chromatograms. (c)
Diagnostic Tfil digest of pCMVp and pCMVR376X. The
elimination of a Tfil site created a novel 351 bp fragment
from the fusion of 219bp and 132bp fragments. The loss
of the 132bp fragment is visible as a reduction in intensity
of the upper of two bands (the lower band being 112bp)
which is a doublet with a 140bp fragment present after
digestion of both plasmids.
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5.2.2 in vitro validation of the R26X construct
Because of doubts over the performance of the CMV promoter in vivo (Norris et al.,
1998), particularly in the lung (Schmidt et al., 1990), it was replaced with a 0.8kb
fragment derived from the genomic ROSA26 locus (R26 promoter, provided by P.
Soriano) (see appendix, section A2.1). The R26 promoter, in combination with two
different reporter genes, had previously been shown to recapitulate the ubiquitous
Pgal expression pattern of ROSA26 (Friedrich and Soriano, 1991) in mice and rats
generated by conventional transgenesis (Kisseberth et al., 1999). A fragment
containing the R26 promoter and mutated lacZ gene were then subcloned upstream
of an IRES-eGFP sequence to produce pR26X (see appendix, section A2.2).
In order to confirm the activity of the R26 promoter, and further assess the affect of
the induced stop mutation, pR26X and its wild-type counterpart pR26Z were
transfected into four cell lines representing different tissues (Figure 5.4): COS-7,
SV40-transformed African green monkey kidney fibroblast; A-549, human lung
epithelial; Huh7, human hepatoma; HT-1080, human acetabulum epithelial. pCMVp,
included as a positive control, demonstrated levels of Pgal visually detectable
without magnification, in each of the cell lines. Xgal staining was less intense
following transfection with pR26Z, and was detectable by eye only in COS-7 and
Huh7 cells. However, magnification revealed the presence of Pgal-positive cells in
all lines, indicating the competence of the R26 promoter to drive expression in cells
from a range of tissues.
In each of the cell lines, pR26Z consistently produced lower levels of Pgal than
pCMVp, despite cell line-specific variation of Pgal expression from the latter
plasmid. This suggested that differential transfection efficiencies between cell lines
may have been responsible for the apparent low level of expression driven by the
R26 promoter, particularly in A-549 and HT-1080 cells. However, it is clear that the
CMV promoter drives stronger, if not more widespread, expression than the R26
promoter. The extent of this difference is under-represented in COS-7 cells, which










Figure 5.4 in vitro validation of pR26X.
Four different cell lines (a-d) were transfected with pR26X, pR26Z and pCMVp. The cells were then fixed
and xgal stained, and analysed by eye (a-d(i)) and microscopically (a-d (ii-iv)). The CMV promoter
expressed Bgal at levels detectable without microscopy in all four lines, while cells stained after transfection
with pR26Z were visible unmagnified only in COS-7 and Huh7 cells. Magnification revealed flgal production
from pR26Z in all lines, though at consistently lower levels than from pCMVp. No stained cells were
detectable after transfection with pR26X. Scale bar = 400pm.
A functional, in vivo modelfor gene correction
pERES-eGFP vector, absent in pCMVp, resulting in amplification of transfected
molecules. Thus the observed level of (3gal production from pR26Z is exaggerated
with respect to pCMVp in COS-7 cells.
No Pgal activity was detected after microscopic examination of pR26X-transfected
cells. pR26X was assumed to have entered cells to an extent comparable with
pR26Z, suggesting that the induced stop mutation had rendered Pgal non-functional.
That both plasmids had been successfully transfected was supported by fluorescence
microscopic examination of duplicate transfected cells, which revealed a low level of
eGFP expression from both pR26Z- and pR26X-transfected cells, but not from
pCMVP-transfected cells (data not shown).
5.2.3 Microinjection of constructs and identification of transgenic
founders
Transgenic mice were produced as described in chapter 7 section 7.6. Constructs
pR26X and pR26Z were linearised prior to microinjection with BspHI, which cut the
vector backbone twice, and microinjected into F1 fertilised oocytes. The
microinjection sessions are summarised in Table 5.1. Genomic DNA prepared from
ear-clip biopsies was used as template for genotyping. A transgene-specific PCR,
using primers based on lacZ sequence, was combined with a myogenin (myoG)-
specific DNA quality control PCR, as shown for the K5A1 transgene, chapter 2,
Figure 2.3.
Additional PCRs were conducted on founders identified by the lacZ-specific reaction
in order to check the 5' and 3' integrity of the transgenes, and to ensure that genomic
DNA preparations were not contaminated with the plasmids from which the
transgenes were derived (Figure 5.5). The 3' integrity-checking and plasmid
contamination control PCRs were as shown for the K5A1 transgene (chapter 2,
Figure 2.3). The corresponding 5' PCRs, using a primer within the R26 promoter
sequence, are shown in Figure 5.5a,b. These PCRs demonstrated that both of the
R26X or R26Z reporter construct termini were present in all founders, suggesting
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Construct, Total no. total no. Total no. Total no. Total no. Total no.
Session embryos injected cultured transferred born transgenic
date
R26Z
05/12/01 187 102 87 73 21 (1 died) 5
R26X
17/10/01 290 192 146 128 10 (1 died) 2
21/11/01 204 151 130 100 13 (1 died) 4
28/11/01 207 133 120 99 13 2
03/12/01 345 191 145 119 28 5
10/12/01 345 228 148 111 27 7
Total
_____
895 689 557 89 20


























(S3 - AS5) x Tfil
0.5kb—
Figure 5.5 PCR analysis of integrated R26X transgenes.
(a) Schematic showing the position and orientation of PCR primers on the R26X construct, including the
sizes of the amplification products. R26 promoter, lacZ and eGFP represented by black, blue and green
bars, respectively. The BspHI sites used to linearise the construct for microinjection, are shown. lacZ
genotyping (lacZ-F - lacZ-R) and 3' integrity-checking and plasmid contamination PCRs are as shown
for the K5A1 construct in chapter 2, Figure 2.3. (b) 5' integrity-checking PCR for two positive (1,2) and
two negative (3,4) R26Xfounders (left) and 5' plasmid contamination PCRs showing that both founders
1 and 2 are genuinely positive, and not contaminated with pR26X. (c) PCR-RFLP of product amplified
from genomic DNA using lacZ sequencing primers (S3 - AS5), subsequently digested with Tfil. A novel
R26X 351 bp fragment is generated from the loss of a Tfil site between 219bp and 132bp R26Z fragments.
M = 1 kb ladder. Map not to scale, fragment sizes in bps.
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integrity of the transgenes, and that there was no plasmid contamination of the
genomic samples.
Although both R26X and R26Z mice were genotyped using the same lacZ-specific
PCR, if necessary they could be distinguished by PCR-RFLP. The product of another
/acZ-specific PCR, employing primers situated on either side of the R376X mutation,
when digested with Tfil gave a pattern of fragments indicative of whether the
mutation was present in the amplified sequence (Figure 5.5a,c).
5.3 Analysis of R26Z lines
Before attempting to analyse expression from R26X lines carrying the mutated
reporter, the five R26Z lines were examined for expression of the functional lacZ
gene in El2.5 embryos, to allow comparison with ubiquitously expressed human
alkaline phosphatase (hPAP) and eGFP in embryos reported by Kisseberth and
colleagues (Kisseberth et al., 1999). Timed matings were set up between founder
males, or male progeny produced from crosses between female founders and
C57BL/6 males, and non-transgenic CD1 females. The first embryonic litters
obtained from each line were genotyped from genomic DNA prepared from yolk
sacs or from amputated limb or tail tissue. Both methods allowed embryos to be
identified with respect to their genotype, to confirm that phenotypically-detected
transgene expression was associated with inheritance of the transgene. In lines
producing no genotypically transgene-positive embryos in the first litter, a second
litter was genotyped. One of the five R26Z lines, line R26Z500, failed to demonstrate
transmission of the transgene.
5.3.1 Expression of eGFP
Prior to fixing the embryos for xgal staining, they were examined by fluorescence
microscopy for expression of eGFP. Litters from two of the lines, R26Z100,300,
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(Figure 5.6a) exhibited generalised, low-level fluorescence, with no structures
appearing particularly prominent. Contrastingly, transgenic embryos from R26Z300
(Figure 5.6b-f) demonstrated marked fluorescence in a pattern consistent with the
central nervous system (CNS): eGFP expression appeared most intense in the
telencephalon, but was also visible in the diencephalon, the midbrain, and the
hindbrain and spinal cord. eGFP levels outside these regions did not appear
appreciably higher than in non-fluorescent embryos. At E15.5, visually detectable
fluorescence was confined to the forebrain region in R26Z300, and was absent from
line R26Z100 (data not shown).
5.3.2 Expression of figal
Fixing and xgal staining of whole embryos revealed eGFP expression to accurately
indicate those embryos expressing (3gal, while PCR genotyping confirmed eGFP and
(3gal expression was limited to embryos carrying the transgene (transgene-positive
embryos from lines R26Z200 and R26Z400 did not show eGFP or Pgal activity).
Although eGFP expression predicted those embryos staining after xgal treatment, the
enzymatic pgal assay provided a more informative expression pattern than the
fluorescent signal. At E12.5 (Figure 5.7a-c), line R26Z100 showed widespread
staining, with regions of apparently elevated Pgal expression, not evident from eGFP
visualisation, including the developing ear, muscle groups in the limbs and, most
notably, the forebrain and midbrain, though not in the hindbrain or spinal cord. Pgal
expression was low or absent in the forelimbs and hindlimbs, and the ventral trunk.
At El5.5 (Figure 5.7f-i), staining was more homogenous but was excluded from the
distal limbs, the tail, and the snout. An El5.5 embryo bisected along the sagittal
midline prior to xgal treatment revealed widespread internal staining, though no Pgal
expression was apparent in the developing lungs or liver (Figure 5.7i).
In R26Z300 at E12.5 (Figure 5.8a-e), Pgal expression reflected the strong CNS-
specific pattern of eGFP production, with a low level of xgal staining elsewhere,
appearing slightly more intense in the follicles of the vibrissae. A sagittal section
indicated that expression may be higher in the telencephalon and spinal cord than in
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Figure5.7p alexpressioninR26Z100embryos. FixedE12.5(a-c)n5.f iembryosstainedw thgalto visualisepg lexpression,(a-c)E12.5mbryoshowing widespreadpgalactivity,thregionsofmoreint nssta n g, includingtheelencephalon,die ,andmidbrai whatappeartoblimbusclegroups(arr wheads,))nd thedevelopingear(arr w,)).O rallexpr ssioapp edI/) significantlylessthani eR26-hPAPembryo((d),Kisseb rth■ etal,1999).( )Nostainingwasobservedinthon-transge icCN E12.5embryo,(f-h)At5.5,stainingwasorehomoge us,t— thoughedistallimbs,aindnoutremainedunst ,(i)LUEmbryobisectedagittallytoallowx alc ssinternal tissues.Moststr cturesdemonstrat dpg lac ivity,th ugh liverandu gremainedunstai ,(j)Xg lstai dROSA26 embryoshowingignifica tlylevatedp lexpressicompared toR26Z100.(k)Absencefpgalactivityinon-transg nicE15.5 embryo.Tel ncephalon,;di alon,DidbraiM;liver LI;lung,U.Scaleb r=800pm(a-c, ),16 0pmf k)2m (d).
lateral
lateral
Figure5.8p alexpressioninR26Z300embry s. FixedE12.5(a-e)n5f iembryosstainedw thxgalto visualisepg lexpression,(a-c)E12.5embryohowingintense pgalactivityintheCNS,refl ctingGFPpattern(Figu e5.6). Stainingwasmarkedlyreducinon-CNStiss swa absentfromthdistallimbsandventraltru k,(d)Ant riorview showingpgalactivityint ebra nndspinalc r ,(e)Sag tt lif)section,counterstainedwi hosi ,showingth txpressioit midbrainanddienceph lonap e redl sst n ethaO telencephalonandspinalor .Alth ughwidespread,o -l v l̂ stainingwasgenerallylostiths ct on,clo eexaminationM revealedpatch sofxpressiondistributedthrough utin rnal structures,incl dingthehea tn salpas ages,branchialr e anddorsalrootga glia.Reducedstaininge tiocomp red









A functional, in vivo modelfor gene correction
the diencephalon and midbrain region. At E15.5 (Figure 5.8f-i), expression appeared
ubiquitous, but not as strong as in the ROSA26 embryo (Figure 5.7j). Unlike in
R26Z100, expression of [3gal extended into the distal limbs, the tail, and the snout.
Pgal production remained detectably elevated in the telencephalic vesicles (the future
cerebral hemispheres), and the midbrain.
5.3.3 Adult tissues
Attempts to discriminate between transgenic and non-transgenic live adult littermates
using a hand-held UV lamp, as has been described for mice ubiquitously expressing
eGFP (Okabe et al., 1997), was not successful. This was due the apparent lack of
expression in adult skin, as discovered subsequently.
A range of tissues including brain, heart, kidney, liver, spleen, trachea, lung, skin and
gonads were taken from four adult hemizygous R26Z100 and R26Z300 mice
(including both sexes) and examined for eGFP fluorescence. No tissues demonstrated
expression of eGFP. For xgal staining, larger tissues were cut into two or more
pieces to increase penetration of the fixative and the stain into the tissue.
Corresponding tissues were taken from homozygous ROSA26 mice and non-
transgenic littermates as positive and negative staining controls, respectively. Except
for the brain, none of the adult tissues from either line demonstrated Pgal activity
above background levels, as determined by comparison with non-transgenic tissues.
In the brain (Figure 5.9), Pgal expression in R26Z100 appeared restricted to the
cerebrum and pineal gland, derivatives of the telencephalon and diencephalon
forebrain structures, respectively, both of which were observed to express the
transgene at E12.5 (Figure 5.7a). While the embryonic midbrain also stained with
xgal, the corresponding adult structures are mainly internal. R26Z300 adult brain
additionally showed Pgal activity in the cerebellum and medulla, albeit at lower






Figure 5.9 pgal expression in R26Z adult brain.
Dorsal view of xgal stained brains from R26Z100,300 and non-transgenic mice, (a) Annotated non-
transgenic brain showing no staining, (b) R26Z100 brain exhibiting pgal expression in the cerebrum and
pineal gland, both derived from the embryonic forebrain (telencephalon and diencephalon, respectively),
(c) R26Z300 brain was more intensely, but less uniformly, stained than that of R26Z100, with expression
strongest in the cerebrum and pineal gland, but also evident in the cerebellum and medulla (both
hindbrain-derived). Cerebrum, CR, pineal gland, P; cerebellum, CL; medulla, M; olfactory lobes, OL.
Scale bar = 3200|xm.
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5.4 Analysis of R26X lines
5.4.1 Expression ofeGFP
Of the 20 R26X founders generated, four male founders and male offspring from
three of the female founders, were crossed with non-transgenic CD1 females to
obtain E12.5 embryos. eGFP fluorescence was detected in only one of the seven lines
examined (line R26X100, Figure 5.10a,b). While fluorescing embryos appeared
generally, but not greatly, brighter than non-fluorescing littermates, significantly
elevated eGFP expression appeared confined to the midbrain. Genotyping revealed
the presence of transgenic embryos in litters from all lines, indicating that all seven
founders were able to transmit the transgene, with eGFP fluorescence correlating
with inheritance of R26X in R26X100. eGFP was undetectable at E15.5 (data not
shown).
5.4.2 Expression of/3gal
Xgal staining of fixed E12.5 embryos revealed all lines to be negative for |3gal
production. While this may have reflected a lack of transgene activity in some of the
lines tested, expression of eGFP in R26X100 indicated transcription was occurring
and suggested that the absence of xgal staining was a result of the premature stop
codon in lacZ (Figure 5.10c,d).
5.4.3 Adult tissues
Tissues corresponding to those taken from R26Z mice (section 5.3.3) were taken
from three adult R26X100 mice and were examined for eGFP and pgal expression.
None of the tissues exhibited detectable eGFP fluorescence or xgal staining. The xgal
stained brain, which exhibited eGFP embryonically, is shown (Figure 5.10g).
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Figure 5.10 eGFP and figal expression in R26X100.
(a) Unfixed transgenic and non-transgenic (n-t) E12.5 embryos analysed for eGFP expression by
fluorescence microscopy. The R26X embryo showed a generalised low-level increase in fluorescence
compared to the non-transgenic embryo, with significantly elevated eGFP confined to the dorsal midbrain.
The boxed region in (a) is magnified in (b). (c,d) Fixed, xgal stained E12.5 (c) and E15.5 (d) transgenic
embryos showed a complete absence of staining, and appeared indistinguishable from non-transgenic
E12.5 (e) and E15.5 (f) embryos, (g) Transgenic adult brain showing no staining after xgal treatment.
Scale bar = 800pm (b), 1600pm (a,c-f), 3200pm (g).
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In the absence of visible eGFP expression in the adult tissues of the only line in
which embryonic eGFP fluorescence was observed (R26X100), RT-PCR was used to
detect transcription of lacZ in selected tissues from a range of R26X lines (Figure
5.1 l(i)). Lungs and trachea were chosen for their relevance as targets for CF therapy,
while liver was included as hepatocytes have been reported to be efficiently
corrected with RDOs (Kren et al., 1997; Kren et al., 1998). lacZ-specific RT-PCRs
with RNA from 12 R26X lines, including ROSA26 RNA as a positive control,
revealed that while half of the lines did not show transgene expression in any of the
tissues analysed, three lines exhibited detectable expression in all three tissues
(R26X100,500,1700). The remaining three lines demonstrated lacZ transcription
either in the lung (R26X400), or both the lung and trachea (R26X1300,1800). B.
Stevenson provided some technical assistance with RNA extraction and RT-PCR.
To confirm that the amplification product was specific to lacZ, a gel containing the
RT-PCR products was blotted onto a nylon membrane. This blot was probed with a
radiolabelled internal lacZ oligonucleotide (Figure 5.11(h)). As a demonstration that
the RT-PCR product amplified from the R26X lines carried a deviation from the
wild-type lacZ sequence, the blot was stripped and re-probed with a radiolabelled
internal lacZ oligonucleotide containing the R376X mutation. The differences in
intensity between the R26X signals and the ROSA26 signal increased markedly




Figure 5.11(i) RT-PCR analysis of lacZ expression in 12 R26X lines.
(a) Schematic showing the position of PCR primers on the R26X transgene with respect to the R376X
mutation, (b) RNA from liver (LI), lung (LU) and trachea (T) of 12 R26X lines plus non-transgenic (n-t)
and ROSA26 controls was subjected to 30 cycles of RT-PCR with /acZ-specific primers (MutS - MutAS)
amplifying a 484bp product spanning the R376X mutation site. Six lines showed lacZ expression in at
least one tissue (R26X100,400,1300,500,1700,1800), with R26X100,500,1700 exhibiting expression in
all three tissues (expression in R26X500 trachea and liver is difficult to visualise on photograph). As
expected, ROSA26 showed expression in all tissues, while no product was generated from non-transgenic
samples, (c) The lacZ -RT controls confirmed that RNA samples were not contaminated with genomic
DNA. (d) Primers amplifying a 209bp product from GAPDH cDNA revealed the presence of RNA in all
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Figure 5.11(ii) R26X lines express mutated lacZ transcript.
(a) Schematic showing position of oligonucleotide probes on the R26X transgene with respect to the
R376X mutation and the PCR primers used in (i). (b) lacZ RT-PCRs of 12 R26X lines plus controls were
blotted and probed with a 19mer radiolabeled oligonucleotide complementary to wild-type lacZ sequence
5' of R376X, within the region amplified by the primers used in (i) ("wild-type lacZ probe", shown in blue).
Specific hybridisation confirmed the identity of the RT-PCR amplification products. No hybridisation was
observed on the -RT blot, or in the non-transgenic control. The blots were then stripped of the wild-type
lacZ probe and hybridised with a 17mer probe corresponding to the mutated region and containing the
R376X base pair ("R376X probe", shown in red). While the R26X samples showed a similar hybridisation
intensity with both probes, the ROSA26 sample showed significantly reduced hybridisation to the R376X
probe, indicative of a deviation from wild-type lacZ sequence within the R26X RNA. No hybridisation was
observed on the -RT blot using the R376X probe (not shown).
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5.5 Discussion
The generation and analysis of a transgenic mouse designed to facilitate the efficient
and functional evaluation of gene correction methodologies in vivo, has been
described. Disadvantages in using mouse disease models for this purpose are that (1)
the functional assays required to detect and quantify correction events are often time-
consuming and labour-intensive and (2) the functional data they provide is generally
tissue-specific in nature. An approach employing a ubiquitously expressed mutation,
the functional correction of which being detectable by routine histochemistry, would
counter both of these weaknesses and be an invaluable reagent for the further
investigation and development of gene correction protocols.
5.5.1 Site-directed mutagenesis of lacZ
The mutation introduced into the lacZ sequence of pCMVP, a C to T substitution at
base pair 1126, was chosen for several reasons. Firstly, since complete abrogation of
(3gal activity is a prerequisite for the confident detection of rare correction events, a
premature nonsense mutation was desirable. This mutation at position 1126
corresponds to a CGA (arginine, R) to UGA (opal stop, X) at amino acid residue
376. Since the version of (3gal protein in pCMVP consists of 1047 residues, mutation
R376X should result in a truncated peptide approximately one third of wild-type
length. While a premature stop codon which also induced a ffameshift would have
provided protection in the event of unanticipated readthrough of the stop codon, a
base insertion or deletion would have been required to effect this. Although both
RDOs and SDFs are known to be capable of correcting such mutations, at least
RDOs do so with a lower frequency than base substitutions (Liu et al., 2001). Thus, a
ffameshift mutation would be potentially more refractory to the intended correction
methods. No translational suppression of the R376X mutation was observed, other
than faint xgal staining in bacterial transformation colonies.
208
A functional, in vivo modelfor gene correction
Secondly, the R to X substitution was selected with the intention that it would
provide confirmation of the "correctability" of lacZ. It has been reported that
aminoglycoside antibiotics such as G-418 are able to suppress premature nonsense
mutations through the misincorporation of an amino acid following the pairing of a
near-cognate animoacyl tRNA with the stop codon (Manuvakhova et al., 2000). The
ability to effect translational readthrough of the mutated lacZ gene in cell culture
would provide an elegant means of validating the potential functionality of the gene,
demonstrating an absence of additional defects introduced during mutagenesis. Opal
codons were found to be the most susceptible to antibiotic-induced suppression
(Manuvakhova et al., 2000), and two of four premature stop codons within the CFTR
gene, which were suppressed by G-418 and gentamicin (Howard et al., 1996;
Bedwell et al., 1997), were arginine (CGA) to opal mutations. However, the use of
G-418 at concentrations previously described to cause suppression (Howard et al.,
1996) did not induce detectable levels of readthrough, though this failure was
consistent with current, similar attempts by fellow researchers (B. Stevenson,
personal communication). Integrity of the mutant lacZ gene was subsequently
confirmed by sequencing.
Finally, the R376X-induced loss of a Tfil restriction enzyme recognition sequence
provided a crucial means of checking plasmid or transgene identity. Simple RFLP
analysis of digested plasmids, or of PCR products amplified from the genomic DNA
of transgenic mice, permitted rapid and unambiguous detection of the mutated
sequence. This assay prevented any potential confusion arising from the parallel
production ofR26X and R26Z transgenic mice.
5.5.2 The R26 promoter
In order that the model would be useful for evaluating gene repair efficiencies in all
tissues, a ubiquitously active promoter was required to drive expression of the
mutated lacZ gene. The plasmid in which the R376X mutation was inserted into lacZ
contained the human CMV promoter, which is generally considered to be active in a
broad array of tissue types, and is commonly used to drive transcription in
209
A functional, in vivo modelfor gene correction
mammalian expression vectors. However, it is known that many constitutive viral
promoters can undergo cytokine-mediated attenuation in a transgenic context (Qin et
al., 1997; Paillard, 1997). While the CMV promoter is broadly and strongly active in
vitro, it becomes attenuated in vivo (Norris et al., 1998), and there is evidence to
suggest it performs poorly in the lung (Schmidt et al., 1990), an important target
tissue for gene correction research. For these reasons, the CMV promoter was
replaced with the R26 promoter, a 0.8kb fragment derived from sequence 5' of exon
1 of the ROSA26 locus, which had previously demonstrated promoter activity when
fused to lacZ and electroporated into embryonic stem (ES) cells (Zambrowicz et al.,
1997). When R26-driven transgenes were used to make transgenic mice and rats by
conventional pronuclear microinjection, the promoter was shown to drive expression
of both hPAP and eGFP in a ubiquitous pattern which faithfully reflected that of the
genomic ROSA26 locus (Kisseberth et al., 1999).
5.5.3 R26Z lines
To assess the performance of the R26 promoter, the R26Z control construct carrying
non-mutated lacZ was generated. In cell culture, Pgal production was observed in a
range of cell types, though at consistently and markedly lower levels than produced
by an equivalent construct containing the CMV promoter. However, it is known that
the relative activity of various promoters observed in vitro is not necessarily reflected
in transgenic mice (Palmiter and Brinster, 1986), this point being particularly
pertinent given the acknowledged difference in CMV promoter activity between in
vitro and in vivo contexts. Examination of E12.5 embryos from the two lines which
expressed the R26Z transgene revealed widespread, if not ubiquitous, Pgal
production, though expression levels did not appear equal between these lines. One
of the lines exhibited intense xgal staining in the CNS, while in the other line, Pgal
expression was elevated in the developing brain, but not in the spinal cord. In both
lines, Pgal expression in non-CNS tissues appeared significantly lower than reporter
gene expression in E12.5 embryos described by Kisseberth and colleagues
(Kisseberth et al., 1999).
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In that study, embryos stained for hPAP activity displayed broadly uniform transgene
expression and were indistinguishable in photographs from xgal stained
heterozygous ROSA26 embryos (Kisseberth et al., 1999). An R26-eGFP transgene
revealed that the promoter was active in late four-cell embryos, and by E12.5 eGFP
protein was detectable throughout embryos. Importantly, the authors report that
hPAP expression is maintained in adult tissues, with lung being amongst the highest
expressing organs when analysed visually for metabolised substrate. Transgene
expression was sufficiently strong that foci of hPAP- or eGFP-positive cells were
visible in recipient mouse liver after transplantation of transgenic liver cells. This
finding suggested that infrequent cells expressing a corrected lacZ gene from the R26
promoter would be detectable against a background of non-corrected cells.
However in the R26Z lines, despite (3gal expression appearing increasingly
homogenous at E15.5, probably as a result of greater cell density and a reduced
ability to visualise internal structures, the only adult tissue examined which exhibited
|3gal production was the brain. Xgal staining in the brain was more intense and
widespread in R26Z300 than R26Z100, reflecting the embryonic situation.
5.5.4 R26X lines
Given the presence of xgal stained cells after transfection with pR26Z, the lack of
apparent Pgal activity in cells transfected with pR26X could be taken to demonstrate
the successful inactivation of the protein. However, due to the variable effects of
integration site and copy number on transgene expression in vivo, it was desirable to
monitor transgene expression directly in each line, without comparison to other lines.
As a result of the premature stop codon engineered into the lacZ gene of construct
R26X, Pgal production could not be used as an assay for transgene expression in
R26X animals. For this reason, the eGFP gene was incorporated such that R26X (and
R26Z, produced in parallel) was a bicistronic construct in which lacZ and eGFP
would be transcribed as one unit, but translated independently, through the use of an
IRES sequence upstream of eGFP. Of seven lines analysed for eGFP fluorescence in
E12.5 embryos, only one showed visually detectable expression. R26X100 embryos
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exhibited a generalised low-level fluorescence compared to non-transgenic
littermates, with increased eGFP production in the midbrain. As in the case of the
R26Z lines, eGFP expression was not apparent in adult tissues.
The complete absence of observed (3gal activity in R26X embryos and adult tissues,
including R26X100 which evidently expressed the transgene embryonically,
suggested that the stop codon was not inappropriately suppressed to produce full-
length protein at a level likely to, in principle, impair use of the mice in detecting
rare gene correction events.
Analysis of (3gal expression in selected tissues from twelve R26X lines, four of which
were previously examined for embryonic eGFP production (including R26X100),
revealed six lines showing some degree of lacZ transcription. Three of these lines,
including R26X100, showed expression in all three tissues analysed (lung, trachea,
and liver). While (3gal expression in R26X100 was predicted by embryonic eGFP
production, line R26X500, which exhibited less intense RT-PCR signals in all three
tissues, showed no fluorescence. R26X1700, giving similar RT-PCR signal strengths
to R26X100, was not analysed for eGFP. Although differences in the amount of RT-
PCR product generated between lines may have been broadly reflective of relative
transcription rates, a comparison of the strength of hybridisation of the ROSA26
product and the R26X100 and R26X1700 product with the wild-type lacZ probe
revealed the quantitative limits of non-limiting cycle RT-PCR. Although apparently
similar levels of RT-PCR product were generated, it is highly unlikely that R26X100
produced (mutant) (3gal in quantities comparable to that produced by ROSA26, given
the evidently reduced level of eGFP production from R26X100 compared to
R26Z300 (Figure 5.10a,b and Figure 5.6b-f). R26Z300 clearly produced lower levels
of [3gal than ROSA26 (Figure 5.8f and Figure 5.7j). Inclusion of RNA samples from
R26Z100,300 in the lacZ RT-PCR, and the use of quantitative or semi-quantitative
RT-PCR methods, would have been useful in clarifying relative expression levels.
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5.5.5 Low levels of eGFP expression from the IRES-eGFP
Although sufficient to allow the visual (using fluorescence microscopy)
discrimination of transgenic and non-transgenic embryos in certain lines, eGFP
fluorescence was weak compared to Pgal activity, and was not useful as a means of
identifying live transgenic animals either directly or by ear biopsy (data not shown).
More importantly, fluorescence could not be used as an indicator of transgene
activity in adult tissues, as indicated by the strongly Pgal positive, but eGFP
negative, brain tissues of R26Z300 mice. This demonstrated the value of generating
the control R26Z lines: had the loss of detectable eGFP production, but maintenance
of Pgal activity, from embryo to adult brain in R26Z300 not been observed, it may
have been assumed that the absence of eGFP in adult R26X100 brain indicated
inactivity of the transgene.
Although eGFP signal is potentially less intense than the signal from
histochemically-visualised reporters, which can be enhanced through prolonged
incubation with substrate, the weak eGFP signal observed in this study was likely
partly due to the use of the IRES. It has been shown that in biscistronic constructs of
the type described here, expression of the ERES-dependent second gene is typically
20-50% that of the first gene (Mizuguchi et al., 2000). The strength of IRES-driven
translation appears to be dependent on both the composition and arrangement of the
cistrons, with certain gene sequences, when in the upstream position, able to exert an
inhibitory effect over expression of the downstream gene (Hennecke et al., 2001).
The behaviour of lacZ as the upstream cistron, in this regard, is not known. However,
the IRES-eGFP sequence was incorporated into the constructs as a single unit,
ensuring the crucial spacing between the IRES and eGFP components (Houdebine
and Attal, 1999), presumably optimised in the production of the commercial parent
vector (pIRES2-eGFP), was not disturbed.
213
A functional, in vivo modelfor gene correction
5.5.6 Non-ubiquitous expression of R26X and R26Z transgenes
The discrepancy between the ubiquitous R26-mediated expression reported by
Kisseberth and colleagues (Kisseberth et al., 1999) and the weaker, apparently CNS-
biased expression observed in this study, is intriguing. Since only two transgene-
expressing R26Z lines were obtained, position effect on the transgene integration
sites cannot be eliminated as a cause. However, it would seem that at least the CNS
aspect of the expression profile, also observed by eGFP analysis of R26X100
embryos, must be dictated by the promoter sequence. Support for position effect
susceptibility of the promoter fragment comes from the previous study: although
more than half of the R26-hPAP lines expressed highly, only about one in five of the
R26-eGFP lines expressed highly enough to be suitable marker animals, and
expression levels correlated with transgene copy number (E. Sandgren, personal
communication). Thus, the nature of the coding sequence might influence the degree
to which expression is epigenetically modulated. It is known that different genes,
when expressed from the same promoter/enhancer, can generate markedly different
levels of mRNA not explainable by variations in mRNA stability alone (Palmiter and
Brinster, 1986). This suggests that different genes can influence the rate of
transcription, through uncharacterised mechanisms.
lacZ in particular is prone to exhibiting unanticipated or variegated expression
patterns (Ramirez et al., 2001). In a previous study, tandem arrays of 8-9 copies of a
ubiquitously expressed lacZ transgene were found to be entirely methylated after
passage through the female germline, the methylation status correlating with
complete inactivity of the transgene in adult tissues (Lau et al., 1999). Paternally-
inherited transgene arrays, which produced detectable levels of Pgal, were
methylated at all but one copy of the transgene. The unmethylated, active copy was
found to reside adjacent to the junction with the host genome. It is believed that the
tandem fashion in which transgenes tend to integrate is recognised by the host cell
and becomes a target for methylation-mediated silencing. The methylated transgene
copies may then become a source of spreading heterochromatin, with only the
proximity of the terminal copy to cellular euchromatin maintaining its expression.
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Downregulation of a lacZ transgene during development from embryo to adult,
similar to that observed in this study, has previously been reported and may suggest
that the lacZ sequence, rather than the R26 promoter, is responsible (Beddington et
al., 1989). Also, the presence of prokaryotic vector sequences have been shown to be
inhibitory for the expression of some transgenes (Palmiter and Brinster, 1986),
though whether this remains an issue given the prokaryotic origin of the transgene
coding sequence is unclear. Although most of the vector sequence was removed from
the R26Z and R26X constructs, approximately 1.4kb remained adjacent to the
terminal BspHI sites.
With hindsight, clues to the unexpectedly weak expression driven by the R26
promoter fragment may have been present since its initial isolation. When fused to
lacZ and electroporated into ES cells, expression from the R26 promoter was
observed to be 8-fold less than that from the positive control phosphoglycerate
kinase-1 (PGK) promoter, which itself produced (3gal at levels 3-fold less than ES
cells isolated from ROSA26 mice (Zambrowicz et al., 1997). The authors speculated
that the difference between expression from the genomic ROSA26 locus and the
0.8kb R26 promoter may have been due to position effects on the randomly
integrated transgene. In a personal communication, E. Sandgren stated that he found
lacZ technically difficult to work with, despite producing ubiquitously expressing
lines with hPAP and eGFP. It may be that, when fused to lacZ, deleterious
consequences of position effect manifest on the R26 promoter at any integration site
other than the native ROSA26 locus. It is notable that, in the four years since the
publication of what appeared to be an excellent choice of promoter for ubiquitous
transgene expression, no additional mouse lines harbouring R26-driven transgenes
have been described. Anecdotal reports indicate that, while several groups may have
had success using the R26 fragment, most have failed to mimic the expression
described by Kisseberth and co-workers (Kisseberth et al., 1999) (A. Schedl, K.
Foley, personal communications).
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5.5.7 Alternative approaches
5.5.7.1 The CAGG promoter
The CAGG promoter may be a better choice for driving ubiquitous and strong
expression of randomly integrated transgenes. This promoter is a fusion between the
CMV-immediate early enhancer and the chicken p-actin promoter, and was initially
shown to demonstrate strong expression of lacZ in transfected cells (Niwa et al.,
1991). It has since been used to drive strong expression of eGFP in "green mice",
which express the transgene in all cells except erythrocytes and hair (Okabe et al.,
1997). When analysing promoters to drive ubiquitous expression of the Z/AP
conditional double reporter for Cre recombinase activity, Lobe and colleagues found
the CAGG promoter to drive stronger and more consistent expression than the CMV,
human P-actin, and pIIHMG-coenzyme A reductase promoters (Lobe et al., 1999).
More recently, the promoter has been used to express an inducible Cre recombinase,
though the authors had to screen 17 lines to find two exhibiting ubiquitous
expression (Hayashi and McMahon, 2002). It is possible that, had many more than
five R26Z lines been available for analysis, a subset may have produced the expected
ubiquitous expression, although this depends upon whether the lacZ sequence has
unanticipated influence over the expression pattern. Interestingly, Hayashi and
colleagues reported that in ten of the 17 lines examined, Cre activity was restricted to
the heart, somites and a portion of the CNS (Hayashi and McMahon, 2002). Thus,
restriction of transgene expression to a predictable subset of tissues in multiple
independent lines may be a common feature of randomly integrated, supposedly
ubiquitously expressed transgenes.
5.5.7.2 The genomic ROSA26 locus
The ubiquitous and robust transgene expression driven by the ROSA26 locus, from
which the R26 promoter fragment was derived, has been well characterised
(Friedrich and Soriano, 1991; Zambrowicz et al., 1997). A more reliable, though
more complex and time-consuming approach to achieving robust and ubiquitous
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expression of the mutated reporter gene, would be to insert ("knock-in") the
construct into the ROSA26 locus of mouse ES cells using homologous targeting. This
has been done using a glutamic acid to lysine substitution at amino acid position 461
of lacZ, previously demonstrated to abolish Pgal activity in vitro (Nickerson and
Colledge, 2003). Expression of the mutated lacZ gene was comparable to that of the
ROSA26 mouse, and the mutant Pgal protein was detected in all tissues analysed,
however no in vivo correction has yet been achieved (H. Nickerson, personal
communication).
5.5.7.3 A new reporter system for gene correction strategies
Recently, a novel correctable reporter system was shown to sensitively detect repair
in cell culture, and could potentially be used as a non-invasive means of assessing in
vivo correction rates (Bennett and Schaack, 2003). The luciferase genes from Renilla
(sea pansy, RLuc) and the firefly (FLuc) were fused, before a single base pair in the
downstream FLuc was deleted to introduce an ochre stop codon, and shift the
downstream sequence out of frame. In initial tests, the "RLuc/Fluc" transgene, under
the control of a ubiquitous viral promoter, was transfected into cells with known
amounts of the non-mutated version of the construct. It was shown to generate a
readout indicative of the degree of simulated repair, providing the "correction" rate
was below 50%. The variable error rate is a function of the complex formula used to
calculate correction efficiencies, which incorporates the internal control RLuc
reading, the FLuc reading (both adjusted for background and dilution), the known
ratio of FLuc/RLuc activity, and the RLuc activity difference (RAD, the
unanticipated cell line-specific difference in RLuc activity between the non-mutated
and mutated versions of the construct), to calculate a percent correction efficiency.
Since the system measures the total increase in light emitted as a result of substrate
metabolism by a population of cells, it reveals the number of corrected, functional
sequences (Bennett and Schaack, 2003). In this aspect it differs from conventional
systems, such as mutated lacZ (Nickerson and Colledge, 2003) or eGFP (Thorpe et
al., 2002a), which depend on the discrimination of individual corrected cells, and
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thus indicate the number of cells in which one or more conversion events have
occurred. The fusion of the luciferase genes is crucial to the consistency of the
system, preventing differential ratios of RLuc and FLuc transcription or translation
between cell lines, as may have occurred had separate promoters, or an IRES, been
used. The system was used to demonstrate SDF- and SSO-mediated correction both
in cell lysates and non-invasively, using a highly sensitive camera to detect light
emission after addition of the respective luciferase substrates to the cell culture
medium. The authors believe the latter technique could be used to measure gene
correction in transgenic mice carrying the RLuc/FLuc construct. The dual luciferase
system appears to address the same limitations inherent to mouse disease models that
prompted the development of the R26X mouse. However, the necessary input of the
cell line-specific RAD into the formula may complicate attempts to assess in vivo
correction rates from tissue lysates comprising multiple cell types.
5.5.8 Future Work
Further analysis of the R26X lines is necessary to determine whether one or more
lines express the transgene in a manner appropriate for use in evaluating gene
correction activity. However, several factors led to a decision to cease further study
of the model, and to abandon plans to use the mice for in vivo gene correction within
the course of the work undertaken for this thesis. The departure of Dr P. Thorpe, who
was leading the gene correction project in the Porteous Cystic Fibrosis Gene Therapy
laboratory (Thorpe et al., 2002a; Thorpe et al., 2002b), to undertake more basic
research into recombinational processes in yeast, meant that gene correction
experiments were not performed after September 2002. Also around this time, the
Cystic Fibrosis Trust Gene Therapy Consortium, which was funding the gene
correction research, became reluctant to continue this support in a climate of
increasing scepticism regarding the efficiency and reproducibility of gene correction,
particularly the use of RDOs (van der Steege et al., 2001; Taubes, 2002). Combined
with the time demanded by the work described elsewhere in this thesis, these
circumstances prompted the decision to preserve the lines for investigation and
possible use by others.
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5.5.8.1 Further analysis of R26X lines
Despite the increasing scepticism surrounding RDOs and derivative technologies
purported to operate via induction of host mismatch repair systems (Albuquerque-
Silva et al., 2001; Taubes, 2002; Diaz-Font et al., 2003), reports continue to emerge
which describe the successful application of this technique (Bertoni et al., 2003; Lu
et al., 2003), and of SFD-mediated repair (Bruscia et al., 2002). In fact, the first
report of gene correction by oligonucleotides (SSOs) in ES cells appeared recently,
and indicated that the mismatch repair machinery acts as a significant impediment to
the process of homology-mediated gene repair (Dekker et al., 2003). Given the
persisting interest in the concept of gene correction (Sullenger, 2003; Liu et al.,
2003) as the ideal manifestation of gene therapy, it is conceivable that others may
wish to utilise the in vivo gene correction model described here. However, this would
only be feasible after further analysis of the lines to identify whether, within the 12
R26X lines preserved as frozen sperm stocks (corresponding to the 12 lines analysed
by RT-PCR, section 5.4.3), a subset may exhibit ubiquitous and sufficiently strong
expression of the transgene. This could involve the use of anti-(3gal, or potentially
anti-eGFP, antibodies on tissues sections or western blots. Quantitative RT-PCR
could be employed to accurately determine relative levels of transcript for
comparison with, for example, the ROSA26 line.
It would be important to calculate, for any line believed to be suitable for the
intended use, its transgene copy number. Since correction of a single copy of the
R26X transgene should be sufficient to yield a Pgal-positive cell, correction
frequency may increase as the number of correctable transgenes increases. Thus, a
comparison of correction frequency between different R26X lines, or between an
R26X line and the ROSA26 locus-targeted mouse mentioned previously (section
5.5.7.2), would have to take account of the relative number of target sites. The
potential for multiple copies of the correctable reporter, compared to the maximum
of two copies in a mouse homozygous for the ROSA26-targeted mutant lacZ
construct, may be crucial in elevating the frequency of correction events to a
detectable level. Also, the randomly distributed integration sites, which will differ
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between independent R26X lines, could in principle be informative regarding the
ability of gene correction to operate at various genomic locations.
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6.1 A transgenic mouse for the investigation of
putative tracheal stem cells
The main focus of the work presented in this thesis was the further investigation of a
putative stem or progenitor cell niche within submucosal gland (SMG) ducts of the
adult murine proximal trachea. Slow-cycling cells had previously been identified as
label-retaining cells in SMG ducts, and these cells appeared spatially coincident with
cells expressing high levels of keratin protein, also reflected by the expression of a
reporter transgene driven from the human keratin 5 (K5) promoter. To further
investigate the proposition that K5 might be a marker for these putative stem cells,
transgenic lines were produced in which a fusion gene encoding an inducible Cre
recombinase was linked to the human K5 promoter. The intention was that the onset
of ubiquitous, permanent expression of a Cre-dependent reporter gene could be
temporally activated within the K5 promoter-expressing population, resulting in
marking of these cells and their cellular progeny. Induction of lineage marking after
injury-stimulated stem cell recruitment would permit the evaluation of the
contribution made by the K5 promoter-expressing cells to epithelial regeneration. A
range of techniques was used to select lines in which detectable levels of reporter
gene activation could be achieved through administration of an exogenous inducer.
The available time permitted only a preliminary experiment using one of these lines.
While not informative with regard to the trachea, inducible reporter gene activity was
detected in other tissues, and the experiment served to highlight parameters which
might productively be adjusted in subsequent studies employing this system. Efforts
are ongoing to further evaluate the use of these lines in marking tracheal cell lineage.
A parallel preliminary experiment with a transgenic mouse expressing constitutive
(non-inducible) Cre from the bovine K5 promoter revealed potentially interesting
lineage patterns consistent with the proposed existence of a stem cell niche within
SMG ducts. However, as anticipated, the clarity of the lineage data obtained was
undermined by the frequency of marking effected by the constitutive activity of Cre,
partially validating the inducible strategy. Further studies using this system are
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required to determine the significance of the patterns observed, and may prove
informative with regard to the role of K5 promoter-expressing cells in both
regenerative and steady-state contexts.
6.2 The molecular basis of alternate recombination
patterns mediated by the bK5Cre transgenic mouse
In studies preceding the latter experiment, the constitutive bK5 promoter-driven Cre
transgenic line revealed alternate patterns of expression from a Cre-dependent
reporter transgene. Analysis of embryonic litters revealed a correlation between the
pattern of reporter gene expression and the sex of the parent from which the Cre
transgene was inherited: while the paternally-inherited transgene resulted in the
expected K5-derived pattern of reporter gene expression, ubiquitous reporter
expression was apparent in the progeny of Cre transgene-bearing females.
Interestingly, the ubiquitously expressing phenotype was independent of Cre
transgene inheritance. Immunofluorescence and histochemical analysis of Cre
transgenic ovaries indicated the unanticipated expression of Cre protein in oocytes.
The accumulation of Cre protein in oocytes caused recombination of the Cre-
dependent reporter transgene within the female germline. Propagation of this
permanent genetic rearrangement throughout development resulted in ubiquitous
reporter gene expression in offspring. That ubiquitous recombination was detected in
mice inheriting the Cre-dependent reporter transgene paternally, but failing to inherit
the maternal Cre transgene, suggested the persistence of maternally-synthesised Cre
protein into the early zygote. The bK5Cre line thus provides both tissue-specific and
generalised recombination of floxed alleles, depending on the sex of the bK5Cre
transgene-transmitting parent.
6.3 An in vivo model for functional analysis of gene
correction
Gene correction is a recent concept in gene therapy, and describes the site-specific
repair of mutations at their chromosomal loci. Before gene correction systems and
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protocols can be employed to clinical benefit, they must be extensively evaluated and
developed in vivo. While animals models have provided elegant demonstrations of
gene correction, the functional readouts are often time-consuming and labour-
intensive, and thus unsuitable for the large-scale evaluation of experimental
parameters. To address this, a transgenic mouse was generated which carried a
mutated, but potentially correctable, reporter gene under the control of a ubiquitously
expressing promoter. Analysis of control transgenic lines carrying a non-mutated
version of the reporter transgene suggested the promoter did not reliably drive
ubiquitous expression. In a subset of the mutated reporter transgenic lines, transcript
corresponding to the mutated reporter sequence was detected in several adult tissues.
While this suggested that these mice may be usefully employed in the evaluation of
gene correction strategies, further work is required to confirm this.
6.4 Airway stem cells as targets for gene correction
therapy
Both the inducible and constitutive Cre transgenic lines described in this thesis have
the potential to be valuable reagents in the further investigation of putative airway
stem cells. The identification of stem cells within the respiratory epithelium would
facilitate attempts to target them in gene therapy strategies. Because of their potential
for repopulating entire tissues, stem cells are obvious targets for gene
complementation or correction. With respect to cystic fibrosis (CF) gene therapy, the
existence of a putative stem cell compartment in the SMG duct is intriguing given
that certain cell types within SMGs represent the primary sites of cystic fibrosis
transmembrane conductance regulator (CFTR) expression in the human airway
(Engelhardt et al., 1992). Cftr has also been detected in the mouse SMG (Borthwick
et al., 1999). The relationship between the K5-expressing, label-retaining, and Cftr-
expressing cells of the SMG is not clear. Murine SMGs are thought to be clonally-
derived, and observations from ROSA26lwM-\yp& chimaeric mice (Borthwick,
1999) and bK5Crets R26Rtg mice (chapter 3), suggests a relationship between SMGs
and the local surface epithelium. It may be that SMGs act as structural-proliferative
units (Slack, 2000), in which keratin-rich, label-retaining stem cells are responsible
224
Concluding Remarks
for populating gland cells and a finite region of neighbouring epithelium. In this way,
assuming that the CFTR-expressing cells are not themselves stem cells, a CF gene
therapy targeted at the SMG duct stem cell might be transmitted to the other gland
cells including those expressing CFTR, with therapeutic consequences.
While the delivery of gene therapy reagents to stem cells is a prerequisite for a
single-dose therapy, many conventional gene complementation protocols provide
only transient therapeutic benefit, necessitating repeated administration. Combined
with stem cell targeting, the potential of gene correction strategies to offer heritable
restoration of physiologic gene expression may facilitate the realisation of a single-
dose "cure". However, much work is required to advance current gene correction
technologies to a level of therapeutic efficacy. The mutated reporter transgenic lines
described in this thesis may prove valuable in the further development of such
strategies.
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7.1 Manipulation of nucleic acids
7.1.1 General molecular biology reagents
All chemicals were analytical grade and were supplied by Sigma, Promega, Gibco
BRL, Invitrogen, BDH, and Fisher Scientific. Restriction enzymes were supplied by
Roche and New England BioLabs (NEB). Nucleic acid manipulations were
performed in 1.5ml or 0.5ml microfuge tubes. General solutions were prepared by
technical staff, autoclaved and stored at room temperature.
Tris.HCl
Tris base (tris[hydroxymethyl]aminomethane was dissolved in sterile water. HC1 was
used to adjust the pH to the required value.
EDTA
EDTA (ethyldiaminetetra-acetic acid di-sodium salt) was dissolved in sterile water.
The solution was adjusted to pH8.0 by adding solid NaOEL
TE buffer
lOmM Tris.HCl (pH7.5); ImM EDTA.




Distilled water was added to a final volume of 1 litre. Stock was diluted to lx with
distilled water.
TAE buffer. 5 Ox stock
Tris base 242g




Distilled water was added to a final volume of 1 litre. Stock was diluted to lx with
distilled water.
7.1.2 Agarose gel electrophoresis
For preparing gels, the required amount of agarose (BioGene) was dissolved in either
lx TBE or TAE by heating. Molten agarose was cooled and ethidium bromide added
to a final concentration of 5(lug/100ml agarose. DNA size markers were run
alongside experimental samples to estimate the size and amount of DNA in the
samples. The size markers used routinely were lkb DNA ladder (Invitrogen) and
bacteriophage lambda DNA digested with Hindlll (Invitrogen). Samples were run in
lx loading buffer. Electrophoresis was used when DNA fragments of a particular
size needed to be purified. To do this, samples were electrophoresed using low
melting point agarose (Flowgen), excised from the gel using a razor blade, and the
DNA was recovered using a Gel Extraction Kit (Qiagen), according to the
manufacturer's instructions. Ethidium bromide stained gels were visualised by UV
transillumination using a digital camera (BioRad).
7.1.2.1 Solutions
Gel loading buffer, lOx
Reagents were added to distilled water to obtain a final concentration of lOOmM
EDTA, 20% Ficoll and 1% Orange G.
7.1.3 DNA quantification
DNA concentrations were determined in one of two ways: by agarose gel
electrophoresis or by measuring the absorbance in a spectrophotometer at 260nm
(A26o). To determine the concentration by electrophoresis, several different volumes
of the DNA were run alongside Low or High DNA Mass Ladder (Invitrogen). An
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estimate of the concentration was made by visual comparison of the samples with the
known amounts ofDNA under UV illumination.
To determine the concentration with a spectrophotometer, the DNA or RNA sample
was diluted 1:40 with dH20. The spectrophotometer was calibrated using a dH20
blank sample. The samples were placed in clean quartz cuvettes and the absorbance
at 260nm (A26o) was measured. The concentration of the original sample in mg/ml
was calculated as follows:
Concentration (mg/ml) = A26o x 40 (dilution factor) x 50.
7.1.4 Restriction enzyme digestion
Digests were ideally carried out in a large volume (usually 50-100pi) to minimise
effects of evaporation. Minimum reaction volume was dictated by the requirement
that the total volume of enzyme never exceeded 10% of the total reaction volume, to
prevent inhibition of digestion by glycerol. Enzyme was added at a concentration of
5-10units/pg DNA, depending on the duration of the digests. The manufacturer's
guidelines were followed to determine the correct buffer and incubation temperature
for each enzyme. Double digests were performed where enzyme buffer requirements
and incubation temperatures were compatible.
7.1.5 Making cohesive ends blunt
When cohesive ends needed to be made blunt for subsequent ligations, T4 DNA
polymerase and Mung Bean Nuclease (both Roche) were used for filling in 3'
recessed ends and removing 3' protruding ends, respectively.
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7.1.5.1 T4 DNA polymerase
For every lpg of DNA, lx T4 DNA polymerase buffer, 1 ul bovine serum albumin
(BSA), 100pm dNTPs, lpl T4 DNA polymerase, and dH20 to final volume was used
in the incubation (20 minutes at 11°C), and the reaction terminated by heating at
75°C for 10 minutes.
7.1.5.2 Mung Bean Nuclease
For every lpg of DNA, lx Mung Bean Nuclease buffer, 1 unit of Mung Bean
Nuclease, dfTO to final volume was used in the incubation (30 minutes at 30°C), and
the reaction terminated by addition of SDS to 0.01%.
After every enzymatic reaction (restriction/nuclease/polymerase), samples were
cleaned using the PCR Purification Kit or Nucleotide Removal Kit (both Qiagen),
following the manufacturer's instructions.
7.1.6 Removal ofphosphorylated 5' termini
Prior to ligation, vector DNA was treated with calf intestine alkaline phosphatase
(CIP) (Roche) to dephosphorylate the 5' termini of vector DNA, preventing self-
ligation. The linearised, purified vector DNA was made up to a volume of 90pl with
sterile dFftO followed by the addition of lOpl lOx buffer and 1 ul CIP. Following
2x15 minute incubations, the first at 37°C and the second at 56°C, a further lpl CEP
was added and the 2x15 minute incubations repeated. The reaction was terminated
by the addition of 2pi EDTA and the CEP enzyme heat inactivated by incubation for
20 minutes at 65°C. The dephosphorylated vector DNA was purified using a PCR




Fragments with cohesive complementary ends were ligated overnight at 16°C, using
1 unit of T4 DNA ligase (Roche). Blunt-ended ligations were performed overnight at
room temperature using 5 units of high concentration ligase (Roche). In order to
maximise the ligation efficiency, ligations were usually set up with 1:3, 1:1, 3:1
vector: inset molar ratios, usually using 50ng vector. The supplied ligation buffer was
used, normally in 10pi reaction volume.
7.1.8 Removal of buffer salts
Prior to electroporation of ligation reactions, buffer salts were removed by drop
dialysis. A nitrocellulose filter (Millipore) was placed in a petri dish containing filter
sterilised dH20. The ligation reaction was carefully placed on the filter and salts
were left to diffuse through the filter for at least 1 hour at room temperature.
7.1.9 Extraction of genomic DNA for Southern blot hybridisation
Tissue samples were re-suspended in 500pl of tail mix buffer (1M Tris pH8.0; 0.5M
EDTA; 10% SDS; 5M NaCl). 5pi of proteinase-K (10 mg/ml) (Sigma) was added with
gentle mixing. The samples were incubated at 55°C overnight, followed by incubation
for 1 hour at 37°C with lOpl of lOmg/ml DNase-ffee RNase (Roche). The DNA was
cleaned by 2x phenohchloroform extractions, plus one chloroform extraction. DNA
was precipitated from the aqueous layer with 0.6 volumes of 100% ethanol and
centrifuged at 13,000 rpm for 20 minutes at 4°C. The supernatant was removed and
the pellet was washed with 70% ethanol. The supernatant was discarded and the
pellet was allowed to dry at room temperature and then re-suspended in dH20.
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lOpg of genomic DNA was digested overnight with Bglll. The sample was then
mixed with 5 pi of loading buffer, and loaded onto an ethidium bromide stained
agarose (0.8% lx TAE) gel. Samples were electrophoresed until appropriate
separation of lkb ladder fragments had occurred, as detected by UV
transillumination, and the position of the ladder fragments were noted with a ruler.
The gel was immersed in denature buffer (0.5M NaOH; 1.5M NaCl) with agitation
for 30 minutes and neutraliser buffer (0.5M Tris; 1.5M NaCl) for 15 minutes, before
being placed onto 20x SSC-soaked 17mm filter paper (Whatman) in the blotting
apparatus. The following was then placed on top of the gel: 1 piece of Hybond-N+
membrane (Amersham pharmacia biotech) soaked in 20x SSC, 2 pieces of 20x SSC-
soaked 3mm filter paper (Whatman), followed by a 5cm stack of dry paper towels, a
glass plate, and two 500ml bottles half-filled with water (weight approximately
0.5kg). The blotting apparatus was left overnight. The apparatus was dismantled and
the position of the wells marked on the blot with a pencil. The blot was rinsed briefly
in 2x SSC before the DNA was UV cross-linked using the auto cross-link feature on
a Stratalinker 1800 (Stratagene). The same technique was used to blot
electrophoresed PCR products for oligonucleotide hybridisation.
7.1.10.1 Preparation of radioactively labelled DNA probes
To label double stranded DNA probes, approximately 50ng of purified DNA in a
total volume of 12pl was boiled for 10 minutes to ensure denaturation and then
labelled using 4pl of High Prime (Roche) and 30mCi [a-32P]-dCTP. The reaction
was incubated at 37°C at 30 minutes and labelled DNA was separated from
unincorporated nucleotides by passing the labelling reaction through TE equilibrated
spin columns (Amersham pharmacia biotech). The probe was denatured by boiling
for 10 minutes with lmg sonicated salmon sperm DNA (Sigma) and incubating at
68°C for 45 minutes. The probe was then added to the pre-hybridised blot.
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7.1.10.2 Preparation of radioactively labelled oligonucleotide probes
Labelled probes from oligonucleotides were made by end-labelling. Approximately
50ng of oligonucleotide were labelled in a total volume of 20ul containing 2ul of
10x polynucleotide kinase (PNK) buffer, 10 units of PNK (Roche), and 30mCi [y-
32P]-dATP. The reaction was incubated at 37°C for 1 hour and then added directly to
the pre-hybridised blot.
Sequences of oligonucleotide probes (5'-3'):
Asel-Mlul bridging probe (section At. 1) ATTAGTTATTACGCGTGTAAAA
pCI-as probe (section A1.2) GTTAGTCGACCCAGAGAGCTCCTTAAGAG
lacZ probe (section At .3) GATTTCCTTACGCGAAATACG
Wild-type lacZ probe (Figure 5. ll(ii)) CAGCGCGGCTGAAATCATC
R376X probe (Figure 5.11 (ii)) TGCTGATTTGAGGCGTT
Cre probe (Figure 2.15,2.19) CAACGAGTGATGAGGTTC
loxP probe (Figure 3.10) ATAACTTCGTATAGCATACATTATACGAAGTTAT
7.1.10.3 Hybridisation of radioactive DNA probes
Blots were pre-hybridised at 68°C for a minimum of 1 hour in rotating hybridisation
bottles (Hybaid) with 20-50ml hybridisation solution (6x SSC; 10% (w/v) Dextran
sulphate; 0.5% (w/v) SDS; 0.1% (w/v) BSA; 0.1% (w/v) Ficoll; 0.1% (w/v)
polyvinylpyrrolidone; 0.1% (w/v) disodium pyrophosphate). After pre-hybridisation,
radiolabeled probe was added directly to the solution and the blots hybridised
overnight at 68°C. Blots were washed with 2x SSC; 0.1% (w/v) SDS at 68°C for 15
minutes with monitoring of background radiation using a Geiger counter. The blots
were wrapped in saran wrap and exposed to a Molecular Dynamics Phosphorimager
screen. The image was then scanned into the Storm phosphorimager (Molecular
Dynamics) and analysed using ImageQuant software.
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7.1.10.4 Hybridisation of radioactive oligonucleotide probes
Blots were pre-hybridised at 48°C for a minimum of 1 hour in rotating hybridisation
bottles with 20-50ml oligo-hybridisation solution (6x SSC; 0.5% (w/v) SDS; 0.1%
(w/v) BSA; 0.1% (w/v) Ficoll; 0.1% (w/v) polyvinylpyrrolidone; 0.1% (w/v)
disodium pyrophosphate) and lmg sonicated salmon sperm. After pre-hybridisation,
radiolabelled oligo probe was added directly to the solution and the blots hybridised
overnight at 48°C. Blots were washed with 4x SSC; 0.1% (w/v) SDS for 15 minutes
followed by a second wash of 2x SSC; 0.1% (w/v) SDS if required, with monitoring
of background radiation using a Geiger counter. The blots were exposed to Kodak X-
OMAT AR film at -70°C in cassettes containing intensifying screens. To strip the
blot of the existing probe to allow hybridisation with a second probe, it was washed
in 5x SSC; 1% SDS (w/v) at temperatures up to 80°C. The loss of the probe was
monitored using a Geiger counter, and checked by exposing to film. Re-probing was
performed as for the initial probe.
7.2. Polymerase chain reaction (PCR)
7.2.1 Reagents
dNTPs
dNTPs were purchased from ABgene as stocks of lOOmM. Working stocks of 25mM
were made by mixing 25pi of each of the dNTPs (dATP, dCTP, dGTP, dTTP) to a
final volume of lOOpl and stocks were stored at -20°C. dNTPs were used in PCRs at
a final concentration of 0.2mM.
Oligonucleotide primers
PCR primers were designed by selecting a sequence, usually between 17 and 25
nucleotides in length, for which the [G+C]:[A+T] ratio was approximately equal.
Care was taken to avoid the likelihood of primers self-annealing or annealing with
each other. Primers were purchased from MWG Biotech as lyophilised desalted
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compounds. Stocks were made up at lOOpM using sterile dH20 and primers were
used in PCRs at a final concentration of 0.5-1 pM.
Additional reagents
Amplilag DNA polymerase (5units/pl) (Roche) was used at 0.1 pi per 25pl reaction.
PCR buffer (Roche) was a lOx stock and therefore diluted 1:10 for reactions. Mg2+
(Roche) was used at a final concentration of 1.5mM. The reaction was made up to
25pi with sterile dribO.
7.2.2 Amplification programmes
PCRs were performed in 0.5ml centrifuge tubes or 96-well PCR plates in a MJ
Research DNA Engine Tetrad. Throughout this chapter, PCR thermal cycles are
represented by formulas resembling the following:
lx(94°C[7m]) - 30x(94oC[lm]57°C[lm]72°C[lm]) - lx(72°C[10m])
The formula shown describes a reaction comprising a single cycle of 7 minutes at
94°C, followed by 30 cycles of 1 minute at 94°C, 1 minute at 57°C, 1 minute at
72°C, and finishing with 1 cycle of 10 minutes at 72°C.
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Sequences of primers and amplification programmes used in non-genotyping PCRs
(5 '-3'):
Cre PCR probe Cre forward CAATTTACTGACCGTACAC
(Figure 2.18) Cre reverse CAGATTACGTATATCCTGG
Programme lx(94°C[7m]) - 30x(94°C[lm]57°C[lm]72°C[lm]) -
lx(72°C|"10m|)
R26R excision LacZ4 forward GTGCGGGCCTCTTCGCTAT
PCR 5921R reverse GGTTGAGGACAAACTCTTCGC
(Figure 3.10) Programme lx(94°C[5m]) - 40x(94°C[40s]57oC[40s]72°C[lm30s]) -
lx(68°C17ml)
Transgene 5'neg forward CCATAGCCTCAGGTTACTC
integrity- and 5'pos forward GGCGATAAGTCGTGTCTTAC
contamination- 5'R26 reverse CACCATTGCACCGCTCTTGC
PCRs 5'K5 reverse GCTGACAGGTGACTGTGATG
(Figure 2.3) 3'neg reverse CTACTTCTGGAATAGCTCAG
and 3'pos reverse GGTGATGGTTCACGTAGTG
(Figure 5.5) 3'eGFP forward CTGGAGTACAACTACAACAG
Programme lx(94°C[7m]) - 30x(94°C[lm]55oC[lm]72°C[lm30s]) -
lx(72°Cri0ml)
lacZ (R376X) S3 forward CAGCGATTTCCATGTTGCCAC
PCR-RFLP AS5 reverse GGAAGGGCTGGTCTTCATC
(Figure 5.5) Programme lx(94°C[7m]) - 30x(94°C[lm]57oC[lm]72°C[lm]) -
lx(72°C[10m])
7.3 DNA sequencing
Plasmid DNA used for sequencing was prepared using a Miniprep or Maxiprep Kit
(both Qiagen), according to the manufacturer's instructions. Samples were cleaned
using the PCR Purification Kit or Nucleotide Removal Kit (both Qiagen). DNA was
sequenced using dye-labelled terminators for cycle sequencing. The dye used was
either dRhodamine or Big Dye Terminator RR mix. Reagents were thawed on ice
and dyes were protected from light as much as possible. Reactions were set up in
0.2ml centrifuge tubes as follows:
200-500ng plasmid DNA in dH20 llfil
dRhodamine or Big Dye Terminator RR mix 8pl




Cycle sequencing was performed using an MJ Research DNA Engine Tetrad. The
sequencing program was as follows: 24x(96°C[30s]50°C[15s]60°C[4m]). Reactions
were ethanol precipitated following transfer to a fresh 1.5ml centrifuge tube
containing 50 id ethanol and 3M 2pi sodium acetate, pH 5.2. Reactions were left on
ice to precipitate, then centrifuged at 13,000g at 4°C for 30 minutes. Pellets were
washed with 200pl 70% ethanol. The supernatant was removed following a second
centrifugation step and pellets were allowed to air dry at room temperature for
approximately 20 minutes. Samples were submitted to the sequencing service to be
run on an ABI machine.
Sequences of sequencing primers (5'-3'):
R26 promoter T3 AATTAACCCTCACTAAAGGG
(section A2.1) T7 GTAATACGACTCACTATAGGGC
K5 promoter K5 5' CATAGAGGAACAGGCTGAG
(section A 1.1) K5 3' GTGCTCAGCATGTACCGTAC
pCI intron pCI-s GGAACTCGAGCTTCTGCGTCCTGCTGAGC










lacZ (R376X) S6 GACCGCACGCCGCATCCAG
sequencing S7 CATCCCGCATCTGACCACCAG
primers S8 GAAGTGGCGAGCGATACAC









Site-directed mutagenesis was achieved using the QuikChange Site-Directed
Mutagenesis Kit (Stratagene), following the manufacturer's instructions. Briefly,
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125ng of both mutagenic primers (shown below, mutation indicated in bold) were
incubated with 50ng parental plasmid DNA, 5ng lOx supplied reaction buffer, 1 jlxI
supplied dNTP mix, ljal supplied PfuTurbo DNA polymerase, and dEbO to a final
volume of 5(Jul. The reaction mixture was subjected to the following thermal cycle
using a MJ Research DNA Engine Tetrad:
lx(95°C) - 16x(95oC[30s]55°C[lm]68°C[15m])
After completion of the thermal cycle, 1 jul of Dpnl enzyme was added and the
reaction incubated at 37°C for 1 hour. 1 pi of the reaction was transformed into
supplied Epicurian Coli XLl-Blue competent cells, and mutated clones selected on
xgal/EPTG indicator plates.
Primers for introducing R376X mutation into lacZ in pCMVP (Clontech) (5'-3'):
(section 5.2.1) rams GCAAGCCGTTGCTGATTTGAGGCGTTAACCGTCACG
mmas CGTGACGGTTAACGCCTCAAATCAGCAACGGCTTGC
7.5 Microbiology
Aseptic technique was observed for all steps involving the growth of bacterial cells
(setting up cultures, pouring agar plates, selecting single colonies and storing
bacterial stocks). Liquid cultures were grown with vigorous shaking (220rpm) and
dry cultures were grown on inverted agar plates at 37°C overnight.
7.5.1 Growth media for bacterial cultures
Technical staff prepared Luria-Bertani broth (L-Broth) and Luria-Bertani agar (L-


























Stock concentration Working concentration
Ampicillin (Amp) lOmg/ml in dfLO 50pg/ml
Kanamycin (Kan) lOmg/ml in dH20 50ug/ml
Aliquots were stored at -20°C.
7.5.1.2 Xgal/IPTG indicator plates
When attempting to select clones carrying mutated (R376X) pCMV(3 plasmids
(chapter 5, section 5.2.1), xgal (Melford) was added to the molten L-agar at a final
concentration of 40pg/ml whilst EPTG (Melford) was added at a final concentration
of 0.2mM, before pouring plates.
7.5.2 Production of electrocompetent cells
A single colony of DH5a E. coli cells from an agar plate was used to inoculate
approximately 10ml L-Broth for overnight growth at 37°C. The overnight culture
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was used to inoculate 2x 400ml fresh L-Broth the following morning and cells were
grown to an ODeoo of 0.5-1.0. Flasks were chilled on ice for 15-30 minutes and cells
were centrifuged at 4°C, 4,000g (6,000rpm) for 15 minutes. Pellets were re-
suspended in 800ml ice-cold sterile dFEO. The centrifugation step was repeated and
cells were re-suspended in 400ml chilled, sterile dH^O. Following a further
centrifugation step, cells were re-suspended in 20ml 10% cold, sterile glycerol. Cells
were centrifuged once more and re-suspended in 2-3ml 10% glycerol. Aliquots of
cells were frozen on dry ice and stored at -70°C.
7.5.3 Transformations
Competent cells were transformed with 10-100ng plasmid DNA by electroporation.
Electrocompetent cells were thawed on ice and 50pi was added to each DNA sample
in an ice cold centrifuge tube. The mixture was transferred to ice cold 0.2cm
electroporation cuvettes (EquiBio) and allowed to sit for 1 minute on ice. Cells were
electroporated using a BioRad Gene Pulser set at 25pF, 2.5kV, and 200Q.
Immediately after electroporation, 1ml L-Broth/Mg2+ was added to the cells, which
were then allowed to recover for 1 hour at 37°C, shaking, prior to plating on selective
media and overnight incubation at 37°C. Transformants carrying cloned insert were
identified by restriction digestion or PCR analysis of plasmid DNA preparations.
When low numbers of such transformants were anticipated, many colonies were
screened by colony hybridisation.
7.5.4 Preparation of bacterial colony hybridisation filters
Transformation colonies were transferred using sterile toothpicks to the equivalent
positions on two agar plates, and both plates were incubated at 37°C. After storage of
one of these plates at 4°C for 5 minutes, a circular nitrocellulose filter (0.45pm,
Schleicher and Schuell) was placed onto the agar plate for 1 minute, and marked for
orientation. The filter was transferred for 5 minutes to each of a series of 3mm filter
papers (Whatman) soaked in, respectively, 10% SDS, denature buffer, and
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neutraliser buffer. The DNA was UV cross-linked using the auto cross-link feature
on a Stratalinker 1800 (Stratagene). Filters were probed using oligonucleotide probes
(section 7.1.10.4). Useful transformants were then picked from the duplicate agar
plate and DNA prepared.
7.5.5 Isolation ofplasmid DNA
Plasmid DNA was prepared using a QIAquick Spin Miniprep Kit (Qiagen). For the
extraction of small amounts of plasmid DNA (miniprep), a single colony was
selected to inoculate 2ml L-Broth containing a suitable antibiotic for overnight
growth at 37°C. The following morning, plasmid DNA was extracted using the kit
according to the manufacturer's instructions. Plasmid DNA was eluted in either 3 (Jul
or 5Opl elution buffer. The DNA concentration was determined either by agarose gel
electrophoresis or by spectrophotometry. For the extraction of larger amounts of
plasmid DNA (maxiprep), a 2ml starter culture was established as described above
and incubated at 37°C for 8 hours. The starter culture was then re-suspended in
400ml L-Broth, with antibiotic selection, in a large conical flask to allow aeration of
the bacteria and the larger volume culture was incubated at 37°C overnight. Plasmid
DNA was extracted the following morning using the Qiagen Maxi Kit according to
the manufacturer's instructions. DNA was eluted in 400pl autoclaved TE, pH8.0, and
the concentration determined as for miniprep DNA.
7.6 Production of transgenic animals
7.6.1 Preparation of recombinant DNA for microinjection
10Lig plasmid DNA was digested with enzymes (BspHI for pR26X, pR26Z, pK5Al
and Sfil for pK5CE) to release or linearise the transgene, respectively. A sample of
DNA was run on an agarose gel alongside an equivalent amount of undigested DNA
to ensure the DNA was completely digested and products were the predicted size.
Once the transgene had been released/linearised, the remainder of the reaction was
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run on an agarose gel in TAE buffer. The transgene fragment was excised from the
gel, and the DNA extracted using a QIAEXII Agarose Gel Extraction Kit (Qiagen).
DNA was eluted in 60pl microinjection buffer (O.lmM EDTA/lOmM Tris pH7.4)
and the concentration determined by electrophoresis. DNA was stored at -20°C until
the day of microinjection. For microinjection, DNA was diluted in microinjection
buffer to a final concentration on 2ng/pl and spun through a Spin-X 0.22pm column
(Corning).
7.6.2 Reagents and equipment used during the manipulation of
preimplantation embryos
7.6.2.1 Equipment
Embryos were transferred between dishes using pulled pasteur pipettes and mouth
pipette tubing. A Zeiss Stemi SV11 dissecting microscope was used to aid in
manipulating embryos in sterile glass staining blocks and petri dishes.
Microinjection apparatus
The microinjection apparatus consisted of a Zeiss Axiovert 100 microscope with a
variable temperature stage set to 37°C, and mounted holders for the microinjection
and holding pipettes (Narashige, Eppendorf). The equipment rested on an anti-
vibration table (Carl Zeiss). Embryo holding pipettes were either made in-house
using a microforge (MF90) (Narashige) and capillaries (size GC100 T15, Elarvard
Apparatus) or purchased (Eppendorf). Microinjection pipettes were purchased
(Eppendorf). Microinjection needles were filled with DNA at a concentration of
2ng/ul using pipette filler tips (Eppendorf). DNA was microinjected with the aid of






H6 media was used for handling embryos outside of the incubator. T6 media was
used for growing embryos in the incubator (5% C02, 37°C). Media was either
purchased (Sigma) or prepared in-house by Transgenic Facility staff using embryo
culture grade reagents. Media was made using embryo culture grade dH20, filter
sterilised, and embryo tested prior to use.











Sodium lactate 0.34ml 0.34ml
Hepes - 0.50
Phenol red 0.001 0.001
BSA 0.4 0.4
7.6.3 Microinjection of recombinant DNA into fertilised eggs
Embryos used for microinjection were derived from [CBA x C57BL/6] Fix [CBA x
C57BL/6] F1 matings. [CBA x C57BL/6] F1 females were superovulated by
intraperitoneal (IP) injection of 5 units of pregnant mare serum (PMS) (Intervet) at
noon on the first day, followed by 5 units of human chorionic gonadotrophin (hCG)
(Intervet) 48 hours later. They were then mated to F1 males. Plugged females were
sacrificed the following morning (E0.5) and oviducts were removed and rinsed in
warm saline. Oviducts were placed in H6 media and fertilised eggs were removed by
tearing the swollen ampullae with fine forceps. Several drops of hyaluronidase
(lmg/ml PBS) (Sigma) were added to the media for approximately three minutes to
remove the cumulus cells from the outside of the eggs. Fertilised eggs were
identified by the presence of two large pronuclei and often polar bodies. Eggs
awaiting microinjection were kept at 37°C, 5% C02 in drops of T6 media under
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paraffin oil in sterile petri dishes. Eggs were microinjected in batches of 30-50 in a
large drop of H6 media under oil in a glass dimple slide (the injection dish).
During microinjection, embryos were picked up and held on the holding pipette
using mouth pipette tubing. The microinjection needle on the automatic injector was
set such that a constant stream of DNA left the pipette. Once a pronucleus was in
focus, the injection needle was brought into the same plane of focus and used to
pierce the zona pellucida and egg cell membrane, before entering the pronucleus.
The needle was held until the pronucleus swelled slightly, and then removed quickly
and cleanly. Following microinjection, eggs were returned to drops of T6 media
under paraffin oil and kept at 37°C, 5% CO2 overnight. For each experiment, five to
ten uninjected embryos were retained and cultured overnight to control for problems
with media, oil, and incubation conditions.
7.6.4 Oviducal transfers
Microinjected embryos were screened the following morning. Only embryos that had
developed to the two-cell stage were transferred into recipient females.
Pseudopregnant recipients were prepared by selecting CD1 females in oestrous and
mating them to vasectomised CD1 males. Plugged E0.5 females were used for
oviducal transfers. Recipients were anaesthetised with an IP injection of anaesthetic
at O.lml/lOg per mouse: [0.75ml of Hypnorm (Fentanyl 0.315mg/ml /
fluanisonelOmg/ml): 4.5ml water: 0.2ml Hypnovel (Midazolom 10mg/2ml)]. The fat
pad adjacent to the ovary and uterus was isolated and held in autoclips (Brownes
Diagnostics). The bursa surrounding the oviduct was broken carefully to expose the
infundibulum of the oviduct. The end of the pulled pipette containing the embryos
was inserted into the infundibulum and embryos were delivered by mouth pipette.
The successful delivery of the embryos was confirmed when bubbles that had been
placed at either end of the embryos in the pipette were seen in the swollen ampulla.
Ten to 20 embryos were transferred to each side of the recipient. The fat pad was
released and tucked back into the abdominal cavity and the peritoneum was closed
with sutures (HM&S). The skin was closed using Dieffenbachs bulldog clips
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(Holborn surgical and medical instruments, ltd.), and analgesia was administered at
O.lml/lOg mouse of [lOjal of Vetergesic (Buprenorphine 0.3mg/ml): 990li1 dH20].
The animal was allowed to recover in a warmed post-operative cage with solid drink
pouches (BS&S). Embryos were allowed to develop to term.
7.6.5 Genotyping of breeding mice
Breeding animals were genotyped by PCR amplification of transgenic sequences
from genomic DNA extracted from ear-clips. The DNA was extracted from each ear
clip by incubating the tissue in 50ul of 25mM NaOH, 0.2mM EDTA (pH12) at 95°C
for 20 minutes, followed by vortexing briefly to break up the tissue. The reactions
were neutralised by the addition of 50ul of 40mM Tris.HCl (pH5). 2pi of extracted
DNA solution was used in 25pi genotyping PCR assays. Extracted genomic DNA
was stored at -20°C.
Sequences of primers and amplification programmes used in genotyping PCRs (5'-
3'):
R26Z, R26X, LacZF forward GTGACTACCTACGGGTAACA
K5A1,R26R LacZR reverse ATTCATTGGCACCATGCCGT
(Figure 2.3) MyoG forward TTACGTCCATCGTGGACAGC
and MyoG reverse TGGGCTGGGTGTTAGTCTTA
(Figure 3.3) Programme lx(94°C[7m])-30x(94°C[lm]58°C[lm]72°C[lm])-lx(72°C[l0m])
K5CE Cre forward CAATTTACTGACCGTACAC
(Figure 2.13) Cre reverse AGCTGGCCCAAATGTTGCTG
Programme lx(94°C[7m])-30x(94°C[lm]57°C[lm]72°C[1m])-- lx(72°C[10m])
R26R wild R523 forward GGAGCGGGAGAAATGGATATG
-type allele R26F2 reverse AAAGTCGCTCTGAGTTGTTAT
(Figure 3.3) Programme 40x(94°C[30s]58°C[30s]65°C[lm])
7.6.6 Animal husbandry
All animals were maintained in a specific pathogen free (SPF) environment and
experiments were carried out under Home Office licence. Wild-type animals (CD1,
C57BL/6, and CBA x C57BL/6 Fl) were either bred in-house or obtained from
Charles River Laboratories. Embryos for all experiments were generated from timed
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matings, with the morning of vaginal plug detection being counted as embryonic day
0.5 (E0.5).
7.6.7 Harvesting ofpostimplantation embryos
Postimplantation embryos were harvested for wholemount xgal staining and
sectioning for immunodetection. The mothers were sacrificed by cervical dislocation.
The abdominal cavity was opened and uteri were removed to petri dishes containing
PBS. Embryos were removed from the uteri and freed from extraembryonic
membranes using scissors and forceps. For some experiments, extraembryonic
membranes were retained to genotype embryos by PCR. Embryos were rinsed in
fresh PBS prior to subsequent processing.
7.6.8 Genotyping of embryos
In some experiments, embryos were genotyped using DNA extracted from yolksacs.
These were digested overnight at 55°C in 0.5ml yolksac lysis buffer containing
proteinase K.
Yolksac lysis buffer
Proteinase K (stock lOmg/ml) (Sigma) was added to a final concentration of
0.2mg/ml.
Following overnight digestion, tubes were centrifuged at 13,000rpm for 10 minutes
to pellet debris. The supernatant was transferred to a clean tube, to which 1ml chilled
70% acetone/5% DMF (in 25% dH20) was added. The solution was mixed manually
by inversion of tubes and DNA pelleted by centrifugation for 10 minutes at











ethanol on a rotator for at least 30 minutes. Tubes were then centrifuged for 2
minutes at 13,000rpm, the supernatant discarded, and following air drying of
samples, DNA was re-suspended in 100-5 OOpl TE, pH8.0 depending upon the size of
the pellet. Incubation at 55°C for 15 minutes aided re-suspension of the DNA.
Alternatively, DNA was extracted from small pieces of amputated limb or tail tissue.
Unique combinations of tail and limb amputation allowed embryos to be identified,
and phenotypes could be correlated with genotypes. DNA was extracted from
amputated tissue using the ear-clip digestion method used to genotype adult mice
(section 7.6.5).
For both methods, lpl of DNA was used in genotyping PCR reactions.
7.7 Wholemount expression analysis
7.7.1 Visualisation of eGFP
eGFP was visualised in fresh, unfixed embryos and tissues using a stereo
fluorescence microscope with Leica GFP1 and GFP2 filters (section 7.7.4)
7.7.2 Fixing tissue
Paraformaldehyde
4% paraformaldehyde (PFA) (Sigma), used to fix embryos and tissues, was made by
dissolving 20g PFA in 500ml PBS at 65°C until dissolved. Aliquots were stored at -
20°C.
Embryos were dissected in PBS and fixed in 4% PFA at 4°C for between 1.5 and 3
hours depending upon age (E13.5-E16.5). Tissues were rinsed in PBS before fixing
in 4% PFA, and large tissues were cut into smaller pieces to aid penetration of
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fixative. Duration of tissue fixation was dictated by sample size, but never exceeded
3 hours. Tracheas were routinely fixed for 1 hour.
7.7.3 Xgal staining
Following fixation, embryos and tissues were first rinsed in PBS and then washed in
detergent wash 3 times for 30 minutes each at room temperature. Samples were
stained overnight (approximately 15 hours) in xgal staining solution, protected from
light, at room temperature. Ear tissue from ROSA26 and non-transgenic CD1 mice
served as positive and negative staining controls, respectively. The following
morning the staining solution was removed and samples were rinsed in detergent
wash twice for 20 minutes at room temperature. In certain experiments, samples
were fixed again in 4% PFA at 4°C overnight. The fix was removed and tissues were
washed, and stored, in PBS. In other experiments, samples were immediately
embedded in wax.
7.7.3.1 Solutions
Detergent wash (in PBS)
Compound
MgCl2 (Riedel-de Haen)
Nonidet P-40 (ICN Biomedicals Inc.)
Per 500ml Final concentration
0.406g 2mM
200pl 0.02%
Xgal staining solution (in PBS)
Compound Per 500ml Final concentration
K3Fe(CN)6 (Sigma) 820mg 5mM
K4Fe(CN)6 (Sigma) 1050mg 5mM
MgCl2 (Riedel-de Haen) 0.406g 2mM
Sodium deoxycholate (Sigma) lg 0.1%
Nonidet P-40 (ICN Biomedicals Inc.) 200pl 0.02%
Prior to use, 250pl xgal substrate (40mg/ml in dimethylformamide, DMF) was added
per 10ml staining solution required. In some experiments an alternative figal
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substrate, bluogal (Sigma), was used. It was prepared and used exactly as xgal. Xgal
staining solution was pH7.4.
7.7.4 Wholemount microscopy
Dissections of post-implantation embryos were effected with the aid of a Leica
Stereo MZFLIII stereo fluorescence microscope (Leica Microsystems, Milton
Keynes, UK) fitted with a 100W Hg source for fluorescence imaging, and fibre optic
cold light source and illuminated base for incident/transmission illumination. Images
of wholemount stained embryos and tissues were captured with a Photometries
CoolSnap colour CCD camera (Roper Scientific, Tucson, Arizona) controlled by
scripts written for EPLab Spectrum (Scanalytics Inc., Fairfax, VA). Prior to imaging,
wholemount intact stained tracheas were cut dorsally and pinned out onto a wax bed
under PBS to permit examination of the luminal surface. Embryos were oriented
within wells cut into agarose-filled petri dishes, and imaged under PBS.
7.8 Histology
7.8.1 Tissue processing for paraffin wax sectioning
For histochemisty, immunohistochemistry, and immunofluorescence, tissues and
embryos were processed for paraffin wax embedding, and microtome sectioned.



























Each stage was of equal duration, but durations varied between experiments from 20
minutes to 2.5 hours, depending on sample size. Following the final wax stage,
samples were transferred into a suitable mould, oriented using a pair of forceps, and
the wax allowed to solidify. The wax block was trimmed to the desired size and the
edges angled to improve capture of the sections.
7.8.2 Microtome sectioning
Wax-embedded samples were sectioned at 7- 10pm on a microtome and ribbons of
sections floated out in a 42°C waterbath. With the aid of a fine-tipped paintbrush, the
sections were transferred to Superfrost Plus slides (BDH) and the slides incubated at
55°C overnight to allow sections to dry. To remove the wax, slides were washed 3
times in fresh xylene for 10 minutes each, followed by 3x 10 minute washes in 100%
ethanol. Slides were then passed through a graded ethanol series, washed in dH20,
and stained with haematoxylin and/or eosin, with staining performed according to a
standard protocol. Typically, slides were immersed in eosin for two minutes, and
haematoxylin for 10 seconds. Tissue sections were mounted in DePeX (BDH) or
Histomount (National Diagnostics) mounting medium.
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7.8.3 Immunohistochemistry and immunofluorescence
Typically, 7pm sections were used for immunodetection. After dewaxing, sections
were microwaved on full power in lOmM citrate buffer (Na3Cit, pH 6.0) for 20
minutes, allowed to cool, and washed in dELO. They were then washed in PBS
containing 0.1% Tween 20 (PBST), and blocked in PBST with 10% normal goat
serum (NGS) (Scottish Antibody Production Unit) for 1 hour.
7.8.3.1 Anti-Cre immunofluorescence
For immunofluorescence analysis of ovaries, bK5Cre females were superovulated
with 5 units PMS, followed 48 hrs later with 5 units hCG. Ovaries were removed
after a further 12 hours (prior to ovulation), processed, and sectioned. The sections
were then incubated with the primary rabbit polyclonal anti-Cre antibody (Novagen)
at 1:1000 dilution for 1.5 hours, washed in PBST for 30 minutes, and incubated with
the secondary Alexa 594 fluorescent antibody (Molecular Probes Europe BV) at
1:400 dilution in darkness for 1 hour. Finally, slides were washed in PBST for 30
minutes in darkness and mounted in Vectashield (Vector Laboratories Ltd.),
containing lpg/ml DAPI. The Alexa 594 fluorescence was visualised using a
compatible Texas Red filter set (absorbance and emission maxima of 595nm/615nm,
respectively).
7.8.3.2 Anti-figal immunofluorescence
Sections were incubated with the primary rabbit polyclonal anti-pgal antibody
(Europa Bioproducts Ltd) at 1:2000 dilution for 1.5 hours, washed in PBST for 30
minutes, and incubated with the secondary Alexa 594 fluorescent antibody
(Molecular Probes Europe BV) at 1:400 dilution in darkness for 1 hour. Finally,
slides were washed in PBST for 30 minutes in darkness and mounted in Vectashield
(Vector Laboratories Ltd), containing 1 ug/ml DAPI. Signal was visualised as for the




Prior to antigen retrieval, slides were dewaxed to 95% ethanol, then washed in 1%
H2O2 in methanol for 20 minutes to block peroxidase activity. After washing in
dH20 for 5 min, antigen retrieval and blocking was performed as described in section
7.8.3. Sections were incubated with the primary affinity purified rabbit anti-mouse
anti-K14 antibody (courtesy of S. Randell) at 1:40 dilution (2.5pg/ml) at 4°C
overnight. Slides were washed in PBST for 30 minutes then incubated with the
secondary biotinylated swine anti-rabbit antibody (DAKO) at 1:400 for 30 minutes,
before washing with PBST.
Immunostaining was visualised by immunoperoxidase assay. Vectastain ABC
complex (Vector Laboratories Ltd) was prepared 30 minutes prior to use according
to manufacturer's instructions. ABC complex was added for 30 minutes, before
washing with PBST. The slides were then incubated with DAB substrate (Vector
Laboratories Ltd) for 10 minutes, and washed in running water. Slides were
counterstained with haematoxylin and mounted as described in section 7.8.2.
7.8.4 Microscopic analysis of tissue sections
Tissue sections were analysed for brightfield (using DIC optics) and fluorescence
using a Zeiss Axioplan II fluorescence microscope (Carl Zeiss Ltd., Welwyn Garden
City, UK) equipped with colour additive filters (Andover Corp, Salem, NH) for
sequential colour imaging and a Photometries CoolSnap HQ monochrome CCD
camera (Roper Scientific, Tucson, Arizona). Image capture was by scripts written for
IPLab Spectrum (Scanalytics Inc., Fairfax, VA) which controlled camera capture and




7.9 Analysis of mRNA expression
7.9.1 RNA extraction
Extraction of RNA was performed prior to expression analysis of various transcripts
by reverse transcription (RT)-PCR. During this procedure, extreme care was taken to
avoid contamination of samples with RNases. Filter pipette tips were used for all
RNA/cDNA work. All solutions were made with DEPC-dH20, separate reagents
reserved for RNA work only, and surfaces of benches and glassware treated with
RNaseZAP (Sigma) to inactivate RNases. DEPC-dH20 was made by adding lpl/ml
DEPC (Sigma) to dH20, followed by gentle mixing using a magnetic stirrer for 1-2
hours, and solutions were allowed to sit at room temperature in a fumehood
overnight prior to re-autoclaving. Reagents were kept on ice until required. RNA was
extracted as quickly as possible after obtaining samples in order to minimise the
degradation of crude RNA by limiting the activity of endogenous RNases.
Tissues (trachea, depilated back skin, lung, liver) were harvested into RNAlater
(Ambion) and stored at -20°C. Total RNA was extracted by homogenisation using a
rotor-stator homogeniser (Omni) fitted with disposable Omni-Tips (Fisher
Scientific). The homogenate was processed using an RNeasy Mini Kit (Qiagen),
using on-column DNase treatment (RNase-Free DNase Kit, Qiagen) and eluted in
Rnase-free dFI20. Eluates were further treated with amplification grade DNase I
(Sigma) according to the manufacturer's instructions. RNA samples were
electrophoresed for visual inspection ofRNA quality. The concentration of RNA was
determined by spectrophotometry as for DNA (section 7.1.3) but calculated as
follows:




Using a First Strand cDNA Synthesis Kit (Roche) with random primers, 1 ug of RNA
was reverse transcribed to cDNA according to the manufacturer's instructions.
Reactions were consistently performed in duplicate, with one set of reactions lacking
reverse transcriptase enzyme as a control to confirm the absence of contaminating
genomic DNA. Following the cDNA synthesis reaction, 2ul of sample was used in
PCRs as described in section 7.2.
Sequences of primers and amplification programmes used in RT-PCRs (Cre-specific
RT-PCRs used Cre-specific K5CE genotyping PCR primers at either 30 or 45 cycles
for skin or tracheal RNA, respectively) (5'-3'):
R26X MutS forward GATGAGCGTGGTGGTTATG
(Figure 5.11 (i)) MutAS reverse GTTACGCGTTCGCTCATC
Programme lx(95°C[5m])-30x(94oC[30s]55oC[30s;i72oC[lm)
GAPDH GAPDH forward TGGAGCCAAACGGGTCATCA
(Figure 2.15,2.19) GAPDH reverse GTGGCAGTGATGGCATGGAC
(Figure 5.11 (i)) Programme lX(94°C[3m]55°C[lm]72°C[lm])-29x(93oC[30s]55<>C[lm]72°C[lm])
7.10 Induced injury to tracheal epithelium
7.10.1 Preparation and administration of polidocanol
Poloxethylene-9-lauryl-ether (polidocanol, POL) (Sigma) was weighed out and
added to sterile PBS to make a 2% (w/v) solution. The mixture was heated at 37°C to
aid dissolution.
Mice were anaesthetised with an IP injection of anaesthetic at O.lml/lOg per mouse:
[0.75ml of Hypnorm (Fentanyl 0.315mg/ml / fluanisonelOmg/ml): 4.5ml water:
0.2ml Hypnovel (Midazolom 10mg/2ml)]. Mice were placed in a tracheal instillation
frame as described by Ho and Furst (Ho and Furst, 1973), shown in Figure 3.4. The
anaesthetised mouse was placed with its upper teeth hooked over a wire at the top of
the support frame, with a spring pushing the thorax forward to position the pharynx,
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larynx and trachea in a vertical straight line. The lower jaw was held open with a
loop of thread around the lower teeth and weighted. The airway was illuminated
using a fibre optic lamp placed against the mid sternum. The tongue was moved to
one side and, using a cut-off microloader pipette tip (Eppendorf), 10pi of POL or
PBS alone was slowly instilled into the proximal region of the trachea. The animal
was maintained in an upright position for 1 minute following instillation to allow the
solution to spread down the trachea. Following subsequent administration of
tamoxifen or oil control (section 7.1.11.2), analgesia was administered (O.lml/lOg
per mouse) by IP injection of [10pl of Vetergesic (Buprenorphine 0.3mg/ml): 990pl
dH20]. Animals were allowed to recover in a warmed post-operative cage with solid
drink pouches (BS&S).
7.11 Ligand-inducible Cre recombinase activity
7.11.1 Preparation and administration of tamoxifen
Tamoxifen (TAM) (free base form) was obtained from Sigma and ICN Biomedicals.
7.11.1.1 Ear-painting assay
For delivering 50pi volumes of 5mg and lOmg TAM solution to mouse pinna,
lOOmg/ml and 200mg/ml solutions of TAM in dimethyl sulphoxide (DMSO),
respectively, were prepared. TAM has a limited solubility in DMSO and formed a
suspension after vortexing. The suspensions were stored, protected from light, in
aliquots at -80°C. Prior to use, suspensions were agitated in a sonicating water bath,
protected from light, for 15 minutes.
TAM was administered by dispensing the 50pi aliquot onto the dorsal surface of
pinna of an animal restrained by Transgenic Facility staff. A cotton bud stripped of
most of the cotton to reduce absorbency, was used to spread the suspension over both
inner and outer surfaces of the pinna. Animals received 50pl of lOOmg/ml and
255
Materials and Methods
200mg/ml solution to respective pinna, corresponding to 5mg and lOmg TAM.
Control animals received 50pi DMSO alone to each pinna. The protocol was
repeated each day for 5 days, with ear-clip biopsies taken for xgal staining on day 6.
7.1.11.2 Systemic administration
For systemic delivery, 60mg TAM was added to 600pl 100% analytical grade
ethanol (BDH) and vortexed briefly, though complete dissolution was not obtained.
5.4ml corn oil (Sigma) was added to make a lOmg/ml solution. The mixture, in a
15ml polyethylene tube (Corning), was placed in a beaker of ice and subjected to
repeated 5 minute sonications at high power using a sonicating probe (MSE).
Complete dissolution was usually achieved after 3-4x 5 minutes. This procedure was
repeated to produce fresh TAM solution for each day of injections.
4mg (400jal) of the solution, or the ethanol/oil mixture alone, was administered by IP
injection for 3 consecutive days following polidocanol treatment (section 7.10).
7.12 in vitro validation of R26X and R26Z constructs
7.12.1 G-418-mediated translational readthrough assay
A 12-well tissue culture plate (Corning) was seeded with COS-7 cells (Gluzman,
1981) at a density of 105 cells per well. COS-7 cells were grown in Dulbecco's
Modified Eagles Medium (DMEM) with 10% foetal calf serum, 2mM L-glutamine
and penicillin (10 units/ml) and streptomycin (lOug/ml) (all GibcoBRL). The LID
transfection reagent (Parkes et al, 2002), a kind gift of S. Hart, was prepared
previously by cyclising the P6 peptide by dissolving it to O.lmg/ml in OptiMEM
(GibcoBRL), pipetting the media into a conical flask, and leaving loosely covered at
4°C overnight. After filter sterilisation, the media was stored at -70°C or -20°C
depending on the duration of storage. When the cells had reached an appropriate
density, the transfection mixture was prepared: 1.5pl lmg/ml lipofectin (Gibco),
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80pl (8pg) of P6 peptide, and 2pg of pCMVR376X or pCMVP (positive control)
plasmid DNA were mixed per well, and allowed to complex at room temperature for
approximately 1 hour. The complex was diluted with OptiMEM to lpg plasmid
DNA per 1ml OptiMEM, and added to cells after the removal of supplemented
media. Cells were incubated with the transfection mixture for 4 hours, before
supplemented media was replaced, containing 0, 0.05, 0.1 or 0.2mg/ml G-418
sulphate (Geneticin, GibcoBRL). Normal supplemented media was replaced after
approximately 12 hours, and 48 hours later the cells were fixed in 2%
formaldehyde/0.2% glutaraldehyde at 4°C for 5 minutes and stained with xgal
overnight in a humidor at 37°C.
7.12.2 Evaluation of R26 promoter activity and inactivity of the
R376X lacZ sequence
COS-7, A549 (Lieber et al., 1976), HT1080 (Rasheed et al., 1974), and Huh7
(Health Science Research Resources Bank, Osaka, Japan; #JCRB0403) were grown
as for COS-7 (section 7.12.1), though HT1080 cells were supplemented with 1%
non-essential amino acids (Invitrogen). Cells were seeded at 2xl05 cells per well of a
6-well plate (Corning) and transfected with pR26X, pR26Z, or pCMVp by scaling-up
the LID transfection method described in section 7.12.1. After 48 hours, half of the
samples were fixed in 2% formaldehyde/0.2% glutaraldehyde at 4°C for 5 minutes
for xgal staining.
Duplicate transfections were fixed with 4% PFA for 30 minutes and viewed under
PBS by fluorescence microscopy using eGFP filters.
7.13 Statistical analysis
The data regarding the frequency of xgal stained cells in tracheas in the experiment
described in chapter 3 section 3.2.3 were analysed by standard analysis of variance
(ANOVA) methods using MINITAB Release 11 for Windows (1996, Minitab, Inc,
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State College, Pennsylvania). The main effects were "treatment" (POL or PBS),
"timepoint" (+3d, +7d, +20d), the "position" of stained cells within the trachea
(proximal or distal), and the variation in the individual "tracheas" themselves. The
outcome variables were total number of cells, total number of clusters, and average
number of cells per cluster. Preliminary analysis revealed that the variation between
individual tracheas was in all cases significantly greater than the residual variation
between replicates. Thus all further analyses were carried out on a simplified data
format, in which observations were averaged over the two replicates (per treatment,
timepoint, position, and tracheas).
7.14 Computational methods
All vector construction was simulated in silico using Clone Manager 6, version 6.00
(Science and Educational Software). This allowed the exact prediction of restriction
fragment and PCR product sizes shown throughout this thesis. The Emboss suite of
programs (download via http://www.hgmp.mrc.ac.uk/Software/EMBOSS) was also
used for general sequence manipulation.
The bioinformatics programmes and resources referred to in this thesis are listed








A1 Construction of transgenic lines K5A1 and K5CE
The DNA manipulations required to generate the transgenic lines K5A1 and K5CE
are described. The cloning scheme is summarised schematically in chapter 2, Figure
2.2.
A 1.1 Cloning the human K5 promoter into the promoter-less
plRES2-eGFP
The human K5 promoter was provided (courtesy of S. Randell) in plasmid
pK5LH14, where it was positioned upstream of the eGFP gene, from which it was
separated by a short intron. Sequence information for pK5LH14 or the K5 promoter
was not available. It was desirable to obtain sequence data for the K5 promoter in
order to predict restriction enzymes suitable for use in the subcloning of the
promoter. The NCBI LocusLink facility was used to find a genomic bacterial
artificial chromosome (BAC) clone (GenBank accession AC055736) corresponding
to the proposed K5 locus at chromosome 12ql2-13. The 150kb sequence was
analysed for restriction enzyme patterns resembling those known approximately for
pK5LH14. Using this method, approximate 5' and 3' regions of the promoter were
identified, and outward-facing sequencing primers were designed in anticipation that
respective sequencing reactions would encompass the 5' and 3' limits of the cloned
promoter fragment. The limits were identified by using the BLAST program to
compare the resulting sequence data against the BAC clone (data not shown). In both
cases, homology between the sequenced K5 promoter and the chromosome 12 clone
ended within the sequenced region, indicating the 5' and 3' junctions between the
promoter and flanking vector sequence. This revealed the K5 promoter fragment to
be 6213bps in length. The intervening and flanking (vector) sequences were used to
identify useful enzyme recognition sites for subsequent manipulations.
The 6.2kb K5 promoter was released from pK5LH14 by cutting 5' with Mlul before
liberating the fragment by cutting 3' with Aflll. The recipient vector, pfRES2-eGFP
(Clontech), was prepared by digestion with Asel and Bglll to release the CMV
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promoter. The incompatible Mlul-Asel and Aflll-Bglll ends were blunted with T4
DNA polymerase before the K5 promoter insert was ligated into the vacated position.
Transformed clones containing correctly-oriented inserts were identified by colony
hybridisation using an oligonucleotide probe designed to recognise sequence
corresponding to the filled-in and ligated Mlul and Asel sites, and flanking bases
(Figure Al.la,b). These clones were further verified by diagnostic restriction digests
(Figure Al.lc,d).
A1.2 Incorporating the pCI intron from pK5LH14
Immediately downstream of the K5 promoter in pK5LH14 was a chimaeric (human
[3-globin/immunoglobulin) intron from the pCI expression vector (Promega). Since
the promoter-intron combination appeared to work well in lines derived from
pK5LH14 ((Schoch et al., 2003) and S. Randell, personal communication), it was
desirable to maintain this configuration. The distribution of restriction enzyme sites
in pK5LH14 did not permit subcloning of the entire K5 promoter-intron fragment in
one step, necessitating the subsequent subcloning of the intron. The relatively short
length of the intron meant that PCR-cloning was the most convenient strategy
(Figure A1.2a,b), which also allowed suitable enzyme recognition sequences to be
incorporated into the primer tails. Primers were designed from sequence information
generated during the prior sequencing of the 3' of the K5 promoter, with the limits of
the intron corresponding to Aflll sites known to exist within pK5LH14. Xhol and
Sail sites were included in the 5' and 3' primers, respectively, and the digested PCR
fragment was cloned into the Sail site 3' of the K5 promoter in pK5-eGFP.
Transformed clones containing the insert were identified by colony hybridisation
with the 3' pCI intron PCR primer oligonucleotide ("pCI-as"), and three correctly-
oriented inserts were identified by PCR using the 3' K5 promoter sequencing primer
("3'K5") and the 3' pCI intron PCR primer (Figure A1.2a,b). A subtle difference in
size between PCR products generated from clones 2 and 3 was reflected in a BamHI
diagnostic digest (the digest also revealed clone 7 to be aberrant, Figure A1.2d).
Sequencing the intron, which confirmed no errors had been induced by PCR, also
revealed that while clone 3 had been ligated as anticipated, clone 2 had undergone a
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recombination event at the 5' ligation site between flanking sequence duplicated in
the PCR product, reconstituting precisely the sequence present at the junction of the
K5 promoter and the pCI intron in pK5LH14 (Figure A1.2c). An Aflll digest
confirmed the presence of the intron, detectable as an 197bp fragment (Figure
A1.2c,d). Thus, clone 2 was used in subsequent cloning steps.
A1.3 Cloning lacZ to generate pK5A1
To prepare the pK5CI-eGFP plasmid to receive the lacZ gene, SacII was used to cut
3' of the pCI intron, then blunted using T4 DNA polymerase. Sail was then used to
cut lObp 5' of the blunted SacII site. lacZ was excised from plasmid pPB2 (courtesy
of P. Budd) using Sail to cut 5' and Dral to cut at the 3' of the gene. Dral cut
upstream of the lacZ polyadenylation signal, which if included in the subcloning
would have reduced or prevented transcription proceeding into the downstream
JRES-eGFP cistron. The Sall-Dral fragment was ligated into the Sall-SacII(blunt)
interval in pK5CI-eGFP to create pK5Al (Figure A1.3a). Transformed clones
containing the insert were identified by colony hybridisation with a lacZ-specific
oligonucleotide. A sequencing reaction originating in the 5' of the IRES verified the
3' integrity of the lacZ insert (data not shown), and diagnostic digests were used to
detect successful cloning events (Figure A1.3b).
A1.4 Cloning CreER72 into pK5-eGFP to create pK5CE
The CreER72 fusion gene (courtesy of P. Chambon) was subcloned, along with the
rabbit (3-globin intron II, downstream of the human K5 promoter in pK5-eGFP. The
donor plasmid was first digested with NotI to remove a 2.86kb fragment that would
otherwise have been co-purified with the desired 2.89kb Sall-NotI fragment, which
was subsequently isolated after blunting the NotI end. The recipient pK5-eGFP
vector was prepared using SacII, which was blunted using Mung Bean Nuclease,
before cutting 5' with Sail and ligating with the intron-CreER72 insert (Figure A1.4a)
to create pK5CE. Diagnostic digests (Figure A1,4b) and sequencing (data not shown)
of the 3' of the insert identified an intact clone.
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Figure A1.1 Cloning the K5 promoter into the promoter-less plRES2-eGFP vector.
(a) plRES2-eGFP was digested with Asel + Bglll to remove the CMV promoter, and the cohesive ends
were blunted to make them compatible with the blunted Mlul and Aflll sites used to release the K5
promoter from pK5LH14 (top). Correctly-oriented clones were identified by hybrisidisation to a radiolabeled
22mer bridging oligonucleotide containing sequence complementary to the ligated, blunted Asel and
Mlul sites (bottom), (b) Autoradiograph showing hybridising colony streaks resulting only from ligations
involving dephosphorylated receipient vector blunt ends. In ligations performed without dephosphorylation,
reannealing of vector blunt ends prevented insertion of the promoter fragment, (c) Map of cloned K5
promoter showing restriction sites used in diagnostic digests, including predicted fragment sizes, (d)
Diagnostic digest of two clones which show restriction patterns predicted of successful cloning. Donor
cloning sites are highlighted in green. Although both sites were blunted, both were reconstituted after
blunt-end ligation. M = 1kb ladder. Map not to scale, fragment sizes in bps. Bracketed fragment sizes
indicate proportion of total fragment size.
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Figure A1.2 Cloning the pCI intron into pK5-eGFP.
(a) The pCI intron was amplifed by PCR from pK5LH14 using primers pCI-s - pCI-as which included 5'
tails containing Xhol and Sail restriction sequences, respectively. The position of primer 3'K5 is shown.
(b) The product from four PCR reactions was pooled and the 272bp fragment gel purified (left), before
digestion with Xho + Sail. The pCI intron fragment was ligated into Xhol-cut pK5-eGFP. Once successful
clonings were selected by probing with radiolabelled pCI-as oligonucleotide, correctly-oriented clones
were identifed by PCR amplification using primers 3'K5 and pCI-as (right). Of eight pCI intron-containing
clones, three (2,3,7) were correctly oriented. pK5LH14 included as control, (c) Restriction fragments
predicted from diagnostic digests of a successful cloning, including predicted fragment sizes, (d) Diagnostic
digests of three correctly- (2,3,7) and one incorrectly- (8) oriented clones from (b). Only clones 2 and 3
gave the predicted pattern, though they showed variation in size of the predicted 1.1 kb fragment.
Sequencing revealed clone 3 to be exactly as predicted, corresponding to additional fragments in red in
(c), though 53bp fragment is too small to visualise in digests. Due to sequence duplication between pCI
intron 5' amplification primer and sequence flanking the 5' cloning site, a recombination event occurred
in clone 2, reconstituting the exact sequence from pK5LH14. Clone 2 does not contain the fragments in
red in (c). The size difference between clones 3 (715bp, as predicted) and 2 (669bp) is subtly discernible
in (b). The 197bp Aflll fragment is faint but present in both clones 2 and 3 (d). Cloning sites in green,
brackets indicate site was not reconstituted. M = 1kb ladder. Map not to scale, fragment sizes in bps.
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Figure A1.3 Cloning lacZ into pK5CI-eGFP.
(a) pK5CI-eGFP clone 2 (Figure A1.2) was prepared to receive lacZ (Sall-Dral fragment) by cutting with
Sacll 3' of the pCI intron, blunting the cohesive end, and cutting 10bp 5' with Sail. Restriction fragments
diagnostic of a successful cloning are shown, including predicted fragment sizes, (b) Two clones showing
restriction patterns predicted for a successful cloning in three different digests. The recipient pK5CI-eGFP
vector was included in the digests, and gave a pattern expected in the absence of the lacZ sequence
(the 1131 bp BamHI fragment was too small for inclusion on BamHI gel). Donor cloning sites in green,
brackets indicate site may not have been reconstituted. M = 1kb ladder. Map not to scale, fragment sizes
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Figure A1.4 Cloning the CreER72 fusion gene into pK5-eGFP.
(a) pK5-eGFP was prepared to receive CreERT2' including the 5' rabbit (3-globin intron II (p on map), by
cutting with Sacll 3' of the K5 promoter, blunting the cohesive end, and cutting 10bp 5' with Sail. The
intron-CreER72fragment was liberated from the donor vector using Notl 3' (subsequently blunted) and
Sail 5'. Restriction fragments diagnostic of a successful cloning are shown, including predicted fragment
sizes, (b) Two clones showing restriction patterns similar to those predicted for a successful cloning in
three different digests. However, only clone 2 exhibited the 173bp BamHI fragment which confirmed the
presence of the BamHI site in, and thus the integrity of, the 3' intron-CreER'2fragment. The sequence
difference between clones 1 and 2 was also detected by sequencing, and additional EcoRV, Hindlll, and
EcoRI + Notl digests confirmed the orientation of the intron-CreER72fragment and overall integrity of the
final pK5CE construct (not shown). The recipient pK5-eGFP vector was included in the digests, and gave
patterns expect in the absence of the intron-CreERT2fragment sequence. Donor cloning sites in green,
brackets indicate site may not have been reconstituted. M = 1kb ladder. Map not to scale, fragment sizes





A2 Construction of transgenic line R26X
The DNA manipulations required to generate the transgenic mutated reporter line
R26X are described. The cloning scheme is summarised schematically in chapter 5,
Figure 5.2. The non-mutated control line R26Z was produced identically and in
parallel, omitting the initial mutagenesis step.
A2.1 Exchanging the CMV promoter for the R26 promoter
The R26 promoter, provided in pBluescript (Stratagene), was sequenced using T3
and T7 primers to obtain 5' sequence to complement the available 524bp of 3'
sequence (GenBank accession U83173). The composite sequence was subsequently
confirmed using the BLAST program to align the 3' portion against the Ensembl
mouse genome assembly.
The CMV promoter fragment was removed from pCMVP by cutting at the 3' Xhol
site, filling in the cohesive ends using T4 DNA polymerase, before cutting 5' with
EcoRI. The 822bp R26 promoter fragment was ligated into the open vector following
its liberation from pBluescript using BamHI to cut 3', which was filled in for ligation
with the previously blunted Xhol site, before cutting 5' with EcoRI (Figure A2.1a).
Diagnostic digests were as predicted for the correct construct (Figure A2.1b).
A2.2 Addition of IRES-eGFP to make a bicistronic construct
An IRES-eGFP component was incorporated into the construct by cloning the
fragment containing the R26 promoter and R376X lacZ gene into pIRES2-eGFP
(Clontech). pIRES2-eGFP was first prepared by removing the CMV promoter
through a double digestion with Asel and Bglll which cut 5' and 3' of the promoter,
respectively. The cut ends were made blunt and ligated to re-circularise the plasmid
(Figure A2.2(i)a). A double EcoRI/NotI digest gave a pattern of fragments consistent
with loss of the promoter fragment. Digestion with SnaBI, which cut pIRES2-eGFP
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uniquely within the CMV promoter, was shown to linearise the parental vector.
Plasmids which had re-circularised after excision of the Asel-Bglll CMV promoter
fragment remained uncut (Figure A2.2(i)b).
The DNA fragment containing the R26 promoter and R376X lacZ gene was released
from vector sequences by cutting initially with EcoRl 5' of the R26 promoter, then
digesting with Sacll 5' of the SV40 polyadenylation signal. An additional Sacll site
existed within the 5' region of lacZ, necessitating the use of a controlled partial
digest (Figure A2.2(i)c). A Sacll digest of pR26R376X was monitored to determine
the incubation time at which the optimal proportion of the desired partial digest
product was present (Figure A2.2(i)d). The 4.5kb EcoRI-SaclI fragment containing
the R26 promoter and R376X lacZ gene was gel purified from the four remaining
products and ligated into the promoter-less pIRES2-eGFPnp after cutting the vector
at the EcoRI and Sacll polylinker sites (Figure A2.2(ii)a). A diagnostic Notl digest
(supported by a linearising Sail reaction, not shown) was used to select successfully
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Figure A2.1 Cloning the R26 promoter into pCMVp following the removal of the CMV promoter.
(a) The R26 promoter fragment was subcloned using EcoRI (5') and blunted BamHI/Xhol sites (3') into
pCMVp, following removal of the CMV promoter. Restriction sites used in diagnostic digests are shown,
along with predicted fragment sizes, (b) Diagnostic digests of two clones which show fragments predicted
for the correct construct, plus parental pCMVp vector. 639bp fragment predicted in EcoRI + Xhol digestion
of pCMVp is too weak to visualise. Cloning sites are highlighted in green (digests reveal reconstitution
of Xhol site after ligation of blunted Xhol site to blunted BamHI site). M = 1kb ladder. Map not to scale,



































EcoRI + Sacll partial fragments
Figure A2.2(i) Addition of an IRES-eGFP component.
(a,b) Re-circularisation of plRES2-eGFP after removal of the CMV promoter, (a) 602bp Asel-Bglll fragment
containing the CMV promoter was removed and the vector backbone re-ligated. Restriction sites used
in diagnostic digests are shown, along with predicted fragment sizes, (b) Diagnostic digests of two clones
which showed fragments predicted for the successful removal of the promoter, plus the parental plRES2-
eGFP. SnaBI, unique to the CMV promoter, cuts plRES2-eGFP (evident as loss of supercoiling) but not
clones 1 and 2. (c,d) Liberation of the R26-/acZ component, (c) After incubation with EcoRI, a Sacll time-
course was conducted to determine the digest duration which yielded the optimal proportion of the desired
4 5kb EcoRI-Sacll fragment. The relevant restriction sites are shown, along with predicted complete and
partial digest fragment sizes, (d) Sacll time-course showing changing ratios of five EcoRI-EcoRI, Sacll-
Sacll and EcoRI-Sacll fragments (" = seconds,' = minutes). A 40 second Sacll incubation was used in



















Figure A2.2(ii) Addition of an IRES-eGFP component.
Following re-circularisation of the promoter-less plRES2-eGFPnp, the vector was re-cut with EcoRI +
Sacll to receive the R26-/acZ fragment, (a) The final pR26X construct. Restriction sites used in diagnostic
digests are shown, along with predicted fragment sizes, (b) Diagnostic digest of four clones: clones 2
and 4 show the predicted pattern of four fragments (the larger fragments visible as a doublet), while
clones 1 and 3 give the same pattern as the plRES2-eGFPnp backbone. Cloning sites are highlighted
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